
<html lang="en"     class="pb-page"  data-request-id="9c45da17-b71b-4c9b-b58a-158503cefa15"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-14;article:article:10.1021/acs.jmedchem.5b00742"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate" /></meta><meta name="dc.Creator" content="Michael A.  Letavic" /></meta><meta name="dc.Creator" content="Pascal  Bonaventure" /></meta><meta name="dc.Creator" content="Nicholas I.  Carruthers" /></meta><meta name="dc.Creator" content="Christine  Dugovic" /></meta><meta name="dc.Creator" content="Tatiana  Koudriakova" /></meta><meta name="dc.Creator" content="Brian  Lord" /></meta><meta name="dc.Creator" content="Timothy W.  Lovenberg" /></meta><meta name="dc.Creator" content="Kiev S.  Ly" /></meta><meta name="dc.Creator" content="Neelakandha S.  Mani" /></meta><meta name="dc.Creator" content="Diane  Nepomuceno" /></meta><meta name="dc.Creator" content="Daniel J.  Pippel" /></meta><meta name="dc.Creator" content="Michele  Rizzolio" /></meta><meta name="dc.Creator" content="Jonathan E.  Shelton" /></meta><meta name="dc.Creator" content="Chandra R.  Shah" /></meta><meta name="dc.Creator" content="Brock T.  Shireman" /></meta><meta name="dc.Creator" content="Lana K.  Young" /></meta><meta name="dc.Creator" content="Sujin  Yun" /></meta><meta name="dc.Description" content="The preclinical characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described. Optimization of physicochemical and DMPK properties led to..." /></meta><meta name="Description" content="The preclinical characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described. Optimization of physicochemical and DMPK properties led to..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 8, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00742" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00742" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00742" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00742" /></link>
        
    
    

<title>Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00742" /></meta><meta property="og:title" content="Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0008.jpeg" /></meta><meta property="og:description" content="The preclinical characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described. Optimization of physicochemical and DMPK properties led to the discovery of compounds with tissue distribution and duration of action suitable for evaluation in the treatment of primary insomnia. These selective orexin-2 antagonists are proven to promote sleep in rats, and this work ultimately led to the identification of a compound that progressed into human clinical trials for the treatment of primary insomnia. The synthesis, SAR, and optimization of the pharmacokinetic properties of this series of compounds as well as the identification of the clinical candidate, JNJ-42847922 (34), are described herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00742"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00742">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00742&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00742&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00742&amp;href=/doi/10.1021/acs.jmedchem.5b00742" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5620-5636</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00682" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00753" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Octahydropyrrolo[3,4-<i>c</i>]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Letavic">Michael A. Letavic</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Bonaventure">Pascal Bonaventure</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+I.++Carruthers">Nicholas I. Carruthers</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Dugovic">Christine Dugovic</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++Koudriakova">Tatiana Koudriakova</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Lord">Brian Lord</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+W.++Lovenberg">Timothy W. Lovenberg</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kiev+S.++Ly">Kiev S. Ly</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neelakandha+S.++Mani">Neelakandha S. Mani</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diane++Nepomuceno">Diane Nepomuceno</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Pippel">Daniel J. Pippel</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele++Rizzolio">Michele Rizzolio</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+E.++Shelton">Jonathan E. Shelton</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chandra+R.++Shah">Chandra R. Shah</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brock+T.++Shireman">Brock T. Shireman</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lana+K.++Young">Lana K. Young</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sujin++Yun">Sujin Yun</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Janssen Pharmaceutical Research & Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3d505158495c4b545e7d54494e13575357135e5250"><span class="__cf_email__" data-cfemail="1d707178697c6b747e5d74696e33777377337e7270">[emailÂ protected]</span></a>. Tel: 1-858-450-2302.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00742&amp;href=/doi/10.1021%2Facs.jmedchem.5b00742" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5620â5636</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 18, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 May 2015</li><li><span class="item_label"><b>Published</b> online</span>8 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00742" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00742</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5620%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BA.%2BLetavic%252C%2BPascal%2BBonaventure%252C%2BNicholas%2BI.%2BCarruthers%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D14%26contentID%3Dacs.jmedchem.5b00742%26title%3DNovel%2BOctahydropyrrolo%255B3%252C4-c%255Dpyrroles%2BAre%2BSelective%2BOrexin-2%2BAntagonists%253A%2BSAR%2BLeading%2Bto%2Ba%2BClinical%2BCandidate%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5636%26publicationDate%3DJuly%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00742"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2103</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00742" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Letavic&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Bonaventure&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;I. Carruthers&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Dugovic&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;Koudriakova&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Lord&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;W. Lovenberg&quot;},{&quot;first_name&quot;:&quot;Kiev&quot;,&quot;last_name&quot;:&quot;S. Ly&quot;},{&quot;first_name&quot;:&quot;Neelakandha&quot;,&quot;last_name&quot;:&quot;S. Mani&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;Nepomuceno&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Pippel&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;Rizzolio&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;E. Shelton&quot;},{&quot;first_name&quot;:&quot;Chandra&quot;,&quot;last_name&quot;:&quot;R. Shah&quot;},{&quot;first_name&quot;:&quot;Brock&quot;,&quot;last_name&quot;:&quot;T. Shireman&quot;},{&quot;first_name&quot;:&quot;Lana&quot;,&quot;last_name&quot;:&quot;K. Young&quot;},{&quot;first_name&quot;:&quot;Sujin&quot;,&quot;last_name&quot;:&quot;Yun&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;5620-5636&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00742&quot;},&quot;abstract&quot;:&quot;The preclinical characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described. Optimization of physicochemical and DMPK properties led to the discovery of compounds with tissue distribution and duration of action suitable for evaluation in the treatment of primary insomnia. These selective orexin-2 antagonists are proven to promote sleep in rats, and this work ultimately led to the identification of a compound that progressed into human clinical trials for the treatment of primary insomnia. The synthesis, SAR, and optimization of the pharmacokinetic properties of this series of compounds as well as the identification of the clinical candidate, JNJ-42847922 (34), are described herein.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00742&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00742" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00742&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00742" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00742&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00742" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00742&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00742&amp;href=/doi/10.1021/acs.jmedchem.5b00742" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00742" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00742" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (990 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00742%26sid%3Dliteratum%253Aachs%26pmid%3D26087021%26genre%3Darticle%26aulast%3DLetavic%26date%3D2015%26atitle%3DNovel%2BOctahydropyrrolo%255B3%252C4-c%255Dpyrroles%2BAre%2BSelective%2BOrexin-2%2BAntagonists%253A%2BSAR%2BLeading%2Bto%2Ba%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D14%26spage%3D5620%26epage%3D5636%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291553" title="Granular materials">Granular materials</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jmcmar.2015.58.issue-14/20150723/jmcmar.2015.58.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The preclinical characterization of novel octahydropyrrolo[3,4-<i>c</i>]pyrroles that are potent and selective orexin-2 antagonists is described. Optimization of physicochemical and DMPK properties led to the discovery of compounds with tissue distribution and duration of action suitable for evaluation in the treatment of primary insomnia. These selective orexin-2 antagonists are proven to promote sleep in rats, and this work ultimately led to the identification of a compound that progressed into human clinical trials for the treatment of primary insomnia. The synthesis, SAR, and optimization of the pharmacokinetic properties of this series of compounds as well as the identification of the clinical candidate, JNJ-42847922 (<b>34</b>), are described herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Orexin-A and -B are excitatory neuropeptides that originate in orexinergic neurons situated in the hypothalamus and play important roles in the regulation of sleep/wake cycles, circadian rhythms, energy metabolism, reward-directed behavior, anxious arousal, and stress responses via a relatively discrete network of neuroanatomical projections.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The orexin (OX) neuropeptides mediate their effect by stimulating two distinct G-protein coupled receptors, orexin-1 (OX1R) and orexin-2 (OX2R) that are colocated or selectively located in specific brain areas suggesting differentiated roles. The salient narcoleptic phenotype of prepro orexin knockout mice<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and the altered orexin signaling in human narcoleptic patients<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> provided both genetic and clinical evidence of the key role of this system for the maintenance of wakefulness. These data prompted numerous drug discovery efforts that have recently been disclosed with the goal of understanding how the orexin system functions and whether modulation of this function could produce therapeutic benefit. These research efforts led to the development of several dual OX1/2 receptor antagonists<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> including almorexant<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (<b>1</b>) and MK-4305<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (<b>2</b>, suvorexant) (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), and both of these compounds progressed into human clinical trials and have been shown to promote sleep in humans. Recently, the U.S. Food and Drug Administration approved Belsomra (<b>2</b>, suvorexant) for the treatment of primary insomnia.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Dual OX1R/OX2R Clinical Candidates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Objectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our efforts in this area have focused on the discovery and development of selective<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> orexin-2 antagonists following our observation, using the selective OX2R antagonist JNJ-10397049 (<b>3</b>), that blockade of the OX2R alone is sufficient to initiate and prolong sleep in rodents.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In additional rat sleep studies, we also demonstrated that pharmacological blockade of the OX1R in the presence of an OX2R antagonist elicited a dysregulation of REM sleep by shifting the balance in favor of REM sleep at the expense of NREM sleep.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> While several OX1R antagonists have been reported to minimally affect spontaneous sleepâwake states,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> controversial data have been found in one study with SB-334867;<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> however, SB-334867 is also known to exhibit off target activities.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As such, we were most interested in identifying novel, selective OX2R antagonists that were suitable for clinical development, and a part of these efforts are now detailed in this report.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Lead Compounds Used To Identify Selective OX2R Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>), and similar compounds, provided potential starting points for the optimization of selective OX2R antagonists; however, we quickly found that the 2,2-dimethyl-1,3-dioxane moiety present in compound <b>3</b> appeared to be essential for activity and, not surprisingly, was also the primary reason for poor oral absorption observed in this series because of the acid labile cyclic ketal.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> So while compound <b>3</b> was a very useful compound to characterize a selective OX2R antagonist in preclinical models of sleep, optimization of this chemotype for oral dosing seemed challenging. The high-level goals of the project at this time were to discover novel, selective OX2R antagonists that were orally bioavailable and safe with an optimal pharmacokinetic profile for the treatment of primary insomnia (quick absorption and short half-life). As such, a high-throughput screening campaign was conducted which, among other chemotypes, identified molecules containing the diazepane core as shown in <b>4</b> (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>). Subsequent to our screening campaign this commercially available compound was also reported as a lead by a team at Merck.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Since that time, several compounds have also been reported in the literature as selective OX2R antagonists, including the arylamides MK-1064<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and MK-3697 (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. MK-1064 and MK-3697</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, a number of piperidines and azepanes have been disclosed as selective OX2R antagonists with sleep promoting properties in preclinical studies.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These include <b>5</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and <b>6</b> (Chart <a class="ref internalNav" href="#cht4" aria-label="4">4</a>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> both of which were recently reported by Merck. Compound <b>5</b> is orally active in rat sleep models, and <b>6</b> has been shown to be orally efficacious in mouse sleep models.</div><figure id="cht4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 4. Compounds <b>5</b> and <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As part of Janssenâs efforts to follow up on compound <b>4</b>, we decided to investigate the OX2R SAR and selectivity of compounds with novel core structures in addition to other diamines including a variety of 3,8-diazabicyclo[4.2.0]octanes, 3,6-diazabicyclo[3.2.0]heptanes,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and octahydropyrrolo[3,4-<i>c</i>]pyrroles.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This manuscript will focus on optimization of the octahydropyrrolo[3,4-<i>c</i>]pyrroles.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to rapidly prepare a variety of analogs, the compounds were initially prepared by one of the general methods shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. As such, first 2-benzyloctahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>7</b>) was converted to hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic acid <i>tert</i>-butyl ester (<b>8</b>) by installation of the Boc group followed by hydrogenation. This sequence was then followed either by addition of the heterocycle, deprotection of the Boc group, and coupling with a benzoic acid or by coupling with a benzoic acid, deprotection of the Boc group, and addition of a heterocycle.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>11</b>â<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DCM; (b) 10% Pd/C, HOAc, 70 psi H<sub>2</sub>, MeOH; (c) various benzoic acids, HATU (or similar), diisopropylethylamine, DMF; (d) DCM, TFA,; (e) various 2-chloroheterocycles, cesium carbonate, DMF.</p></p></figure><div class="NLM_p">In cases where the benzoic acid or 2-chloroheterocycle was not commercially available, these intermediates were prepared by known methods. All the details of the syntheses of compounds <b>11</b>â<b>40</b> are located in the <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p">One of the initial compounds prepared in this series was compound <b>11</b>, which is a rather weak OX2R antagonist (OX2R <i>K</i><sub>i</sub> = 1600 nM).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Iterative SAR led to some improvements in affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and most importantly yielded compounds with modest selectivity over OX1R (compound <b>15</b>, OX2R <i>K</i><sub>i</sub> = 746 nM, OX1R <i>K</i><sub>i</sub> = 10â¯000 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Data for the Human OX2 and OX1 Receptor for Compounds <b>11</b>â<b>15</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0003.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">OX2R <i>K</i><sub>i</sub>Â (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">OX1R <i>K</i><sub>i</sub>Â (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">6-MeO-</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">2200Â Â±Â 870</td><td class="colsep0 rowsep0" align="left">6850<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4-MeO-</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">510Â Â±Â 120</td><td class="colsep0 rowsep0" align="left">5300<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">4-MeO-</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">680Â Â±Â 200</td><td class="colsep0 rowsep0" align="left">>10000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">4-MeO-</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">875Â Â±Â 84</td><td class="colsep0 rowsep0" align="left">>10000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4-MeO-</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">746Â Â±Â 388</td><td class="colsep0 rowsep0" align="left">>10000<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values are the mean of at least three experiments in triplicate unless otherwise stated.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>n</i> = 2 (in triplicate).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last"><i>n</i> = 3 (in triplicate). <i>K</i><sub>i</sub> Â± sd is reported.</p></div></div></div><div class="NLM_p">This initial promising SAR prompted further modifications of both the amide functionality and the benzothiazole group and produced the compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The 2-phenyl and 2-thiophene substituted benzamides <b>17</b>â<b>20</b> were also promising leads with slight improvements in OX2R affinity. However, selectivity was modest at best, but when the 2-thiophene moiety was combined with a quinoxaline (<b>23</b>) or a 4,6-dimethylpyrimidine (<b>24</b>), relatively high affinity OXR2 receptor antagonists were obtained and, at least in the case of <b>24</b>, good selectivity over OX1R was also observed (â¼50-fold).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Data for the Human OX2 and OX1 Receptor for Compounds <b>16</b>â<b>24</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0004.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0005.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are the mean of at least three experiments in triplicate unless otherwise stated.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last"><i>n</i> = 2 (in triplicate).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last"><i>n</i> = 3 (in triplicate). <i>K</i><sub>i</sub> Â± sd is reported.</p></div></div><div></div></div><div class="NLM_p">Unfortunately, compound <b>24</b> suffered from poor in vitro microsomal stability (extraction ratio in rat and human microsomes is >0.92 and >0.95, respectively). Given that the physicochemical properties of the compound are not ideal (MW = 404.5, cLogP = 3.69), these data were not too surprising. Nevertheless, this structure provided a viable lead for the series, and therefore, it was further profiled in vitro prior to in vivo evaluation to benchmark the series. Compound <b>24</b> is devoid of hERG affinity (IC<sub>50</sub> â¥ 10 Î¼M), is a high affinity rat OX2R ligand (<i>K</i><sub>i</sub> = 9.8 nM), and when tested in a commercial panel of 50 ion channel, receptor, and transporter assays (Eurofins-CEREP, <a href="http://www.eurofins.com/" class="extLink">http://www.eurofins.com/</a>) had no significant binding affinity (<50% at 1 Î¼M) for any of these targets. In a preliminary ex vivo autoradiography experiment in rat at 10 mg/kg po, compound <b>24</b> achieved only 26% OX2R receptor occupancy, likely because of poor exposure.</div><div class="NLM_p">Consequently, it was hypothesized that further modifications of the benzamide may help reduce metabolism by improving physicochemical properties and possibly by blocking metabolic pathways. The next set of compounds that was prepared maintained the pyrimidine moiety for selectivity purposes and modified the amide with the goal of further improving affinity and selectivity and, most importantly, to generate compounds with improved oral exposure.</div><div class="NLM_p">Some initial efforts are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. As indicated, the pyrimidines generally have good selectivity over OX1R regardless of the amide moiety, and it appears that 2-heteroaryl substituted benzamide <b>30</b> is the highest affinity OX2R ligand of the compounds in this group. This is fortunate, as the 2-triazolobenzamide utilized to prepare <b>30</b> is also the most polar benzamide in the set.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Data for the Human OX2 and OX1 Receptor for Compounds <b>25</b>â<b>30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0006.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are the mean of at least three experiments in triplicate.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last"><i>n</i> = 3 (in triplicate). <i>K</i><sub>i</sub> Â± sd is reported.</p></div></div><div></div></div><div class="NLM_p">Indeed, compound <b>30</b> (MW = 389.5, cLogP = 2.44) has slightly better calculated physicochemical properties than <b>24</b> and is also marginally superior in the in vitro microsomal stability assay (extraction ratio in rat and human of 0.87 and 0.79, respectively. After confirmation of the rat OX2R affinity (<i>K</i><sub>i</sub> = 7 nM), this compound was dosed 30 mg/kg po in a rat and exhibited good receptor occupancy (67% occupancy at 30 min).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> However, a subsequent rat PK experiment demonstrated that further PK improvements were still needed (<i>F</i> = 8%, CL = 52.1 mL min<sup>â1</sup> kg<sup>â1</sup>, iv <i>t</i><sub>1/2</sub> = 0.27 h, po <i>C</i><sub>max</sub> = 148 ng/mL dosed at 10 mg/kg po and 1 mg/kg iv). In order to address these issues, additional 2-substituted benzamides were prepared and tested with the goal of making additional improvements to the PK properties of these compounds, for example, by blocking or reducing metabolism by introducing fluorine substituents in various positions.</div><div class="NLM_p">These data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. First, focusing on the 2-substituted triazoles <b>31</b>â<b>34</b>, the addition of a fluorine atom is tolerated in positions 3â6 and all the compounds that were prepared in this set have good OX2R selectivity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Data for the Human OX2 and OX1 Receptor for Compounds <b>31</b>â<b>40</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0007.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are the mean of at least three experiments in triplicate. <i>K</i><sub>i</sub> Â± sd is reported.</p></div></div><div></div></div><div class="NLM_p">The 1,2,4-triazole <b>35</b> is also a high affinity OX2R ligand. Several other substituted triazolobenzamides were also prepared, including the methyl substituted compounds <b>36</b>â<b>39</b>, and all are also high affinity OX2R ligands except for the 6-methyl substituted compound <b>38</b>, which unexpectedly exhibits modest affinity for OX1R as well.</div><div class="NLM_p">Selected compounds were evaluated for microsomal stability, hERG binding, functional human OX2R activity (<i>K</i><sub>b</sub>), and rat OX2R binding affinity in order to determine whether they would be suitable candidates for in vivo characterization. These data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The compounds have relatively high extraction ratios, low hERG binding, good functional activity, and adequate rat affinity, and it became clear at this point that these structures would require differentiation in vivo.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Select in Vitro Data for Compounds <b>24</b>, <b>30</b>â<b>40</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">RLM stability<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM stability<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hERG (Î¼M)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">h<i>K</i><sub>b</sub> (nM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">r<i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">RO (%)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">>0.92</td><td class="colsep0 rowsep0" align="char" char=".">>0.95</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">26<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">67<a class="ref internalNav" href="#t5fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">2.9Â Â±Â 1.6</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 2</td><td class="colsep0 rowsep0" align="left">49<a class="ref internalNav" href="#t5fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">5.3Â Â±Â 1.3</td><td class="colsep0 rowsep0" align="left">14Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">72<a class="ref internalNav" href="#t5fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">32Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.6Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="left">10.0Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="left">71<a class="ref internalNav" href="#t5fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">11Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">0<a class="ref internalNav" href="#t5fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">0.76</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="left">8.1</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="char" char=".">>0.92</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">nt</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Stability in rat liver microsomes. Data reported as extraction ratio.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Stability in human liver microsomes. Data reported as extraction ratio. Extraction ratios are calculated as in vitro CL/<i>Q</i> where <i>Q</i> is species specific hepatic blood flow.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">hERG IC<sub>50</sub> as measured in an [<sup>3</sup>H]astemizole competition binding assay in HEK-293 cells expressing the hERG channel.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Human OX2R <i>K</i><sub>b</sub>. Data are the result of a single experiment or the average of two experiments in triplicate except where Â±sd is reported (<i>n</i> = 3).</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Rat OX2R <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Data shown are % occupancy at the times and doses specified.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">At 30 min after a 10 mg/kg po dose.</p></div><div class="footnote" id="t5fn8"><sup>h</sup><p class="last">At 30 min after a 30 mg/kg po dose.</p></div><div class="footnote" id="t5fn9"><sup>i</sup><p class="last">At 15 min after a 30 mg/kg po dose.</p></div></div></div><div class="NLM_p">The results of a screening receptor occupancy assay are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. In this assay, compounds are dosed orally at the dose noted and OX2R occupancy is measured in an ex vivo autoradiography experiment<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with the intention of choosing compounds with high levels of OX2R occupancy for further evaluation. The results of these experiments prompted additional in vivo studies on compounds <b>30</b>â<b>32</b> and <b>34</b>, and they were selected for rat PK experiments. Compound <b>35</b> was included, in spite of poor receptor occupancy, because of the low rat liver microsome extraction ratio (0.51). The pharmacokinetic data generated are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat Pharmacokinetic Parameters for Compounds <b>30</b>â<b>32</b>, <b>34</b>, and <b>35</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">52.1</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">57.0</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">65.5</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">40.0</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">149.6</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Clearance.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">The iv half-life.</p></div></div></div><div class="NLM_p">Compounds <b>30</b>â<b>32</b> and <b>34</b> had rat PK consistent with the microsomal data collected earlier (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), and all had relatively high clearance, moderate volumes of distribution, and short iv half-lives. Compound <b>35</b> has very high clearance which was not predicted by the rat microsomal extraction ratio. The key structural difference is the 1,2,4-triazole present in <b>35</b>, which might be a potential reason for its significantly different behavior. Compounds <b>31</b>, <b>32</b>, and <b>34</b> had acceptable bioavailability, and based on the screening receptor occupancy data, these compounds were progressed for further profiling.</div><div class="NLM_p">Additional in vitro profiling data for compounds <b>31</b>, <b>32</b>, and <b>34</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. The compounds are all permeable with a low propensity for efflux as measured by a Caco-2 assay. All three compounds have relatively high free fractions as measured by protein binding in rat and human, and the two that were tested exhibit a high free fraction in rat brain tissue. In a Cerep assay (a commercial panel of 50 ion channel, receptor, and transporter assays (Eurofins-CEREP, <a href="http://www.eurofins.com/" class="extLink">http://www.eurofins.com/</a>) compounds <b>31</b>, <b>32</b>, and <b>34</b> had a <50% effect at 1 Î¼M and <b>34</b> also had a <50% effect at 10 Î¼M for all of the targets tested.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Secondary Profiling for <b>31</b>, <b>32</b>, and <b>34</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center">compd</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>31</b></th><th class="colsep0 rowsep0" align="center"><b>32</b></th><th class="colsep0 rowsep0" align="center"><b>34</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">407.45</td><td class="colsep0 rowsep0" align="left">407.45</td><td class="colsep0 rowsep0" align="left">407.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2Â AÂ toÂ B<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">62.3</td><td class="colsep0 rowsep0" align="left">58.1</td><td class="colsep0 rowsep0" align="left">64.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2Â BÂ toÂ A<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">49.7</td><td class="colsep0 rowsep0" align="left">26.8</td><td class="colsep0 rowsep0" align="left">24.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ppb (human)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (%)</td><td class="colsep0 rowsep0" align="left">90.5</td><td class="colsep0 rowsep0" align="left">92.5</td><td class="colsep0 rowsep0" align="left">95.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ppb (rat)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (%)</td><td class="colsep0 rowsep0" align="left">72.7</td><td class="colsep0 rowsep0" align="left">88.4</td><td class="colsep0 rowsep0" align="left">92.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat bb<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a> (%)</td><td class="colsep0 rowsep0" align="left">84.4</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">88.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cerep</td><td class="colsep0 rowsep0" align="left">allÂ >1Â Î¼M</td><td class="colsep0 rowsep0" align="left">allÂ >1Â Î¼M</td><td class="colsep0 rowsep0" align="left">allÂ >10Â Î¼M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhib<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1A2Â 3.1Â Î¼M</td><td class="colsep0 rowsep0" align="left">1A2Â 9.3Â Î¼M</td><td class="colsep0 rowsep0" align="left">allÂ >10Â Î¼M</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Reported as <i>P</i><sub>app</sub> Ã 10<sup>â6</sup> cm/s.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Preliminary (tier 1) data.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Rat brain tissue binding.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Reported as an IC<sub>50</sub>, and all other CYP IC<sub>50</sub> values were >10 Î¼M. CYP 2C9, 2C19, 2C8, 1A2, 2D6, and 3A4 were tested.</p></div></div></div><div class="NLM_p">Compounds in this series had moderate CYP inhibition, and of the compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, only <b>31</b> had significant CYP 1A2 inhibition (3.1 Î¼M). Balancing the overall profiles of compounds <b>31</b>, <b>32</b>, and <b>34</b> and considering the fact that <b>31</b> had some CYP and hERG inhibition and that both <b>31</b> and <b>32</b> had slightly higher rat clearance as compared to <b>34</b>, compound <b>34</b> was profiled further in order to predict the human dose required for efficacy and to predict a duration of action for <b>34</b> in humans.</div><div class="NLM_p">As a part of this effort, a po concentrationâresponse curve for ex vivo OX2R occupancy for <b>34</b> was generated and the data are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. Compound <b>34</b> dose dependently occupies the OX2R, and the EC<sub>50</sub> for occupancy in this experiment is 171 ng/mL, which corresponds to an oral ED<sub>50</sub> of 3 mg/kg. This EC<sub>50</sub> is the concentration we used to help predict the dose required for efficacy in human clinical trials. Our goal was to be able to dose high enough to maintain occupancy above 50% for 4â6 h because >50% occupancy has been shown to be required to induce sleep in rat<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and our target duration of action for this indication is around 6 h.</div><div class="NLM_p">In rats implanted with telemetry devices for EEG sleep recording, oral administration of <b>34</b> (JNJ-42847922) at the onset of the dark phase produced a dose-dependent reduction in NREM latency and an increase in NREM sleep time with no significant effect on REM sleep in these experimental conditions (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The lowest effective dose to significantly induce NREM sleep was 3 mg/kg, which corresponds to the ED<sub>50</sub> for receptor occupancy. Further details on the preclinical pharmacology of compound <b>34</b>, including additional sleep studies in rodent models, will be disclosed in a separate venue.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ex vivo OX2R occupancy with compound <b>34</b> in rat: concentrationâresponse after oral administration. Data were collected 15 min postdose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Doseâresponse effects of <b>34</b> (1, 3, 10, and 30 mg/kg, po) on sleep parameters in rat. Data are expressed in minutes (mean Â± SEM of the same 8 animals per dose). Latency to NREM and REM sleep and duration of NREM and REM sleep were calculated for 2 h after compound or vehicle administration at the onset of the dark phase: (â) <i>P</i> < 0.05, (ââ) <i>P</i> < 0.01, and (âââ) <i>P</i> < 0.001 vs vehicle based on one-way ANOVA followed by Dunnettâs multiple comparison post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additional preclinical PK in mouse, dog, and monkey as well as definitive PPB and microsomal CL (across species) studies were performed to enable human PK predictions. These data are summarized in Tables <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a> and <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>. The compound has a short half-life in all species and moderate to low bioavailability.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Mouse, Rat, Dog, and Monkey Pharmacokinetic Parameters for Compound <b>34</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Clearance.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">The iv half-life.</p></div></div></div><div class="NLM_p">Human PK predictions used allometric scaling with the correction for in vitro CL<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with or without correcting for PPB. The half-life predicted from bound and unbound methods was 1.2 and 1.8 h, respectively. By use of the most conservative approach (bound) and assuming a bioavailability of 20%, an estimated human dose required to maintain plasma levels above the IC<sub>50</sub> (330 ng/mL in human or 171 ng/mL in rat, corrected for protein differences between rat and human) for >4 h was 250 mg. On the basis of the preliminary conservative human PK and dose projections and considering the optimal duration of action required for a drug intended to treat primary insomnia, compound <b>34</b> was considered a viable candidate for clinical development.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Mouse, Rat, Dog, Monkey, and Human in Vitro Parameters for Compound <b>34</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">in vitro CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PPB (%Â free)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">In vitro CL calculated as CL<sub>int</sub><i>Q</i>/(CL<sub>int</sub> + <i>Q</i>), where CL<sub>int</sub> is microsomal intrinsic CL derived from in vitro time-course and <i>Q</i> is hepatic blood flow.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to provide sufficient drug substance for the initial 5-day rat and dog toleration studies needed to support nomination into early development, the synthesis of <b>34</b> was optimized and the synthetic procedures used to prepare bulk material for these exploratory toleration studies are shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. First, compound <b>41</b> was converted to the required 2-fluoro-6-[1,2,3]triazol-2-ylbenzoic acid <b>42</b> via a copper mediated coupling reaction in dioxane at elevated temperatures.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Optimized Synthesis of Compound <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, water, <i>trans</i>-1,2-dimethyl-1,2-diamine, 60 Â°C, then 83 Â°C, then 100 Â°C (used crude, â¼80%); (b) thionyl chloride, toluene, 50 Â°C, used in situ; (c) 2-chloro-4,6-methylpyridine, Cs<sub>2</sub>CO<sub>3</sub>, DMF 100 Â°C, 15 h, 96%; (d) 5% Pd/C, HOAc, H<sub>2</sub>, 50 Â°C, 4 h, quant; (e) toluene, 0 Â°C, sodium carbonate in water, then <b>43</b>, 30 Â°C; (f) ethanol, 77 Â°C, cool to 23 Â°C to crystallize, 74% over two steps.</p></p></figure><div class="NLM_p last">Independently, 2-benzyl-5-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>44</b>) was condensed with 2-chloro-4,6-methylpyrimidine to form <b>45</b> which was hydrogenated in the presence of acetic acid to give <b>46</b> as the acetic acid salt. Benzoic acid <b>42</b> was then converted to the acid chloride <b>43</b> and after reaction with <b>46</b> provided crude <b>34</b>. Recrystallization from ethanol provided pure <b>34</b> in good yield. We were able to prepare in excess of 130 g of drug substance by this route.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Developability Properties</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The relatively low p<i>K</i><sub>a</sub> (4.99) of the pyrimidine nitrogen limits the options for salt derivitization to strong acids; therefore, <b>34</b> was evaluated in PK and PD studies as the free base (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>), either solubilized in 30% sulfobutyl ether Î²<b>-</b>cyclodextrin (SBE-Î²-CD) in water or suspended in 0.5% hydroxypropyl methylcellulose (HPMC). The free base is a stable, crystalline (as determined by powder X-ray diffraction (PXRD), <a class="ref internalNav" href="#notes-1" aria-label="Figure S1 in Supporting Information">Figure S1 in Supporting Information</a>), nonhygroscopic anhydrous solid, and only one crystalline form has been identified to date. Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) scans confirm the anhydrous nature of the free base and the endothermic transition at 164 Â°C associated with melting (<a class="ref internalNav" href="#notes-1" aria-label="Figure S2">Figure S2</a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Structural, Calculated, and Measured Properties of Compound <b>34</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">value</th><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">407.45</td><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub>â¯<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">4.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MF</td><td class="colsep0 rowsep0" align="left">C<sub>21</sub>H<sub>22</sub>FN<sub>7</sub>0</td><td class="colsep0 rowsep0" align="left">PSA<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">80.04A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">logÂ <i>D</i><sub>7.4</sub>â¯<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.77</td><td class="colsep0 rowsep0" align="left">cLogPâ¯<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.08</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">Measured at Analiza, Inc.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">Calculated value.</p></div></div></div><div class="NLM_p">The solution solubility properties of <b>34</b> are detailed in Tables <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a> and <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>. The compound is highly soluble in SBE-Î²-CD, simulated gastric fluid, and simulated intestinal fluid. The compound was also assessed for solution stability (Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>) and found to be stable throughout a range of pH values at both room temperature and 60 Â°C.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Solubility Properties of Compound <b>34</b> in Aqueous Media</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>34</b></th><th class="colsep0 rowsep0" align="center">30% SBE-Î²-CD</th><th class="colsep0 rowsep0" align="center">SGF<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a> (pHÂ 1.2)</th><th class="colsep0 rowsep0" align="center">FasSIF<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a> (pHÂ 6.8)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free base</td><td class="colsep0 rowsep0" align="left">â¼100Â mg/mL</td><td class="colsep0 rowsep0" align="left">>0.4Â mM</td><td class="colsep0 rowsep0" align="left">0.176Â mM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">0.2% NaCl in 0.1 N HCl, pH 1.2.</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last">0.029-M Phosphate buffer, 5 mM Na-taurocholate and 1.5 mM Lecithin, pH 6.8.</p></div></div></div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Stability of <b>34</b> in Aqueous Media as a Function of pH</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">stability conditions</th><th class="colsep0 rowsep0" align="center" char=".">%Â remaining, rt, 1Â week</th><th class="colsep0 rowsep0" align="center" char=".">%Â remaining, 60 Â°C, 1Â week</th><th class="colsep0 rowsep0" align="center" char=".">%Â remaining, rt, 4Â weeks</th><th class="colsep0 rowsep0" align="center" char=".">%Â remaining, 60 Â°C, 4Â weeks</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 2</td><td class="colsep0 rowsep0" align="char" char=".">100.4</td><td class="colsep0 rowsep0" align="char" char=".">100.9</td><td class="colsep0 rowsep0" align="char" char=".">102.0</td><td class="colsep0 rowsep0" align="char" char=".">101.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 4</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td><td class="colsep0 rowsep0" align="char" char=".">99.4</td><td class="colsep0 rowsep0" align="char" char=".">101.2</td><td class="colsep0 rowsep0" align="char" char=".">102.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pHÂ 7.4</td><td class="colsep0 rowsep0" align="char" char=".">101.1</td><td class="colsep0 rowsep0" align="char" char=".">102.2</td><td class="colsep0 rowsep0" align="char" char=".">102.8</td><td class="colsep0 rowsep0" align="char" char=".">99.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 10</td><td class="colsep0 rowsep0" align="char" char=".">101.0</td><td class="colsep0 rowsep0" align="char" char=".">102.4</td><td class="colsep0 rowsep0" align="char" char=".">102.3</td><td class="colsep0 rowsep0" align="char" char=".">101.6</td></tr></tbody></table></div></div><div class="NLM_p">Solid state stability of <b>34</b> was also assessed at 22 and 80 Â°C at ambient relative humidity and at 40 Â°C at elevated relative humidity. The compound is stable in the solid state under all conditions tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a>). Overall, <b>34</b> has good properties and exists as a stable crystalline solid with sufficient solubility and stability properties to enable early clinical development.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. Solid State Stability of <b>34</b> under Various Conditions</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">stability conditions<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">%Â remaining</th><th class="colsep0 rowsep0" align="center">physical stability</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">22Â Â°C/ambÂ RH</td><td class="colsep0 rowsep0" align="char" char=".">100.2</td><td class="colsep0 rowsep0" align="left">stable</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40Â Â°C/75%Â RH</td><td class="colsep0 rowsep0" align="char" char=".">100.2</td><td class="colsep0 rowsep0" align="left">stable</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">80Â Â°C/ambÂ RH</td><td class="colsep0 rowsep0" align="char" char=".">100.2</td><td class="colsep0 rowsep0" align="left">stable</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>a</sup><p class="last">The samples were incubated under the conditions listed in column 1 for 4 weeks.</p></div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have demonstrated that this series of novel octahydropyrrolo[3,4-<i>c</i>]pyrroles are highly selective OX2R antagonists. Optimization of the physicochemical and DMPK properties of these compounds led to compounds with adequate preclinical bioavailability and good OX2R receptor occupancy in rat brain. Compound <b>34</b> (JNJ-42849722) was identified as a clinical candidate by utilizing ex vivo autoradiography to provide an estimate of the plasma concentrations of drug required for >50% OX2R occupancy and using sleep EEG to demonstrate target engagement and functional in vivo activity in a rat. Subsequently, a detailed analysis of the preclinical DMPK profile of <b>34</b> demonstrated that the compound was a viable preclinical candidate. The preclinical PK data were used to predict the human PK profile, and this analysis suggested that <b>34</b> would have human PK properties needed for a drug to treat primary insomnia (i.e., acceptable bioavailability and a relatively short duration of action) and prompted nomination of this compound as a clinical candidate for the treatment of primary insomnia. Finally, the synthesis of <b>34</b> was optimized in order to obtain material for preclinical toleration and developability studies that were used to support nomination. Compound <b>34</b> has completed GLP toxicology studies and several phase I clinical trials and is now ready to begin efficacy trials. The results of those studies, including the human PK profile for this compound, will be published in the near future.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry. General Methods</h3><div class="NLM_p">Solvents and reagents were used as supplied by the manufacturer. Unless otherwise indicated, all reactions were mechanically stirred and run under an atmosphere of N<sub>2</sub>. Concentrated refers to concentrated using a rotary evaporator under reduced pressure. Mass spectra were obtained on an Agilent series 1100 MSD using electrospray ionization (ESI) in positive mode. The calculated (calcd) mass corresponds to the exact mass. Unless specified otherwise, normal-phase silica gel column chromatography (sgc) was performed on silica gel (SiO<sub>2</sub>) using prepackaged cartridges and the indicated solvents. Nuclear magnetic resonance (NMR) spectra were obtained on Bruker model DRX spectrometers (300, 500, or 600 MHz).</div><div class="NLM_p last">The following procedures were used to prepare compounds <b>11</b>â<b>15</b> and <b>16</b>â<b>40</b>.</div></div><div id="sec7_2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Representative Procedure A. Step 1. 5-Benzylhexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">To a solution of 2-benzyloctahydropyrrolo[3,4-<i>c</i>]pyrrole (5.62 g, 27.8 mmol) in DCM (100 mL) was added (Boc)<sub>2</sub>O (6.16 g, 28.2 mmol). The reaction mixture was stirred for 24 h at 23 Â°C. The solvent was removed in vacuo, and the resulting product was used in the next step without further purification. MS (ESI) mass calcd for C<sub>18</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>, 302.41; <i>m</i>/<i>z</i> found, 303.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 7.36â7.20 (m, 5H), 3.61â3.46 (m, 4H), 3.24 (br s, 2H), 2.85â2.72 (m, 2H), 2.70â2.63 (m, 2H), 2.43â2.30 (m, 2H), 1.50â1.42 (s, 9H).</div></div><div id="sec7_2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Step 2. Hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester (<b>8</b>)</h3><div class="NLM_p last">5-Benzylhexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic acid <i>tert</i>-butyl ester (19.85 g, 65.6 mmol), MeOH (200 mL), HOAc (3 mL), and 10% Pd/C Degussa type (400 mg) were charged to a Parr shaker vial and shaken for 3 days at 70 psi hydrogen gas. The resulting material was filtered through Celite and concentrated. The crude mixture was purified by flash column chromatography (FCC), DCM to 10% MeOH/DCM containing 1% NH<sub>4</sub>OH, to afford the product. MS (ESI) mass calcd for C<sub>11</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>, 212.29; <i>m</i>/<i>z</i> found, 213.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 3.60â3.55 (m, 2H), 3.38â3.25 (m, 4H), 2.95â2.86 (m, 4H), 1.47 (s, 9H).</div></div><div id="sec7_2_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Step 3. 5-Benzothiazol-2-ylhexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">To a solution of hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic acid <i>tert</i>-butyl ester (200 mg, 0.942 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) were added 2-chlorobenzothiazole (141 Î¼L, 1.08 mmol) and cesium carbonate (353 mg, 1.08 mmol), and the reaction mixture was stirred at 100 Â°C for 18 h under argon. The reaction mixture was poured into water (15 mL) and extracted with EtOAc (3 Ã 8 mL). The combined organic layers were dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography, eluting with hexane/EtOAc (3:1 to 2:1) to give the title compound (265 mg, 0.767 mmol, 82%) as a white powder. LCMS: 100%, <i>t</i><sub>R</sub> = 1.614 min, <i>m</i>/<i>z</i> = 346 [M + H]<sup>+</sup>.</div></div><div id="sec7_2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Step 4. 2-(Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)benzothiazole</h3><div class="NLM_p last">A mixture of 5-benzothiazol-2-ylhexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic acid <i>tert</i>-butyl ester (227 mg, 0.657 mmol) and hydrogen chloride (3.18 M in 1,4-dioxane, 2.3 mL, 7.31 mmol) was stirred at room temperature for 1 h. The reaction mixture was diluted with diethyl ether (15 mL), and the precipitate was collected. The product was washed with diethyl ether (3 Ã 10 mL) to give the title compound (224 mg, 0.704 mmol, >100%) as a white powder. LCMS: 100%, <i>t</i><sub>R</sub> = 0.761 min, <i>m</i>/<i>z</i> = 246 [M + H]<sup>+</sup>.</div></div><div id="sec7_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Representative Procedure B. 5-Methyl-2-[1,2,3]triazol-2-ylbenzoic Acid</h3><div class="NLM_p last">A suspension of 2-iodo-5-methylbenzoic acid (1.0 g, 3.82 mmol), 1<i>H</i>-1,2,3-triazole (555 Î¼L, 9.58 mmol), copper(I) iodide (65 mg, 0.341 mmol), <i>trans</i>-<i>N</i>,<i>N</i>â²-dimethylcyclohexane-1,2-diamine (102 Î¼L, 0.647 mmol), and cesium carbonate (2.10 g, 6.44 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3.5 mL) was stirred at 100 Â°C for 10 min under microwave irradiation. The reaction mixture was diluted with water (15 mL) and extracted with EtOAc (10 mL). The aqueous layer was acidified to pH 4 by addition of 1 M hydrochloric acid and extracted with EtOAc (6 Ã 30 mL). The combined organic layers were washed with water (30 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography, eluting with DCM/HOAc (100:1). The product was triturated with hexane (2 mL) to afford the title compound (440 mg, 2.165 mmol, 57%) as a white crystalline solid. LCMS: 96%, <i>t</i><sub>R</sub> = 1.148 min, <i>m</i>/<i>z</i> = 204 [M + H]<sup>+</sup>, 202 [M â H]<sup>â</sup>.</div></div><div id="sec7_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Representative Procedure C. [5-(6-Chlorobenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl]-(2,6-dimethoxyphenyl)methanone, (<b>11</b>)</h3><div class="NLM_p last">To a solution of the appropriate amine (100 mg, 0.357 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2.5 mL) were added 2,6-dimethoxybenzoic acid (72 mg, 0.395 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (124 Î¼L, 0.712 mmol), and 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (HATU, 150 mg, 0.394 mmol), and the reaction mixture was stirred at room temperature for 2 h under argon. The reaction mixture was poured into water (13 mL) and extracted with DCM (3 Ã 5 mL). The combined organic layers were washed with 5% aqueous sodium carbonate (5 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography, eluting with EtOAc. The product was triturated with EtOAc (1 mL) to afford the title compound (64 mg, 0.144 mmol, 40%) as a white powder. LCMS: 97%, <i>t</i><sub>R</sub> = 1.650 min, <i>m</i>/<i>z</i> = 444 [M + H]<sup>+</sup>.</div></div><div id="sec7_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Representative Procedure D. (2,4-Dimethoxyphenyl)-[5-(6-fluorobenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl]methanone, (<b>15</b>)</h3><div class="NLM_p last">To a mixture of 6-fluoro-2-(hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)benzothiazole (200 mg, 0.595 mmol) in water (1.5 mL) and DCM (0.7 mL) was added potassium carbonate (329 mg, 2.38 mmol). To the reaction mixture was then added freshly prepared 2,4-dimethoxybenzoyl chloride (0.74 M in DCM, 0.8 mL, 0.592 mmol) dropwise, and the mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with DCM (20 mL) and washed with water (5 mL), 1 N sodium hydroxide (5 mL), and water (5 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography, eluting with DCM/ethanol (40:1). The residue was triturated with EtOAc (3 mL) to give the title compound (160 mg, 0.374 mmol, 63%) as a white powder.</div></div><div id="sec7_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Representative Procedure E. [5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl]-(4-fluoro-2-[1,2,3]triazol-2-ylphenyl)methanone, (<b>32</b>)</h3><div class="NLM_p">To a solution of freshly prepared 4-fluoro-2-[1,2,3]triazol-2-ylbenzoyl chloride (0.515 mmol) in DCM (2 mL) was added 2-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (149 mg, 0.512 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (355 Î¼L, 2.07 mmol), and 4 Ã molecular sieves, and the reaction mixture was stirred at room temperature for 16 h. The reaction mixture was diluted with DCM (10 mL) and washed with water (5 mL), 1 N sodium hydroxide (5 mL), and water (2 Ã 5 mL), dried over sodium sulfate, filtered, and evaporated. The residue was triturated with diethyl ether (1 mL). The product was recrystallized from acetonitrile (0.6 mL) to give the title compound (93 mg, 0.228 mmol, 45%) as a white crystalline solid.</div><div class="NLM_p">The analytical LC/MS method used is as follows. An Agilent 1200 HPLC was used to assess purity. The HPLC column used was a Kinetex, 2.6 Î¼m, C18, 50 mm Ã 2.1 mm, maintained at 40 Â°C. The HPLC gradient used was as follows: 1.0 mL/min, 95:5:0.1 water/acetonitrile/formic acid to 5:95:0.1 water/acetonitrile/formic acid in 2.0 min, maintaining for 0.5 min, UV channel 220 nm, SI Â± alternating scans.</div><div class="NLM_p last">The analytical HPLC method used to assess compound purity is as follows. The instrument used was a Waters Alliance 2695. The HPLC column used was a Kinetex, 5 Î¼m, C18, 150 mm Ã 4.6 mm, ambient temperature. The HPLC gradient used was as follows: 1.0 mL/min, 95:5:0.1 water/acetonitrile/trifluoroacetic acid to 10:90:0.1 water/acetonitrile/trifluoroacetic acid in 10.0 min, maintaining for 1.0 min. Dual channel detection was at 220 and 254 nm.</div></div><div id="sec7_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure A. Step 1</h3><div class="NLM_p">To a solution of hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic acid <i>tert</i>-butyl ester (200 mg, 0.942 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) were added heteroaryl chloride (1.15 equiv) and cesium carbonate (1.15 equiv), and the reaction mixture was stirred at 100 Â°C for 18 h under argon. The reaction mixture was poured into water (15 mL) and extracted with EtOAc (3 Ã 10 mL). The combined organic layers were dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography.</div><div class="NLM_p last">The following intermediates were prepared by general procedure A.</div></div><div id="sec7_7_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-(6-Chlorobenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as a white powder (622 mg, 69%); MS <i>m</i>/<i>z</i> 380 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(6-Methoxybenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as an off-white powder (282 mg, 64%); MS <i>m</i>/<i>z</i> 376 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(6-Methylbenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as a white foam (250 mg, 74%); MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(6-Fluorobenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as an off-white powder (779 mg, 65%); MS <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-Quinoxalin-2-ylhexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as a pale yellow powder (320 mg, 66%); MS <i>m</i>/<i>z</i> 341 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(4-Phenylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as a pale yellow powder (212 mg, 49%); MS <i>m</i>/<i>z</i> 367 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-(4-Methylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as an off-white powder (237 mg, 66%); MS <i>m</i>/<i>z</i> 305 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(4-Methoxypyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as a light brown powder (175 mg, 58%); MS <i>m</i>/<i>z</i> 321 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_1_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-(4,6-Dimethoxypyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2-carboxylic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">Isolated as a white powder (199 mg, 48%); MS <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Step 2</h3><div class="NLM_p last">A mixture of Boc-protected amine and hydrogen chloride (3.18 M in 1,4-dioxane, 10 equiv) was stirred at room temperature for 1 h. The reaction mixture was diluted with diethyl ether (15 mL), and the precipitate was collected. The product was washed with diethyl ether (3 Ã 10 mL) to give the title compound.</div></div><div id="sec7_7_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-Chloro-2-(hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)benzothiazole</h3><div class="NLM_p last">Isolated as a white powder (205 mg, 70%); MS <i>m</i>/<i>z</i> 280 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)-6-methoxybenzothiazole Dihydrochloride Salt</h3><div class="NLM_p last">Isolated as a white powder (260 mg, 99%); MS <i>m</i>/<i>z</i> 276 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-(Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)-6-methylbenzothiazole</h3><div class="NLM_p last">Isolated as a white powder (146 mg, 83%); MS <i>m</i>/<i>z</i> 260 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 6-Fluoro-2-(hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)benzothiazole</h3><div class="NLM_p last">Isolated as a pale yellow powder (706 mg, 98%); MS <i>m</i>/<i>z</i> 264 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-(Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl)quinoxaline</h3><div class="NLM_p last">Isolated as a pale yellow powder (415 mg, 54%); MS <i>m</i>/<i>z</i> 241 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(4-Phenylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole</h3><div class="NLM_p last">Isolated as a light brown powder (185 mg, 94%); MS <i>m</i>/<i>z</i> 267 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-(4-Methylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole</h3><div class="NLM_p last">Isolated as an orange oil (181 mg, 84%); MS <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(4-Methoxypyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole Dihydrochloride Salt</h3><div class="NLM_p last">Isolated as a white powder (286 mg, 93%); MS <i>m</i>/<i>z</i> 221 [M + H]<sup>+</sup>.</div></div><div id="sec7_7_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-(4,6-Dimethoxypyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole Dihydrochloride Salt</h3><div class="NLM_p last">Isolated as an orange oil (158 mg, 86%); MS <i>m</i>/<i>z</i> 251 [M + H]<sup>+</sup>.</div></div><div id="sec7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure B</h3><div class="NLM_p last">A suspension of the appropriate 2-iodobenzoic acid (1.0 g), 1<i>H</i>-1,2,3-triazole (2.5 equiv), copper(I) iodide (0.09 equiv), <i>trans-N</i>,<i>N</i>â²-dimethylcyclohexane-1,2-diamine (0.17 equiv), and cesium carbonate (2.5 equiv) in <i>N</i>,<i>N</i>-dimethylformamide (3.5 mL) was stirred at 100 Â°C for 10 min under microwave irradiation. The reaction mixture was diluted with water (15 mL) and extracted with EtOAc (10 mL). The aqueous layer was acidified to pH 4 by addition of 1 M hydrochloric acid and extracted with EtOAc (6 Ã 30 mL). The combined organic layers were washed with water (30 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography.</div></div><div id="sec7_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Methyl-2-[1,2,3]triazol-2-ylbenzoic Acid</h3><div class="NLM_p last">Isolated as a white crystalline solid (440 mg, 57%); MS <i>m</i>/<i>z</i> 204 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 7.88 (s, 2H), 7.66 (d, <i>J</i> = 2.1 Hz, 1H), 7.60 (d, <i>J</i> = 8.2 Hz, 1H), 7.50 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 2.47 (s, 3H).</div></div><div id="sec7_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-Methoxy-2-[1,2,3]triazol-2-ylbenzoic Acid</h3><div class="NLM_p last">Isolated as a dark yellow powder (362 mg, 48%); MS <i>m</i>/<i>z</i> 220 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 7.99 (s, 1H), 7.88 (s, 2H), 7.62 (d, <i>J</i> = 8.8 Hz, 1H), 7.40 (d, <i>J</i> = 2.9 Hz, 1H), 7.25 (dd, <i>J</i> = 8.8, 2.9 Hz, 1H), 3.93 (s, 3H).</div></div><div id="sec7_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-Chloro-2-[1,2,3]triazol-2-ylbenzoic Acid</h3><div class="NLM_p last">Isolated as a pale yellow powder (383 mg, 48%); MS <i>m</i>/<i>z</i> 222 [M â H]<sup>â</sup>; <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 7.94 (s, 2H), 7.82 (d, <i>J</i> = 2.3 Hz, 1H), 7.79 (d, <i>J</i> = 8.8 Hz, 1H), 7.71 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H).</div></div><div id="sec7_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Methyl-6-[1,2,3]triazol-2-ylbenzoic Acid</h3><div class="NLM_p last">Isolated as a light brown crystalline solid (488 mg, 62%); MS <i>m</i>/<i>z</i> 204 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 7.91 (s, 2H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.50 (t, <i>J</i> = 7.9 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 2.48 (s, 3H).</div></div><div id="sec7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> General Procedure C</h3><div class="NLM_p">To a solution of amine (100 mg) in <i>N</i>,<i>N</i>-dimethylformamide (2.5 mL) were added the appropriate benzoic acid (1.1 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (2 equiv), and 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (HATU, 1.1 equiv), and the reaction mixture was stirred at room temperature under argon. The reaction mixture was poured into water (15 mL) and extracted with DCM (3 Ã 10 mL). The combined organic layers were washed with 5% aqueous sodium carbonate (10 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography.</div><div class="NLM_p last">The compounds were prepared using general procedure C are as follows.</div></div><div id="sec7_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> [5-(6-Chlorobenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl]-(2,6-dimethoxyphenyl)methanone (<b>11</b>)</h3><div class="NLM_p last">Triturated with EtOAc (1 mL) to give a white crystalline solid (64 mg, 40%); mp 203â204.5 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.90 (d, <i>J</i> = 2.3 Hz, 1H), 7.44 (d, <i>J</i> = 8.6 Hz, 1H), 7.29 (t, <i>J</i> = 8.7 Hz, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 6.70 (d, <i>J</i> = 8.4 Hz, 1H), 6.66 (d, <i>J</i> = 8.3 Hz, 1H), 3.77 (dd, <i>J</i> = 10.0, 7.8 Hz, 1H), 3.75 (s, 3H), 3.70 (dd, <i>J</i> = 10.6, 7.5 Hz, 1H), 3.67â3.61 (m, 1H), 3.64 (s, 3H), 3.52 (dd, <i>J</i> = 12.5, 4.6 Hz, 1H), 3.43 (dd, <i>J</i> = 10.6, 4.6 Hz, 1H), 3.36 (dd, <i>J</i> = 11.0, 7.3 Hz, 1H), 3.34â3.30 (m, 1H), 3.15â3.08 (m, 1H), 3.07â3.00 (m, 1H), 2.97 (dd, <i>J</i> = 10.8, 4.6 Hz, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.86, 164.00, 155.99, 155.53, 151.82, 132.06, 130.22, 126.05, 124.37, 120.88, 119.11, 115.49, 104.35, 104.16, 55.70, 55.54, 53.48, 52.94, 50.45, 48.76, 41.60, 40.78; HRMS calcd for C<sub>22</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 444.1149; found 444.1152. Anal. Calcd for C<sub>22</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>3</sub>S: C, 59.52; H, 4.99; N, 9.47. Found: C, 59.15; H, 4.83; N, 9.18.</div></div><div id="sec7_9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 6-Chloro-2-{5-[(2,4-dimethoxyphenyl)carbonyl]hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl}-1,3-benzothiazole (<b>12</b>)</h3><div class="NLM_p last">Triturated with EtOAc (1 mL) to give an off-white powder (96 mg, 60%); mp 155â157.5 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.90 (d, <i>J</i> = 2.3 Hz, 1H), 7.43 (d, <i>J</i> = 8.6 Hz, 1H), 7.28 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.12 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (d, <i>J</i> = 2.3 Hz, 1H), 6.53 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 3.81â3.75 (m, 1H), 3.78 (s, 3H), 3.73 (s, 3H), 3.72â3.65 (m, 2H), 3.51â3.40 (m, 3H), 3.36â3.27 (m, 1H), 3.17â3.07 (m, 2H), 3.07â2.98 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.55, 164.87, 161.10, 156.12, 151.80, 132.08, 128.58, 126.04, 124.36, 120.86, 119.53, 119.09, 105.20, 98.40, 55.41, 55.28, 53.51, 52.78, 50.77, 49.21, 41.79, 40.59; HRMS calcd for C<sub>22</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 444.1149; found 444.1135. Anal. Calcd for C<sub>22</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>3</sub>S: C, 59.52; H, 4.99; N, 9.47. Found: C, 59.36; H, 4.92; N, 9.25.</div></div><div id="sec7_9_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-{5-[(2,4-Dimethoxyphenyl)carbonyl]hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl}-6-methyl-1,3-benzothiazole (<b>13</b>)</h3><div class="NLM_p last">Triturated with diisopropyl ether (1 mL) to give an off-white foam (52 mg, 28%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.56 (s, 1H), 7.35 (d, <i>J</i> = 8.2 Hz, 1H), 7.12 (d, <i>J</i> = 8.3 Hz, 1H), 7.08 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (s, 1H), 6.54 (d, <i>J</i> = 8.5 Hz, 1H), 3.85â3.61 (m, 3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.53â3.38 (m, 3H), 3.33â3.29 (m, 1H), 3.18â3.05 (m, 2H), 3.05â2.95 (m, 1H), 2.33 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.55, 163.70, 161.09, 156.12, 150.80, 130.56, 129.77, 128.58, 126.94, 121.02, 119.55, 117.91, 105.20, 98.40, 55.41, 55.28, 53.47, 52.75, 50.86, 49.29, 41.78, 40.58, 20.68; HRMS calcd for C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 424.1695; found 424.1690.</div></div><div id="sec7_9_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 6-Fluoro-2-{5-[(2-thiophen-2-ylphenyl)carbonyl]hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl}-1,3-benzothiazole (<b>18</b>)</h3><div class="NLM_p last">Isolated as an off-white foam (154 mg, 76%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.70 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 7.62â7.38 (m, 5H), 7.35 (dd, <i>J</i> = 7.5, 1.4 Hz, 1H), 7.23â7.15 (m, 1H), 7.11 (td, <i>J</i> = 9.1, 2.8 Hz, 1H), 7.09â6.97 (m, 1H), 3.83â3.60 (m, 2H), 3.60â2.59 (m, 8H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.05, 164.12, 156.89 (d, <i>J</i> = 236.5 Hz), 149.55, 140.55, 135.95, 131.41 (d, <i>J</i> = 11.1 Hz), 130.00, 129.35, 128.97, 127.97, 127.95, 127.00, 126.91, 125.92, 118.66 (d, <i>J</i> = 8.8 Hz), 113.28 (d, <i>J</i> = 23.6 Hz), 108.02 (d, <i>J</i> = 27.3 Hz), 53.12, 52.46, 50.99, 49.21, 41.74, 40.41; HRMS calcd for C<sub>24</sub>H<sub>21</sub>FN<sub>3</sub>OS<sub>2</sub> [M + H]<sup>+</sup> 450.1110; found 450.1112.</div></div><div id="sec7_9_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-{5-[(2-Thiophen-2-ylphenyl)carbonyl]hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl}quinoxaline (<b>23</b>)</h3><div class="NLM_p last">Triturated with diisopropyl ether (5 mL) to give a yellow foam (107 mg, 60%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.35 (s, 1H), 7.82 (d, <i>J</i> = 8.1 Hz, 1H), 7.67â7.50 (m, 3H), 7.50â7.25 (m, 5H), 7.24â7.10 (m, 1H), 7.10â6.84 (m, 1H), 3.93â3.54 (m, 3H), 3.54â3.36 (m, 2H), 3.36â3.12 (m, 2H), 3.11â2.59 (m, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.07, 150.15, 141.63, 140.60, 136.92, 135.98, 129.94, 129.81, 129.31, 128.94, 128.45, 127.96, 127.89, 126.89, 125.90, 125.70, 123.52, 51.14, 50.35, 49.66, 49.39, 41.34, 40.08; HRMS calcd for C<sub>25</sub>H<sub>23</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 427.1593; found 427.1588.</div></div><div id="sec7_9_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-[(2-thiophen-2-ylphenyl)carbonyl]octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>24</b>)</h3><div class="NLM_p last">Purified by preparative HPLC (water/methanol gradient, 1.5% trifluoroacetic acid) to give a pale yellow glass (48 mg, 34%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.62â7.36 (m, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.41 (t, <i>J</i> = 7.5 Hz, 1H), 7.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.26â6.90 (m, 2H), 6.38 (s, 1H), 3.82â2.58 (m, 10H), 2.21 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.04, 166.36, 160.02, 140.55, 136.00, 130.01, 129.29, 128.92, 127.93, 127.89, 126.91, 126.86, 125.82, 108.24, 51.28, 50.33, 49.65, 49.49, 41.34, 40.09, 23.63; HRMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 405.1749; found 405.1738.</div></div><div id="sec7_9_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-(4,6-Dimethoxypyrimidin-2-yl)-5-[(2-thiophen-2-ylphenyl)carbonyl]octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>29</b>)</h3><div class="NLM_p last">Isolated as a pale yellow foam (125 mg, 58%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.63â7.37 (m, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (t, <i>J</i> = 7.5 Hz, 1H), 7.41 (t, <i>J</i> = 7.5 Hz, 1H), 7.35 (d, <i>J</i> = 7.5 Hz, 1H), 7.25â7.13 (m, 1H), 7.13â6.93 (m, 1H), 5.38 (s, 1H), 3.79 (s, 6H), 3.77â2.59 (m, 10H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 171.61, 168.56, 159.55, 141.06, 136.49, 130.47, 129.80, 129.43, 128.45, 128.34, 127.40, 127.32, 126.36, 77.86, 53.46, 51.60, 50.56, 49.88, 41.73, 40.40; HRMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 437.1647; found 437.1649.</div></div><div id="sec7_9_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>30</b>)</h3><div class="NLM_p last">Triturated with diisopropyl ether (1 mL) to give a white crystalline solid (71 mg, 53%); mp 159.5â161.8 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.97 (s, 2H), 7.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.61 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.52 (t, <i>J</i> = 7.4 Hz, 1H), 7.49 (dd, <i>J</i> = 7.6, 1.7 Hz, 1H), 6.39 (s, 1H), 3.73 (dd, <i>J</i> = 11.5, 7.6 Hz, 1H), 3.67 (dd, <i>J</i> = 12.4, 7.5 Hz, 1H), 3.57 (dd, <i>J</i> = 11.7, 7.0 Hz, 1H), 3.48â3.34 (m, 4H), 3.03â2.84 (m, 3H), 2.23 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.43, 166.39, 160.04, 136.37, 135.31, 130.71, 129.92, 128.48, 127.99, 122.33, 108.20, 51.54, 50.35, 49.79, 49.45, 41.45, 40.16, 23.62; HRMS calcd for C<sub>21</sub>H<sub>24</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 390.2042; found 390.2039. Anal. Calcd for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>O: C, 64.76; H, 5.95; N, 25.18. Found: C, 64.63; H, 5.58; N, 25.23.</div></div><div id="sec7_9_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[3-fluoro-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>31</b>)</h3><div class="NLM_p last">Triturated with diethyl ether (1.5 mL) to give a white crystalline solid (125 mg, 59%); mp 151.2â153.2 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.99 (s, 2H), 7.67 (ddd, <i>J</i> = 13.1, 8.2, 5.1 Hz, 1H), 7.62â7.55 (m, 1H), 7.41 (d, <i>J</i> = 7.6 Hz, 1H), 6.39 (s, 1H), 3.70 (dd, <i>J</i> = 11.5, 7.2 Hz, 1H), 3.60 (dd, <i>J</i> = 11.7, 6.8 Hz, 1H), 3.54 (dd, <i>J</i> = 12.6, 7.3 Hz, 1H), 3.50 (dd, <i>J</i> = 10.7, 7.3 Hz, 1H), 3.42 (dd, <i>J</i> = 11.7, 3.8 Hz, 1H), 3.35 (dd, <i>J</i> = 11.6, 4.8 Hz, 1H), 3.26 (dd, <i>J</i> = 12.5, 3.9 Hz, 1H), 3.10 (dd, <i>J</i> = 10.8, 4.8 Hz, 1H), 2.99â2.88 (m, 2H), 2.23 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.43, 164.28, 160.10, 155.39 (d, <i>J</i> = 253.9 Hz), 136.43, 136.27, 131.64 (d, <i>J</i> = 8.3 Hz), 124.51 (d, <i>J</i> = 12.1 Hz), 123.25 (d, <i>J</i> = 3.8 Hz), 117.49 (d, <i>J</i> = 19.4 Hz), 108.23, 51.75, 50.23, 49.70, 49.38, 41.48, 40.10, 23.65; HRMS calcd for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>OF [M + H]<sup>+</sup> 408.1948; found 408.1944. Anal. Calcd for C<sub>21</sub>H<sub>22</sub>N<sub>7</sub>OF: C, 61.90; H, 5.44; N, 24.06. Found: C, 61.48; H, 5.27; N, 23.63.</div></div><div id="sec7_9_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[2-(1<i>H</i>-1,2,4-triazol-5-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>35</b>)</h3><div class="NLM_p last">Triturated with diethyl ether (1.5 mL) to give a white powder (52 mg, 26%). Mixture of tautomers by NMR (approximately 4:1). Major tautomer is tabulated: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 14.09 (s, 1H), 8.50 (s, 1H), 8.07â7.21 (m, 4H), 6.37 (s, 1H), 3.84â3.64 (m, 2H), 3.64â3.18 (m, 5H), 3.06â2.74 (m, 3H), 2.22 (s, 6H). All peaks reported: <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.41, 160.08, 159.94, 136.61, 128.94, 128.59, 127.91, 127.38, 126.75, 108.21, 51.62, 51.40, 50.34, 49.74, 49.38, 41.47, 40.17, 23.64. HRMS calcd for C<sub>21</sub>H<sub>24</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 390.2042; found 390.2043.</div></div><div id="sec7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> General Procedure D</h3><div class="NLM_p">To a mixture of amine (150 mg) in DCM (1.4 mL) and water (1.0 mL) was added potassium carbonate (4 equiv). To the reaction mixture was added freshly prepared 2-biphenylcarbonyl chloride (solution in DCM, 1 equiv) dropwise, and the mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with DCM (15 mL) and washed with water (5 mL), 1 N sodium hydroxide (5 mL) and water (5 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography.</div><div class="NLM_p last">The compounds that were prepared using general procedure D are as follows.</div></div><div id="sec7_10_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-{5-[(2,4-Dimethoxyphenyl)carbonyl]hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl}-6-methoxy-1,3-benzothiazole (<b>14</b>)</h3><div class="NLM_p last">Triturated with EtOAc (1.5 mL) to give a white powder (111 mg, 34%); mp 107.5â111.5 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.40 (s, 1H), 7.37 (d, <i>J</i> = 8.9 Hz, 1H), 7.12 (d, <i>J</i> = 8.3 Hz, 1H), 6.88 (d, <i>J</i> = 8.7 Hz, 1H), 6.59 (s, 1H), 6.54 (d, <i>J</i> = 8.4 Hz, 1H), 3.83â3.59 (m, 3H), 3.78 (s, 3H), 3.75 (s, 3H), 3.73 (s, 3H), 3.52â3.37 (m, 3H), 3.34â3.25 (m, 1H), 3.17â2.94 (m, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.53, 162.91, 161.09, 156.12, 154.08, 147.04, 131.46, 128.57, 119.55, 118.60, 113.54, 105.57, 105.19, 98.40, 55.51, 55.41, 55.27, 53.46, 52.73, 50.88, 49.30, 41.78, 40.59; HRMS calcd for C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 440.1644; found 440.1644. Anal. Calcd for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>S: C, 62.85; H, 5.73; N, 9.56. Found: C, 62.64; H, 5.48; N, 9.43.</div></div><div id="sec7_10_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 6-Fluoro-2-{5-[(2,4-dimethoxyphenyl)carbonyl]hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl}-1,3-benzothiazole (<b>15</b>)</h3><div class="NLM_p last">Triturated with EtOAc (3 mL) to give a white crystalline solid (160 mg, 63%); mp 169â170 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.70 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H), 7.44 (dd, <i>J</i> = 8.9, 4.8 Hz, 1H), 7.12 (d, <i>J</i> = 8.2 Hz, 1H), 7.11 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 6.59 (d, <i>J</i> = 2.4 Hz, 1H), 6.54 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 3.81â3.64 (m, 4H), 3.78 (s, 3H), 3.73 (s, 3H), 3.51â3.40 (m, 3H), 3.15â3.06 (m, 2H), 3.06â2.98 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.56, 164.28, 161.10, 156.90 (d, <i>J</i> = 236.6 Hz), 156.13, 149.60, 131.38 (d, <i>J</i> = 10.9 Hz), 128.58, 119.54, 118.68 (d, <i>J</i> = 8.9 Hz), 113.32 (d, <i>J</i> = 23.8 Hz), 108.05 (d, <i>J</i> = 27.3 Hz), 105.21, 98.40, 55.42, 55.28, 53.48, 52.75, 50.82, 49.25, 41.80, 40.60; HRMS calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 428.1444; found 428.1440. Anal. Calcd for C<sub>22</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>S: C, 61.81; H, 5.19; N, 9.83. Found: C, 61.74; H, 4.91; N, 9.51.</div></div><div id="sec7_10_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Biphenyl-2-yl-[5-(6-methylbenzothiazol-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2-yl]methanone (<b>16</b>)</h3><div class="NLM_p last">Isolated as an off-white foam (86 mg, 43%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.77 (d, <i>J</i> = 7.7 Hz, 1H), 7.55â7.19 (m, 11H), 7.05 (td, <i>J</i> = 7.5, 1.2 Hz, 1H), 3.70â3.50 (m, 2H), 3.50â3.35 (m, 1H), 3.31â2.53 (m, 7H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.51, 164.08, 152.88, 139.46, 137.61, 136.55, 130.56, 129.38, 129.36, 128.32, 128.06, 127.81, 127.64, 126.94, 125.84, 121.13, 120.61, 118.22, 52.97, 52.36, 50.72, 49.05, 41.64, 40.25; HRMS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>3</sub>OS [M + H]<sup>+</sup> 426.1640; found 426.1634.</div></div><div id="sec7_10_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-[5-(Biphenyl-2-ylcarbonyl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl]-6-fluoro-1,3-benzothiazole (<b>17</b>)</h3><div class="NLM_p last">Isolated as an off-white foam (142 mg, 72%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.77â7.65 (m, 1H), 7.59â7.18 (m, 10H), 7.18â7.05 (m, 1H), 3.68â3.49 (m, 2H), 3.48â3.35 (m, 1H), 3.31â2.54 (m, 7H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.50, 164.01, 156.90 (d, <i>J</i> = 236.7 Hz), 149.57, 139.45, 137.59, 136.53, 131.42 (d, <i>J</i> = 11.0 Hz), 129.37, 129.36, 128.30, 128.05, 127.79, 127.63, 126.93, 118.65 (d, <i>J</i> = 8.8 Hz), 113.28 (d, <i>J</i> = 23.8 Hz), 108.02 (d, <i>J</i> = 27.4 Hz), 52.94, 52.34, 50.70, 49.03, 41.63, 40.25; HRMS calcd for C<sub>26</sub>H<sub>23</sub>FN<sub>3</sub>OS [M + H]<sup>+</sup> 444.1546; found 444.1546.</div></div><div id="sec7_10_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-(Biphenyl-2-ylcarbonyl)-5-(4-phenylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>19</b>)</h3><div class="NLM_p last">Triturated with EtOAc (1 mL) to give a white powder (114 mg, 47%); mp 120.3â121.1 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.41 (d, <i>J</i> = 5.1 Hz, 1H), 8.21â8.08 (m, 2H), 7.59â6.95 (m, 12H), 7.20 (d, <i>J</i> = 5.1 Hz, 1H), 3.83â3.40 (m, 3H), 3.40â2.54 (m, 7H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.50, 162.87, 160.03, 158.60, 139.46, 137.61, 136.94, 136.65, 130.59, 129.32, 128.66, 128.20, 127.99, 127.59, 126.92, 126.70, 104.96, 50.99, 50.16, 49.53, 49.32, 41.28, 39.92; HRMS calcd for C<sub>29</sub>H<sub>27</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 447.2185; found 447.2169.</div></div><div id="sec7_10_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-(Biphenyl-2-ylcarbonyl)-5-(4-methylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>21</b>)</h3><div class="NLM_p last">Tan low-melting solid (125 mg, 50%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.17 (d, <i>J</i> = 5.0 Hz, 1H), 7.50 (t, <i>J</i> = 7.5 Hz, 1H), 7.46â7.40 (m, 2H), 7.40â7.16 (m, 6H), 6.49 (d, <i>J</i> = 5.0 Hz, 1H), 3.63â3.48 (m, 2H), 3.48â3.35 (m, 1H), 3.27â3.03 (m, 2H), 3.03â2.54 (m, 5H), 2.27 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.45, 166.72, 159.83, 157.17, 139.43, 137.65, 136.62, 129.32, 129.30, 128.23, 127.95, 127.61, 127.55, 126.90, 108.89, 51.03, 50.15, 49.53, 49.29, 41.24, 39.85, 23.83; HRMS calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 385.2028; found 385.2030.</div></div><div id="sec7_10_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-[(2-methylnaphthalen-1-yl)carbonyl]octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>25</b>)</h3><div class="NLM_p last">Triturated with diisopropyl ether (1 mL) to give a white powder (87 mg, 43%); mp 148.2â149.4 Â°C. Mixture of atropisomers by NMR (approximately 7:3). Major isomer is tabulated below. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.95â7.88 (m, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.52â7.33 (m, 4H), 6.39 (s, 1H), 3.88 (dd, <i>J</i> = 12.5, 7.8 Hz, 1H), 3.82â3.73 (m, 1H), 3.69 (dd, <i>J</i> = 12.5, 4.6 Hz, 1H), 3.58â3.50 (m, 2H), 3.35â3.26 (m, 1H), 3.22 (dd, <i>J</i> = 11.7, 4.6 Hz, 1H), 3.11â3.02 (m, 1H), 2.96â2.87 (m, 1H), 2.67 (dd, <i>J</i> = 11.2, 5.0 Hz, 1H), 2.37 (s, 3H), 2.21 (s, 6H). All peaks reported. <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 167.62, 167.56, 166.43, 160.10, 160.08, 134.07, 134.02, 131.24, 130.67, 130.47, 128.59, 128.52, 128.39, 128.02, 126.96, 126.81, 125.42, 125.36, 123.93, 123.71, 108.31, 50.93, 50.71, 50.63, 50.08, 49.98, 49.27, 49.20, 41.38, 40.20, 23.60, 18.78, 18.73; HRMS calcd for C<sub>24</sub>H<sub>27</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 387.2185; found 387.2193.</div></div><div id="sec7_10_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-(4-Methoxypyrimidin-2-yl)-5-[(2-methylnaphthalen-1-yl)carbonyl]octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>26</b>)</h3><div class="NLM_p last">Isolated as a pale yellow glass (162 mg, 43%). Mixture of atropisomers by NMR (ca. 1:1). All peaks reported. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.05 (d, <i>J</i> = 5.7 Hz, 1H), 7.97â7.88 (m, 1H), 7.86 (d, <i>J</i> = 8.5 Hz, 1H), 7.67â7.33 (m, 4H), 6.08â6.03 (m, 1H), 4.01â3.74 (m, 5H), 3.74â3.44 (m, 3H), 3.36â3.03 (m, 3H), 2.98â2.64 (m, 2H), 2.40â2.26 (m, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.18, 167.67, 167.61, 160.02, 160.00, 158.22, 134.07, 134.00, 131.26, 130.73, 130.45, 128.61, 128.53, 128.42, 128.05, 126.99, 126.82, 125.45, 125.40, 123.95, 123.69, 95.60, 52.59, 50.94, 50.87, 50.62, 50.55, 50.01, 49.88, 49.25, 49.17, 41.36, 40.20, 18.80, 18.74; HRMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 389.1978; found 389.1975.</div></div><div id="sec7_10_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-[(3â²-fluorobiphenyl-2-yl)carbonyl]octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>27</b>)</h3><div class="NLM_p last">Isolated as a pale yellow low-melting solid (168 mg, 78%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.57â7.42 (m, 3H), 7.42â7.29 (m, 2H), 7.27â7.14 (m, 2H), 7.12â6.97 (m, 1H), 6.38 (s, 1H), 3.66â3.50 (m, 2H), 3.50â3.36 (m, 1H), 3.28â3.07 (m, 2H), 3.07â2.57 (m, 5H), 2.22 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.21, 166.29, 161.94 (d, <i>J</i> = 243.9 Hz), 159.94, 141.76 (d, <i>J</i> = 7.8 Hz), 136.62, 136.22, 130.19 (d, <i>J</i> = 8.5 Hz), 129.41, 129.38, 128.12, 126.91, 124.17, 114.75 (d, <i>J</i> = 22.1 Hz), 114.43 (d, <i>J</i> = 20.9 Hz), 108.20, 51.18, 50.21, 49.55, 49.42, 41.27, 39.88, 23.63; HRMS calcd for C<sub>25</sub>H<sub>26</sub>N<sub>4</sub>OF [M + H]<sup>+</sup> 417.2093; found 417.2092.</div></div><div id="sec7_10_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-[(2-ethoxynaphthalen-1-yl)carbonyl]octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>28</b>)</h3><div class="NLM_p last">Triturated with diisopropyl ether (1 mL) to give a white powder (66 mg, 46%); mp 178â180 Â°C. Mixture of atropisomers by NMR (approximately 3:2). Major isomer is tabulated: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.95 (d, <i>J</i> = 9.3 Hz, 1H), 7.92â7.85 (m, 1H), 7.56 (d, <i>J</i> = 8.5 Hz, 1H), 7.54â7.31 (m, 3H), 6.39 (s, 1H), 4.30â4.19 (m, 1H), 4.13 (q, <i>J</i> = 7.0 Hz, 2H), 3.87â3.79 (m, 1H), 3.79â3.72 (m, 1H), 3.66â3.38 (m, 4H), 3.21â3.14 (m, 1H), 3.09â2.99 (m, 1H), 2.95â2.85 (m, 1H), 2.22 (s, 6H), 1.22 (t, <i>J</i> = 7.0 Hz, 3H). All peaks reported: <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.43, 165.82, 165.67, 160.20, 160.08, 151.40, 151.06, 130.12, 130.05, 129.99, 128.24, 128.22, 127.99, 127.15, 127.11, 123.81, 123.49, 123.26, 120.95, 120.84, 114.74, 114.40, 108.31, 108.21, 41.29, 40.35, 40.29, 23.61, 14.91, 14.49. HRMS calcd for C<sub>25</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 417.2291; found 417.2280.</div></div><div id="sec7_10_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>37</b>)</h3><div class="NLM_p last">Recrystallized from diethyl ether (1 mL) to give a white crystalline solid (145 mg, 70%); mp 164.5â166 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.93 (s, 2H), 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.40 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.29 (d, <i>J</i> = 1.8 Hz, 1H), 6.38 (s, 1H), 3.73 (dd, <i>J</i> = 11.5, 7.6 Hz, 1H), 3.65 (dd, <i>J</i> = 12.4, 7.4 Hz, 1H), 3.60â3.51 (m, 1H), 3.49â3.33 (m, 4H), 3.04â2.81 (m, 3H), 2.38 (s, 3H), 2.22 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.51, 166.42, 160.11, 138.30, 136.11, 133.19, 130.63, 130.32, 128.18, 122.25, 108.20, 51.53, 50.34, 49.78, 49.42, 41.45, 40.18, 23.64, 20.33; HRMS calcd for C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 404.2199; found 404.2190. Anal. Calcd for C<sub>22</sub>H<sub>25</sub>N<sub>7</sub>O: C, 65.49; H, 6.25; N, 24.30. Found: C, 65.33; H, 6.10; N, 24.03.</div></div><div id="sec7_10_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[5-methoxy-2-(1<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>39</b>)</h3><div class="NLM_p last">Triturated with diethyl ether (1 mL) to give a white crystalline solid (160 mg, 74%); mp 145.5â147 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.90 (s, 2H), 7.75 (d, <i>J</i> = 8.9 Hz, 1H), 7.14 (dd, <i>J</i> = 8.9, 2.9 Hz, 1H), 7.02 (d, <i>J</i> = 2.9 Hz, 1H), 6.38 (s, 1H), 3.84 (s, 3H), 3.72 (dd, <i>J</i> = 11.5, 7.6 Hz, 1H), 3.64 (dd, <i>J</i> = 12.4, 7.5 Hz, 1H), 3.61â3.51 (m, 1H), 3.44 (dd, <i>J</i> = 11.5, 5.2 Hz, 1H), 3.42â3.33 (m, 3H), 3.05â2.83 (m, 3H), 2.22 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.38, 165.89, 160.09, 158.84, 135.81, 132.34, 128.92, 124.24, 115.28, 112.55, 108.17, 55.73, 51.51, 50.30, 49.74, 49.41, 41.45, 40.17, 23.63; HRMS calcd for C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 420.2148; found 420.2144. Anal. Calcd for C<sub>22</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub>: C, 62.99; H, 6.01; N, 23.37. Found: C, 62.69; H, 5.78; N, 23.12.</div></div><div id="sec7_10_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-{[5-Chloro-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}-5-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>40</b>)</h3><div class="NLM_p last">Triturated with diethyl ether (1 mL) to give a white powder (120 mg, 55%); mp 197.5â199.5 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.00 (s, 2H), 7.91 (d, <i>J</i> = 8.7 Hz, 1H), 7.67 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.64 (d, <i>J</i> = 2.4 Hz, 1H), 6.38 (s, 1H), 3.73 (dd, <i>J</i> = 11.5, 7.6 Hz, 1H), 3.67 (dd, <i>J</i> = 12.4, 7.5 Hz, 1H), 3.62â3.52 (m, 1H), 3.46 (dd, <i>J</i> = 11.6, 5.2 Hz, 1H), 3.43â3.34 (m, 3H), 3.04â2.85 (m, 3H), 2.22 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.41, 164.82, 160.10, 136.74, 134.06, 132.74, 132.10, 129.91, 127.79, 124.09, 108.20, 51.49, 50.28, 49.73, 49.51, 41.47, 40.16, 23.63; HRMS calcd for C<sub>21</sub>H<sub>23</sub>ClN<sub>7</sub>O [M + H]<sup>+</sup> 424.1653; found 424.1652. Anal. Calcd for C<sub>21</sub>H<sub>22</sub>ClN<sub>7</sub>O: C, 59.50; H, 5.23; N, 23.13. Found: C, 59.32; H, 5.17; N, 22.70.</div></div><div id="sec7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> General Procedure E</h3><div class="NLM_p">To a solution of freshly prepared acid chloride (1 equiv) in DCM (2 mL) were added amine (150 mg) and <i>N</i>,<i>N</i>-diisopropylethylamine (4 equiv), and the reaction mixture was stirred at room temperature for 16 h. The reaction mixture was diluted with DCM (10 mL) and washed with water (5 mL), 1 N sodium hydroxide (5 mL), and water (2 Ã 5 mL), dried over sodium sulfate, filtered, and evaporated.</div><div class="NLM_p last">The compounds that were prepared using general procedure E are as follows.</div></div><div id="sec7_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-[5-(Biphenyl-2-ylcarbonyl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl]quinoxaline (<b>20</b>)</h3><div class="NLM_p last">Purified by silica gel column chromatography, eluting with chloroform/methanol (100:0.75 to 100:2) to give a yellow foam (107 mg, 53%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.28 (s, 1H), 7.84 (d, <i>J</i> = 8.1 Hz, 1H), 7.64â7.55 (m, 2H), 7.50 (td, <i>J</i> = 7.4, 1.5 Hz, 1H), 7.47â7.08 (m, 9H), 3.79â3.65 (m, 1H), 3.65â3.44 (m, 2H), 3.35â2.53 (m, 7H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.53, 150.06, 141.67, 139.50, 137.52, 136.91, 136.59, 135.99, 129.83, 129.33, 128.48, 128.26, 128.07, 127.62, 127.57, 126.90, 125.72, 123.52, 50.85, 50.13, 49.51, 49.20, 41.22; HRMS calcd for C<sub>27</sub>H<sub>25</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 421.2028; found 421.2028.</div></div><div id="sec7_11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-[5-{[2-(1<i>H</i>-Pyrazol-1-yl)phenyl]carbonyl}hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl]quinoxaline (<b>22</b>)</h3><div class="NLM_p last">Purified by column chromatography (ISCO), eluting with chloroform/methanol (100:0 to100:0.5) to give a a pale yellow foam (85 mg, 41%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.44 (s, 1H), 8.06 (s, 1H), 7.82 (d, <i>J</i> = 8.1 Hz, 1H), 7.70â7.48 (m, 5H), 7.47â7.40 (m, 2H), 7.39â7.30 (m, 1H), 6.37 (br s, 1H), 3.92â3.80 (m, 1H), 3.76â3.60 (m, 2H), 3.59â3.41 (m, 3H), 3.41â3.23 (m, 1H), 3.12â2.75 (m, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.86, 150.27, 141.69, 140.86, 136.98, 136.04, 135.99, 131.29, 129.85, 129.59, 128.48, 127.88, 127.38, 125.69, 123.50, 123.00, 107.39, 51.21, 50.33, 49.79, 49.28, 41.41, 40.20; HRMS calcd for C<sub>24</sub>H<sub>23</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 411.1933; found 411.1931.</div></div><div id="sec7_11_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[4-fluoro-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>32</b>)</h3><div class="NLM_p last">Triturated with diethyl ether (1 mL) and recrystallized from acetonitrile (0.6 mL) to give a white crystalline solid (93 mg, 45%); mp 175.2â177.0 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.02 (s, 2H), 7.78â7.68 (m, 1H), 7.61â7.52 (m, 1H), 7.43â7.34 (m, 1H), 6.38 (s, 1H), 3.73 (dd, <i>J</i> = 11.6, 7.6 Hz, 1H), 3.67 (dd, <i>J</i> = 12.4, 7.6 Hz, 1H), 3.61â3.51 (m, 1H), 3.50â3.33 (m, 4H), 3.04â2.82 (m, 3H), 2.22 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.41, 165.69, 161.82 (d, <i>J</i> = 247.0 Hz), 160.09, 136.90, 136.54 (d, <i>J</i> = 10.6 Hz), 130.36 (d, <i>J</i> = 9.0 Hz), 126.93 (d, <i>J</i> = 3.0 Hz), 115.42 (d, <i>J</i> = 21.4 Hz), 109.47 (d, <i>J</i> = 26.5 Hz), 108.21, 51.53, 50.35, 49.78, 49.54, 41.45, 40.18, 23.64; HRMS calcd for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>OF [M + H]<sup>+</sup> 408.1948; found 408.1943. Anal. Calcd for C<sub>21</sub>H<sub>22</sub>N<sub>7</sub>OF: C, 61.90; H, 5.44; N, 24.06. Found: C, 61.85; H, 5.31; N, 24.19.</div></div><div id="sec7_11_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-(4,6-Dimethylpyrimidin-2-yl)-5-{[5-fluoro-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]carbonyl}octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>33</b>)</h3><div class="NLM_p last">Triturated with diethyl ether (1.5 mL) and recrystallized from acetonitrile (0.5 mL) to give a white crystalline solid (50 mg, 24%); mp 141.8â142.4 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.97 (s, 2H), 7.93â7.85 (m, 1H), 7.53â7.40 (m, 2H), 6.38 (s, 1H), 3.73 (dd, <i>J</i> = 11.5, 7.6 Hz, 1H), 3.65 (dd, <i>J</i> = 12.5, 7.5 Hz, 1H), 3.62â3.52 (m, 1H), 3.45 (dd, <i>J</i> = 11.6, 5.2 Hz, 1H), 3.43â3.34 (m, 3H), 3.07â2.85 (m, 3H), 2.23 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.40, 164.84, 161.03 (d, <i>J</i> = 247.7 Hz), 160.102, 136.44, 132.80 (d, <i>J</i> = 7.0 Hz), 131.97, 125.00 (d, <i>J</i> = 9.0 Hz), 116.89 (d, <i>J</i> = 23.3 Hz), 114.95 (d, <i>J</i> = 24.3 Hz), 108.20, 51.47, 50.29, 49.73, 49.49, 41.45, 40.15, 23.62; HRMS calcd for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>OF [M + H]<sup>+</sup> 408.1948; found 408.1953. Anal. Calcd for C<sub>21</sub>H<sub>22</sub>N<sub>7</sub>OF: C, 61.90; H, 5.44; N, 24.06. Found: C, 61.52; H, 5.30; N, 23.85.</div></div><div id="sec7_11_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)(3-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl)methanone (<b>36</b>)</h3><div class="NLM_p last">Purified further by column chromatography (ISCO), eluting with chloroform/methanol (100:0 to 100:0.4) to give an off-white foam (90 mg, 32%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.92 (s, 2H), 7.54â7.46 (m, 2H), 7.35 (dd, <i>J</i> = 6.7, 2.3 Hz, 1H), 6.39 (s, 1H), 3.69 (dd, <i>J</i> = 11.5, 6.9 Hz, 1H), 3.59 (dd, <i>J</i> = 11.7, 6.6 Hz, 1H), 3.55â3.39 (m, 3H), 3.36â3.27 (m, 1H), 3.20 (dd, <i>J</i> = 12.4, 3.5 Hz, 1H), 3.13 (dd, <i>J</i> = 10.8, 4.5 Hz, 1H), 2.96â2.85 (m, 2H), 2.24 (s, 6H), 2.10 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.43, 165.79, 160.12, 135.48, 135.40, 135.36, 134.58, 131.58, 129.60, 124.74, 108.21, 51.83, 50.21, 49.69, 49.18, 41.48, 40.11, 23.65, 17.39; HRMS calcd for C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 404.2199; found 404.2197.</div></div><div id="sec7_11_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> (5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)(2-methyl-6-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl)methanone (<b>38</b>)</h3><div class="NLM_p">Purified further by silica gel column chromatography, eluting with chloroform/methanol (100:1 to 100:2) to give an off-white foam (134 mg, 64%). Mixture of atropisomers by NMR (approximately 3:2). Major isomer is tabulated: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.88 (s, 2H), 7.66 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (t, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 7.6 Hz, 1H), 6.38 (s, 1H), 3.80â3.60 (m, 2H), 3.52 (dd, <i>J</i> = 11.7, 6.2 Hz, 1H), 3.49â3.32 (m, 4H), 3.04â2.85 (m, 3H), 2.32 (s, 3H), 2.27â2.22 (m, 6H). All peaks reported: <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.45, 166.40, 165.89, 165.69, 160.13, 160.11, 136.36, 136.09, 135.52, 135.39, 135.37, 135.29, 130.57, 130.44, 130.10, 130.06, 129.20, 120.04, 119.90, 108.33, 108.15, 50.98, 50.66, 50.25, 50.16, 49.61, 49.40, 49.21, 41.52, 41.18, 40.18, 23.64, 23.62, 18.51, 18.46; HRMS calcd for C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 404.2199; found 404.2199.</div><div class="NLM_p last">The procedures used to prepare bulk <b>34</b> are as follows.</div></div><div id="sec7_11_6_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> (5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-(2-fluoro-6-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl)methanone (<b>6s</b>). Step 1. 2-Fluoro-6-[1,2,3]triazol-2-ylbenzoic Acid (<b>42</b>)</h3><div class="NLM_p last">To a 2 L, three-necked, round-bottomed flask equipped with an overhead mechanical stirrer, thermocouple probe, heating mantle, reflux condenser, and nitrogen inlet were added 2-fluoro-6-iodobenzoic acid (127.6 g, 480 mmol), copper iodide (4.57 g, 24 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (312.6 g, 959 mmol). To these solids were added dioxane (640 mL), then water (2.6 mL, 144 mmol), then 1<i>H</i>-1,2,3-triazole (55.6 mL, 959 mmol), and finally <i>trans</i>-1,2-dimethylcyclohexane-1,2-diamine (15.1 mL, 96 mmol). The mixture was then warmed to 60 Â°C for 30 min, then to 83 Â°C for 30 min, and then to 100 Â°C for 3 h. After the 3 h at 100 Â°C, the mixture was cooled and then 1 L of MTBE and 1 L of water were added. After vigorous mixing, the layers were separated and the bottom aqueous layer was acidified to pH 1.72 with â¼148 mL of concentrated hydrochloric acid. The aqueous was then extracted twice with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to provide a dark oil. The oil was stirred overnight in EtOAc (450 mL), and the resulting precipitate was removed by filtration. The mother liquors were concentrated to a brown solid (106.21 g, 75 wt % by quantitative HPLC, 79.7 g, 80%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): 8.22â8.13 (bs, 2H), 7.84â7.80 (m, 1H), 7.74â7.65 (m, 1H), 7.50â7.41 (m, 1H).</div></div><div id="sec7_11_6_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Step 2. 2-Benzyl-5-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>45</b>)</h3><div class="NLM_p last">To a 3 L, three-necked, round-bottomed flask equipped with mechanical stirrer, reflux condenser, temperature probe, and nitrogen inlet was added 2-benzyloctahydropyrrolo[3,4-<i>c</i>]pyrrole (109 g, 538.8 mmol) in DMF (1.6 L). To the resulting solution were added 2-chloro-4,6-methylpyrimidine (76.8 g, 538.8 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (351.1 g, 1.08 mol). The heterogeneous mixture was heated to 100 Â°C and stirred for 15 h. After cooling to room temperature, the mixture was diluted with EtOAc (1.5 L) and water (1.5 L). The layers were thoroughly mixed and separated. The aqueous layer was extracted with additional EtOAc (1.5 L). The combined organics were dried over sodium sulfate, filtered, and concentrated under reduced pressure to a brown solid (160 g, 96% yield). MS (ESI) mass calcd for C<sub>19</sub>H<sub>24</sub>N<sub>4</sub>, 308.20; <i>m</i>/<i>z</i> found 309 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): 7.32â7.26 (m, 4H), 7.25â7.20 (m, 1H), 6.27 (s, 1H), 3.81â3.73 (m, 2H), 3.58 (s, 2H), 3.54 (dd, <i>J</i> = 11.4, 3.5 Hz, 2H), 2.95â2.86 (m, 2H), 2.80â2.68 (m, 2H), 2.47â2.40 (m, 2H), 2.35â2.24 (s, 6H).</div></div><div id="sec7_11_6_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Step 3. 2-(4,6-Dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrroleÂ·HOAc (<b>46</b>)</h3><div class="NLM_p last">To a 4 L high pressure autoclave equipped with mechanical stirring, temperature probe, heating jacket, and gas inlet were added 5% Pd/C (66.9 g, Johnson Matthey 5R338, 56.8% H<sub>2</sub>O, 3.45 mol %) and a solution of 2-benzyl-5-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (160 g, 519 mmol) and HOAc (30 mL, 519 mmol) in ethanol (3.2 L). The mixture was stirred at 50 Â°C under 50 psi of H<sub>2</sub>(g) for 4 h. The catalyst was removed and the resulting solution was then concentrated under reduced pressure to provide the desired product as a white solid (144 g, quantitative yield) as the HOAc salt. MS (ESI): mass calcd for C<sub>12</sub>H<sub>18</sub>N<sub>4</sub>, 218.15; <i>m</i>/<i>z</i> found 219 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): 6.30 (s, 1H), 3.79â3.59 (m, 4H), 3.39 (m, 2H), 3.09â2.88 (m, 4H), 2.29 (s, 6H), 1.93 (s, 3H).</div></div><div id="sec7_11_6_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Step 4. (5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)(2-fluoro-6-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl)methanone (<b>34</b>)</h3><div class="NLM_p last">To a three-necked, 3 L, round-bottomed flask equipped with a nitrogen line, temperature probe, heating mantle, reflux condenser, mechanical stirrer, and 1 N aq NaOH scrubber were added 2-fluoro-6-[1,2,3]triazol-2-ylbenzoic acid (<b>42</b>) (120.98 g, 75 wt %, 90.74 g actual, 438 mmol) and toluene (1 L). The mixture was warmed to 50 Â°C for 1 h with stirring. The mixture was then cooled to 25 Â°C, and thionyl chloride (47.9 mL, 657 mmol) was added. The mixture was warmed back to 50 Â°C and held for 1 h. During this time, in a separate 5 L jacketed reactor equipped with a mechanical stirrer and temperature probe were added toluene (600 mL), aqueous sodium carbonate (185.7 g, 1.75 mol in 1.6 L of water), and 2-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrroleÂ·HOAc (<b>46</b>) (122 g, 438 mmol). This biphasic mixture was cooled to 0 Â°C. After cooling to 0 Â°C, the original slurry was poured through a filter and over the stirring biphasic mixture of amine and aqueous sodium carbonate. The mixture was allowed to warm to room temperature. After 2 h, additional 2-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrroleÂ·HOAc (4 g, 14 mmol) was added and the mixture was stirred for 30 additional minutes. At the end of this period, the layers were separated and an amount of 100 mL of methanol was added to the organic layer. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to a white solid. This solid was taken up in ethanol (1.4 L) and warmed to 77 Â°C. The mixture was then cooled to 55 Â°C and seeded with previously crystallized material. (Note: The seeds were generated from slurrying the initial product in 2-propanol at room temperature [100 mg/mL].) The mixture was cooled to room temperature at a rate of 5 Â°C per hour. After stirring at room temperature for 14 h, the mixture was filtered and dried to provide the final product as a white crystalline solid (136.84 g, 74%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 7.88â7.78 (m, 1.78H), 7.75â7.69 (s, 1.22H), 7.51â7.43 (m, 1H), 7.17â7.11 (m, 1H), 6.30â6.28 (m, 1H), 4.03â3.48 (m, 7H), 3.29â3.21 (m, 1H), 3.15â2.92 (m, 2H), 2.30 (s, 6H). <sup>13</sup>C NMR, all peaks reported (151 MHz, DMSO-<i>d</i><sub>6</sub>) 171.73, 171.67, 166.62, 166.50, 165.40, 165.37, 164.25, 162.62, 162.50, 142.32, 142.24, 142.06, 141.97, 141.61, 141.57, 136.69, 124.21, 124.11, 124.05, 120.77, 120.61, 113.59, 113.46, 56.35, 56.15, 55.85, 55.53, 55.30, 54.97, 54.94, 54.84, 46.64, 46.43, 45.52, 45.46, 45.19, 45.05, 44.91, 44.77, 44.63, 44.49, 44.35, 28.91, 28.89. MS (ESI) mass calcd for C<sub>21</sub>H<sub>22</sub>FN<sub>7</sub>O, 407.19; <i>m</i>/<i>z</i> found, 408 [M + H]<sup>+</sup>. Anal. Calcd for C<sub>21</sub>H<sub>22</sub>FN<sub>7</sub>O: C, 61.90; H, 5.44; N, 24.06. Found: C, 61.83; H, 5.42; N, 24.08.</div></div><div id="sec7_12_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> DMPK. General Methods</h3><div class="NLM_p last">A 10 mM compound stock solution in DMSO further diluted in acetonitrile/water to yield a secondary 1 mM solution was used in all in vitro assays. Pooled human liver microsomes of mixed gender, mouse, rat, beagle dog, and cynomolgus monkey of male gender were purchased from BD Gentest (Woburn, MA). Plasma from various species was purchased from Bioreclamation, Inc. (Westbury, NY). All other commercially available reagents and solvents were either analytical or HPLC grade. In vitro and PK samples were analyzed by LCâMS/MS in the multiple reaction monitoring (MRM) scan mode with electrospray ionization (ESI).</div></div><div id="sec7_12_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Caco-2 Permeability</h3><div class="NLM_p last">Bidirectional permeability (A to B and B to A, pH 7.4/pH 7.4) was assessed in a subclone of the Caco-2 cell line, TC7, by Cerep at a compound concentration of 10 Î¼M using the standard Cerep protocol.</div></div><div id="sec7_12_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Plasma Protein Binding</h3><div class="NLM_p last">The stock solution of compound was spiked into blank plasma to yield 0.1, 1, or 10 Î¼M final concentration. Equilibrium dialysis was performed using the RED Device (Thermo Scientific, Rockford, IL) consisting of Teflon base plate, and RED Device inserts comprised two (sample and buffer) side-by-side chambers separated by dialysis membrane (MWCO â 8000). A 300 Î¼L aliquot of plasma spiked with a compound in triplicate was placed into the sample chamber, and 500 Î¼L of dialysis buffer was loaded into the buffer chamber. The dialysis unit was covered with sealing tape and incubated in a 37 Â°C orbital shaking incubator at 100 rpm for 6 h. After a 6 h dialysis, 10 Î¼L of plasma sample was diluted with 90 Î¼L of PBS buffer, and 90 Î¼L of each buffer sample was mixed with 10 Î¼L of blank plasma in a 96-well plate and extracted with 150 Î¼L of acetonitrile to precipitate proteins. The supernatant was analyzed by LCâMS/MS. The preliminary (tier 1) assay was conducted at a compound concentration of 1 Î¼M using a two-point (0 and 1 Î¼M) calibration curve. The definitive plasma protein binding for compound <b>34</b> was conducted in five species at three different concentrations (0.1, 1, or 10 Î¼M) using the full calibration curve and three sets of quality control samples. Calibration curve samples were prepared by spiking appropriate stock solutions into a mixture of blank plasma and PBS buffer (1:9, v/v).</div></div><div id="sec7_12_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Brain Tissue Binding</h3><div class="NLM_p last">Brain tissue binding was assessed by an equilibrium dialysis technique similar to the procedure described for plasma protein binding. Rat brain tissue homogenate prepared in PBS buffer, pH 7.4 (1:10, w/v), was spiked with compound DMSO stock solution to yield a final concentration of 5 Î¼M. The dialysis was carried out in a shaking incubator at 37 Â°C for 5 h. After incubation, 25 Î¼L of homogenate or 50 Î¼L of buffer was extracted with 50 Î¼L of DMSO and 300 Î¼L of acetonitrile and analyzed by LCâMS/MS using the calibration curves across an appropriate concentration range and quality control samples. All determinations were conducted in triplicate. The apparent unbound fraction (<i>f</i><sub>u,app</sub>) was determined as<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/jm-2015-00742w_m001.gif" alt="" /></img></span>where [A]<sub>homogenate</sub> is the concentration measured in the homogenate and [A]<sub>buffer</sub> the concentration measured in the buffer. The unbound fraction in undiluted brain was calculated as<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/jm-2015-00742w_m002.gif" alt="" /></img></span>where <i>D</i> is the dilution factor of 10. Subsequently, the percentage compound bound to brain tissue (%Â BTB) was determined as<span class="NLM_disp-formula" id="ueq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/jm-2015-00742w_m003.gif" alt="" /></img></span></div></div><div id="sec7_12_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Stability in Liver Microsomes</h3><div class="NLM_p last">Stability in liver microsomes from human, mouse, rat, dog, or monkey was assessed over a time course of 1 h. The incubation mixture consisted of 0.5 mg/mL microsomal protein, 1 Î¼M compound, 1.8 mM MgCl<sub>2</sub>, and 2 mM NADPH in 0.1 M potassium phosphate buffer, pH 7.4. After incubation for 5, 10, 20, 40, and 60 min at 37 Â°C, the reaction was terminated by the addition of 5 volumes of acetonitrile containing internal standard (5,5-diphenylhydantoin). The samples were analyzed by LCâMS/MS, and the percent remaining at various time points was calculated by dividing the observed analyte/internal standard peak ratio by the ratio at the 0 time point. The half-life (<i>t</i><sub>1/2</sub>) was calculated as <i>t</i><sub>1/2</sub> = ln(2)/(â<i>k</i>), where <i>k</i> is the slope of the linear regression from natural log percent remaining versus time. In vitro hepatic clearance (CL) was calculated as CL = (<i>Q</i>)(CL<sub>int</sub>)/(<i>Q</i>+ CL<sub>int</sub>), where <i>Q</i> is the hepatic blood flow in mL min<sup>â1</sup> kg<sup>â1</sup> (mouse, 90; rat, 55; dog, 31; monkey, 44, human, 21) and CL<sub>int</sub> is the intrinsic microsomal clearance determined as CL<sub>int</sub> = (â<i>k</i>)(microsomal protein conc)<sup>â1</sup>(<i>A</i>)(<i>N</i>), where <i>A</i> is the microsomal protein yield (45 mg) per 1 g of liver and <i>N</i> is 25.7, 30, 32, 40, and 87.5 g of liver per kg of body weight for human, monkey, dog, rat, and mouse, respectively. Extraction ratio (ER) was calculated as ER = CL/<i>Q</i>.</div></div><div id="sec7_12_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> CYP Inhibition</h3><div class="NLM_p last">The potential to inhibit various isoforms of human cytochrome P450 (CYP1A2, 2C8, 2C9, 2C19, 2D6, and 3A4) was investigated by incubating human liver microsomes (0.2 mg/mL) with a âcocktailâ of CYP probe substrates (phenacetin for CYP1A2, paclitaxel for CYP2C8, diclofenac for CYP2C9, <i>S</i>-mephenytoin for CYP2C19, dextromethorphan for 2D6, and midazolam for CYP3A4) in the presence of compound at concentrations ranging from 0 (vehicle) to 10 Î¼M. Metabolite formation by probe substrates was quantified by LCâMS/MS. The percent inhibition was measured as the ratio of metabolite peak in the presence and absence of compound Ã 100. The IC<sub>50</sub> values were calculated from the percent inhibition data relative to vehicle.</div></div><div id="sec7_12_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Pharmacokinetic Studies</h3><div class="NLM_p last">Single dose pharmacokinetic studies in preclinical species (male Balb/c mice, Sprague Dawley rats, beagle dogs, or cynomolgus monkeys) were conducted following iv (1 mg/kg) and po (5 mg/kg) administration as a solution in 20% hydroxypropyl-Î²-cyclodextrin (HP-Î²-CD). Blood was sampled at predose and at 0.033 (iv), 0.083 (iv), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose. In dogs, instead of 6 and 8 h time points blood was drawn at 7 h. Plasma concentrations were quantitated by LCâMS/MS. Pharmacokinetic parameters were derived from noncompartmental analysis of the plasma concentration vs time data using WinNonlin software (Pharsight, Palo Alto, CA).</div></div><div id="sec7_12_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Developability Assay Protocols. HPLC</h3><div class="NLM_p last">An Agilent model 1100 equipped with a diode array detector was used for chromatographic quantification. A linear gradient method from 5% to 100% solvent B (organic phase) over 15 min at a rate of 1.0 mL/min was used to separate the compound and its impurities/degradants on a 150 mm Ã 4.6 mm Phenomenex Luna C18 (2) 5 Î¼m, 100 Ã column, maintained at 40 Â°C. The aqueous mobile phase consisted of a 0.05% TFA solution in water while the organic phase contained 0.05% TFA in acetonitrile. Detection was done by UV at 240 nm.</div></div><div id="sec7_12_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Oxidation Stability Studies</h3><div class="NLM_p last">Oxidative stability in solution was assessed in the presence of 0.1% H<sub>2</sub>O<sub>2</sub> and 5 mM AIBN, a free-radical forming agent. Solutions (0.1 mg/mL) in 1:1 methanol/water containing either H<sub>2</sub>O<sub>2</sub> or AIBN were incubated for 24 h at room temperature or at 40 Â°C, respectively, and then assayed by HPLC against external standards and controls.</div></div><div id="sec7_12_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Photostability Studies</h3><div class="NLM_p last">The light stability in 50% aqueous acetonitrile (0.1 mg/mL) was investigated under ICH Guideline, option 2 (cool white fluorescent light, 1.2 million lxÂ·h and near UV 200 WÂ·h/m<sup>2</sup>) using a Caron photostability chamber model 6540-1. The samples were analyzed by HPLC, against external standards.</div></div><div id="sec7_12_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Powder X-ray Diffractometry (PXRD)</h3><div class="NLM_p last">Philips XâPERT PRO with XâCelerator Cu detector equipped with a real time multiple strips X-ray detection technology was used to obtain X-ray powder patterns of the various batches of compound <b>34</b> (JNJ-42847922). The samples were scanned from 4Â° to 40Â° 2Î¸ at a step size 0.0167Â° 2Î¸ and a time per step of 29.8450 s. The tube voltage and current were 45 kV and 40 mA, respectively. The samples were placed onto zero background holders and analyzed on a spinning stage.</div></div><div id="sec7_12_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Thermogravimetric Analysis (TGA)</h3><div class="NLM_p last">The analyses were performed on a TA Instruments model TGA Q 50 and Q 500 under a nitrogen purge. The samples were placed in aluminum pans and scanned at a rate of 10 Â°C/min up to 400 Â°C.</div></div><div id="sec7_12_8_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Differential Scanning Calorimetry (DSC)</h3><div class="NLM_p last">DSC scans were recorded on a TA Instruments model DCS Q 100. The samples, placed in hermetic DSC pans punctured with a single hole in the lid, were scanned at a rate of 10 Â°C/min under a nitrogen purge.</div></div><div id="sec7_12_8_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Moisture Sorption Analysis</h3><div class="NLM_p last">Moisture isotherms were recorded on a Hiden Isochema model IGAsorp moisture sorption analyzer. After weight stabilization at 40% relative humidity (RH), the sample was introduced to increasing amounts of humidity at 10% RH intervals up to 90% RH. During the desorption cycle, the sample was brought to 0% RH in 10% RH increments. Experiments were conducted isothermally at 25 Â°C.</div></div><div id="sec7_12_8_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Solubility in Aqueous Systems</h3><div class="NLM_p last">Solubility in 30 mM phosphate buffers (pH 2 and pH 7), simulated gastric (SGF, 0.2% NaCl in 0.1 N HCl, pH 1.2) and intestinal fluids (FasSIF, 0.029 M phosphate buffer, 5 mM sodium taurocholate, and 1.5 mM lecithin, pH 6.8) was investigated. Compound was dissolved in DMSO solutions at a concentration of 10 mM and was used for the solubility experiment. DMSO solutions (20 Î¼L) are dispensed in 96-well plates, and the solvent is removed by evaporation using a Caliper TurboVap 96 set at 30 Â°C and a flow rate of 40 Fh. Buffers (400 Î¼L) of interest are added to the residual solids, and the resulting mixtures are stirred at room temperature for 3 days using magnetic stir bars. The samples are then filtered using an AcroPrep 1 mL 96 filter plate, and the supernatant is analyzed for compound concentration, against external standards.</div></div><div id="sec7_12_8_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Solid State Stability</h3><div class="NLM_p last">The solid active pharmaceutical ingredient (API) was stored under ambient laboratory conditions and at 80 Â°C/ambient relative humidity (RH) in closed vial configuration and at 40 Â°C/75%RH in open vial configuration. At various time intervals, the solid material was sampled and analyzed by HPLC and PXRD to assess its chemical and physical stability.</div></div><div id="sec7_12_8_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Oxidative Stability in Solution</h3><div class="NLM_p last">Oxidative stability of the molecule in solution was assessed in the presence of 0.1% H<sub>2</sub>O<sub>2</sub> and 5 mM AIBN, a free-radical forming agent. Solutions of JNJ-54717793 in 1:1 methanol/water containing either H<sub>2</sub>O<sub>2</sub> or AIBN were incubated for 24 h at room temperature or at 40 Â°C, respectively, and then assayed by HPLC against external standards and controls.</div></div><div id="sec7_12_8_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Photolytic Stability in Solution</h3><div class="NLM_p last">Solution photostability (0.1 mg/mL) in 1:1 acetonitrile/water mixture was assessed using the Caron chamber model 6540-1 (ICH Guideline, option 1). The controls were stored in aluminum-wrapped vials. The samples were then assayed by HPLC against external standards.</div></div><div id="sec7_12_8_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Chemical Stability as a Function of pH</h3><div class="NLM_p last">The chemical stability as a function of pH at room temperature and 60 Â°C was assessed from pH 2 (30 mM phosphate), pH 4 (30 mM acetate), pH 7.4 (30 mM phosphate), and pH 10 (30 mM carbonate) solutions after 1 and 4 weeks of storage. The samples were assayed by HPLC against external standards.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i116"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00742">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">PXRD scan, DSC, and TGA of <b>34</b>; a csv file containing molecular formula strings. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00742" class="ext-link">10.1021/acs.jmedchem.5b00742</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00742/suppl_file/jm5b00742_si_001.pdf">jm5b00742_si_001.pdf (116.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00742/suppl_file/jm5b00742_si_002.csv">jm5b00742_si_002.csv (2.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00742" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Letavic</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3855545d4c594e515b78514c4b16525652165b5755"><span class="__cf_email__" data-cfemail="204d4c455441564943604954530e4a4e4a0e434f4d">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Bonaventure</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas I. Carruthers</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Dugovic</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana Koudriakova</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Lord</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy W. Lovenberg</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiev S. Ly</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neelakandha S. Mani</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane Nepomuceno</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Pippel</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele Rizzolio</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan E. Shelton</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chandra R. Shah</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brock T. Shireman</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lana K. Young</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sujin Yun</span> - <span class="hlFld-Affiliation affiliation">Janssen Pharmaceutical Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3417e5656-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors gratefully acknowledge the chemistry team at BioBlocks, Inc., for the preparation and characterization of compounds <b>11</b>â<b>33</b> and <b>35</b>â<b>40</b>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i119" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i119"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i120" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i120"> Abbreviations Used</h2><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">OX2R</td><td class="NLM_def"><p class="first last">orexin-2 receptor</p></td></tr><tr><td class="NLM_term">OX1R</td><td class="NLM_def"><p class="first last">orexin-1 receptor</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">RO</td><td class="NLM_def"><p class="first last">receptor occupancy</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">NREM</td><td class="NLM_def"><p class="first last">non rapid eye movement</p></td></tr><tr><td class="NLM_term">REM</td><td class="NLM_def"><p class="first last">rapid eye movement</p></td></tr><tr><td class="NLM_term">EEG</td><td class="NLM_def"><p class="first last">electroencephalogram</p></td></tr><tr><td class="NLM_term">GLP</td><td class="NLM_def"><p class="first last">good laboratory practice</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">SIF</td><td class="NLM_def"><p class="first last">simulated intestinal fluid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i121">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">de Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilduff, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foye, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battenberg, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, F. S.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankel, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Pol, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span><span class="refDoi">Â DOI: 10.1073/pnas.95.1.322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1073%2Fpnas.95.1.322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=9419374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=322-327&author=L.+de+Leceaauthor=T.+S.+Kilduffauthor=C.+Peyronauthor=X.+Gaoauthor=P.+E.+Foyeauthor=P.+E.+Danielsonauthor=C.+Fukuharaauthor=E.+L.+Battenbergauthor=V.+T.+Gautvikauthor=F.+S.+Bartlettauthor=W.+N.+Frankelauthor=A.+N.+van+den+Polauthor=F.+E.+Bloomauthor=K.+M.+Gautvikauthor=J.+G.+Sutcliffe&title=The+hypocretins%3A+hypothalamus-specific+peptides+with+neuroexcitatory+activity&doi=10.1073%2Fpnas.95.1.322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span></div><div class="casAuthors">De Lecea, L.; Kilduff, T. S.; Peyron, C.; Gao, X. -B.; Foye, P. E.; Danielson, P. E.; Fukuhara, C.; Battenberg, E. L. F.; Gautvik, V. T.; Bartlett, F. S., II; Frankel, W. N.; Van Den Pol, A. N.; Bloom, F. E.; Gautvik, K. M.; Sutcliffe, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin.  The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas.  The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus.  Hcrt immunoreactivity is assocd. with large granular vesicles at synapses.  One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons.  These observations suggest that the hypocretins function within the CNS as neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEQa5lFLKr7Vg90H21EOLACvtfcHk0ljJMv3ft9Zh6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D&md5=52bde93a7933953f02930a6f57a0f1b1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.1.322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.1.322%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLecea%26aufirst%3DL.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DPeyron%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DFoye%26aufirst%3DP.%2BE.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DFukuhara%26aufirst%3DC.%26aulast%3DBattenberg%26aufirst%3DE.%2BL.%26aulast%3DGautvik%26aufirst%3DV.%2BT.%26aulast%3DBartlett%26aufirst%3DF.%2BS.%26aulast%3DFrankel%26aufirst%3DW.%2BN.%26aulast%3Dvan%2Bden%2BPol%26aufirst%3DA.%2BN.%26aulast%3DBloom%26aufirst%3DF.%2BE.%26aulast%3DGautvik%26aufirst%3DK.%2BM.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520hypocretins%253A%2520hypothalamus-specific%2520peptides%2520with%2520neuroexcitatory%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D322%26epage%3D327%26doi%3D10.1073%2Fpnas.95.1.322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chemelli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinton, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisanuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">451</span><span class="refDoi">Â DOI: 10.1016/S0092-8674(00)81973-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2FS0092-8674%2800%2981973-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=437-451&author=R.+M.+Chemelliauthor=J.+T.+Willieauthor=C.+M.+Sintonauthor=J.+K.+Elmquistauthor=T.+Scammellauthor=C.+Leeauthor=J.+A.+Richardsonauthor=S.+C.+Williamsauthor=Y.+Xiongauthor=Y.+Kisanukiauthor=T.+E.+Fitchauthor=M.+Nakazatoauthor=R.+E.+Hammerauthor=C.+B.+Saperauthor=M.+Yanagisawa&title=Narcolepsy+in+orexin+knockout+mice%3A+molecular+genetics+of+sleep+regulation&doi=10.1016%2FS0092-8674%2800%2981973-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981973-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981973-X%26sid%3Dliteratum%253Aachs%26aulast%3DChemelli%26aufirst%3DR.%2BM.%26aulast%3DWillie%26aufirst%3DJ.%2BT.%26aulast%3DSinton%26aufirst%3DC.%2BM.%26aulast%3DElmquist%26aufirst%3DJ.%2BK.%26aulast%3DScammell%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKisanuki%26aufirst%3DY.%26aulast%3DFitch%26aufirst%3DT.%2BE.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DHammer%26aufirst%3DR.%2BE.%26aulast%3DSaper%26aufirst%3DC.%2BB.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DNarcolepsy%2520in%2520orexin%2520knockout%2520mice%253A%2520molecular%2520genetics%2520of%2520sleep%2520regulation%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D437%26epage%3D451%26doi%3D10.1016%2FS0092-8674%2800%2981973-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Peyron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overeem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevsimalova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padigaru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku-cherlapati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignot, E.</span><span> </span><span class="NLM_article-title">A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">â</span> <span class="NLM_lpage">997</span><span class="refDoi">Â DOI: 10.1038/79690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1038%2F79690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10973318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms12kt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=991-997&author=C.+Peyronauthor=J.+Faracoauthor=W.+Rogersauthor=B.+Ripleyauthor=S.+Overeemauthor=Y.+Charnayauthor=S.+Nevsimalovaauthor=M.+Aldrichauthor=D.+Reynoldsauthor=R.+Albinauthor=R.+Liauthor=M.+Hungsauthor=M.+Pedrazzoliauthor=M.+Padigaruauthor=M.+Ku-cherlapatiauthor=J.+Fanauthor=R.+Makiauthor=G.+J.+Lammersauthor=C.+Bourasauthor=R.+Kucherlapatiauthor=S.+Nishinoauthor=E.+Mignot&title=A+mutation+in+a+case+of+early+onset+narcolepsy+and+a+generalized+absence+of+hypocretin+peptides+in+human+narcoleptic+brains&doi=10.1038%2F79690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains</span></div><div class="casAuthors">Peyron, Christelle; Farago, Juliette; Rogers, William; Ripley, Beth; Overeem, Sebastiaan; Charnay, Yves; Nevsimalova, Sona; Aldrich, Michael; Reynolds, David; Albin, Roger; Li, Robin; Hungs, Marcel; Pedrazzoli, Mario; Padigaru, Muralidhara; Kucherlapati, Melanie; Fan, Jun; Maki, Richard; Lamers, Gert Jan; Bouras, Constantin; Kucherlapati, Raju; Nishino, Seiji; Mignot, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">991-997</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The authors explored the role of hypocretins in human narcolepsy through histopathol. of six narcolepsy brains and mutation screening of Hcrt, Hcrtr1 and Hcrtr2 in 74 patients of various human leukocyte antigen and family history status.  One Hcrt mutation, impairing peptide trafficking and processing, was found in a single case with early onset narcolepsy.  In situ hybridization of the perifornical area and peptide RIAs indicated global loss of hypocretins, without gliosis or signs of inflammation in all human cases examd.  Although hypocretin loci do not contribute significantly to genetic predisposition, most cases of human narcolepsy are assocd. with a deficient hypocretin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUmBvCqyh0ELVg90H21EOLACvtfcHk0lggzh1SLY2q1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms12kt7o%253D&md5=dad91a4477e7305a4b565241ddcc350b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F79690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79690%26sid%3Dliteratum%253Aachs%26aulast%3DPeyron%26aufirst%3DC.%26aulast%3DFaraco%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DW.%26aulast%3DRipley%26aufirst%3DB.%26aulast%3DOvereem%26aufirst%3DS.%26aulast%3DCharnay%26aufirst%3DY.%26aulast%3DNevsimalova%26aufirst%3DS.%26aulast%3DAldrich%26aufirst%3DM.%26aulast%3DReynolds%26aufirst%3DD.%26aulast%3DAlbin%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DHungs%26aufirst%3DM.%26aulast%3DPedrazzoli%26aufirst%3DM.%26aulast%3DPadigaru%26aufirst%3DM.%26aulast%3DKu-cherlapati%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DMaki%26aufirst%3DR.%26aulast%3DLammers%26aufirst%3DG.%2BJ.%26aulast%3DBouras%26aufirst%3DC.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DMignot%26aufirst%3DE.%26atitle%3DA%2520mutation%2520in%2520a%2520case%2520of%2520early%2520onset%2520narcolepsy%2520and%2520a%2520generalized%2520absence%2520of%2520hypocretin%2520peptides%2520in%2520human%2520narcoleptic%2520brains%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D991%26epage%3D997%26doi%3D10.1038%2F79690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="note"><p class="first last">For reviews on orexin antagonists see the following:</p></div><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Orexin receptors as therapeutic drug targets</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">â</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2FB978-0-444-59489-1.00010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=22813974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgsLbM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2012&pages=163-188&author=A.+L.+Gotterauthor=A.+J.+Roeckerauthor=R.+Hargreavesauthor=P.+J.+Colemanauthor=C.+J.+Winrowauthor=J.+J.+Renger&title=Orexin+receptors+as+therapeutic+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptors as therapeutic drug targets</span></div><div class="casAuthors">Gotter, Anthony L.; Roecker, Anthony J.; Hargreaves, Richard; Coleman, Paul J.; Winrow, Christopher J.; Renger, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">Orexin/Hypocretin System</span>),
    <span class="NLM_cas:pages">163-188</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Orexin (hypocretin) receptor antagonists stand as a model for the development of targeted CNS small-mol. therapeutics.  The identification of mutations in the gene for the orexin 2 receptor responsible for canine narcolepsy, the demonstration of a hypersomnolence phenotype in hypocretin knockout mice and the disruption in orexin signaling in narcoleptic patients provides clear genetic proof of concept for targeting orexin-induced arousal for the treatment of insomnia.  The full characterization of the genes encoding orexin and its two cognate receptors enabled the rapid development of in vitro and ex vivo assays with which to identify lead compd. structures and to optimize potency and pharmacokinetic properties.  Polysomnog. measures with cross-species translatability capable of measuring the sleep-promoting effects of orexin receptor antagonists from mice to man, and the existence of knockout models not only allow efficacy assessment but also the demonstration of mechanism of action.  Focused efforts by a no. of groups have identified potent compds. of diverse chem. structure with differential orexin receptor selectivity for either the orexin 1 receptor (OX1R) or the orexin 2 receptor (OX2R), or both.  This work has yielded tool compds. that, along with genetic models, have been used to specifically define the role these receptors in mediating orexin-induced arousal and vigilance state control.  Optimized dual receptor antagonists with favorable pharmacokinetic and safety profiles have now demonstrated efficacy in clin. development and represent a distinct mechanism of action for the treatment of insomnia relative to current std. of care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL4kWIM-gesbVg90H21EOLACvtfcHk0lggzh1SLY2q1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgsLbM&md5=3f18a84253a9dc9692c5d07c616dc189</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-59489-1.00010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-59489-1.00010-0%26sid%3Dliteratum%253Aachs%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DOrexin%2520receptors%2520as%2520therapeutic%2520drug%2520targets%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2012%26volume%3D198%26spage%3D163%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists: a new concept in CNS disorders</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">â</span> <span class="NLM_lpage">1214</span><span class="refDoi">Â DOI: 10.1002/cmdc.201000132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1002%2Fcmdc.201000132" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1197-1214&author=J.+Gatfieldauthor=C.+Brisbare-Rochauthor=F.+Jenckauthor=C.+Boss&title=Orexin+receptor+antagonists%3A+a+new+concept+in+CNS+disorders&doi=10.1002%2Fcmdc.201000132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000132%26sid%3Dliteratum%253Aachs%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DBoss%26aufirst%3DC.%26atitle%3DOrexin%2520receptor%2520antagonists%253A%2520a%2520new%2520concept%2520in%2520CNS%2520disorders%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1197%26epage%3D1214%26doi%3D10.1002%2Fcmdc.201000132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mieda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span> </span><span class="NLM_article-title">Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">90</span><span class="refDoi">Â DOI: 10.1007/s40263-012-0036-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1007%2Fs40263-012-0036-8" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=83-90&author=M.+Miedaauthor=T.+Sakurai&title=Orexin+%28hypocretin%29+receptor+agonists+and+antagonists+for+treatment+of+sleep+disorders%3A+rationale+for+development+and+current+status&doi=10.1007%2Fs40263-012-0036-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1007%2Fs40263-012-0036-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-012-0036-8%26sid%3Dliteratum%253Aachs%26aulast%3DMieda%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DT.%26atitle%3DOrexin%2520%2528hypocretin%2529%2520receptor%2520agonists%2520and%2520antagonists%2520for%2520treatment%2520of%2520sleep%2520disorders%253A%2520rationale%2520for%2520development%2520and%2520current%2520status%26jtitle%3DCNS%2520Drugs%26date%3D2013%26volume%3D27%26spage%3D83%26epage%3D90%26doi%3D10.1007%2Fs40263-012-0036-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Discovery and development of orexin receptor antagonists as therapeutics for insomnia</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">â</span> <span class="NLM_lpage">293</span><span class="refDoi">Â DOI: 10.1111/bph.12261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1111%2Fbph.12261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=23731216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=283-293&author=C.+J.+Winrowauthor=J.+J.+Renger&title=Discovery+and+development+of+orexin+receptor+antagonists+as+therapeutics+for+insomnia&doi=10.1111%2Fbph.12261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of orexin receptor antagonists as therapeutics for insomnia</span></div><div class="casAuthors">Winrow, C. J.; Renger, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-293</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Insomnia persistently affects the quality and quantity of sleep.  Currently approved treatments for insomnia primarily target Î³-aminobutyric acid-A (GABA-A) receptor signalling and include benzodiazepines and GABA-A receptor modulators.  These drugs are used to address this sleep disorder, but have the potential for side effects such as tolerance and dependence, making them less attractive as maintenance therapy.  Forward and reverse genetic approaches in animals have implicated orexin signalling (also referred to as hypocretin signalling) in the control of vigilance and sleep/wake states.  Screening for orexin receptor antagonists using in vitro and in vivo methods in animals has identified compds. that block one or other of the orexin receptors (single or dual orexin receptor antagonists [SORAs and DORAs], resp.) in animals and humans.  SORAs have primarily been used as probes to further elucidate the roles of the individual orexin receptors, while a no. of DORAs have progressed to clin. development as pharmaceutical candidates for insomnia.  The DORA almorexant demonstrated significant improvements in a no. of clin. relevant sleep parameters in animal models and in patients with insomnia but its development was halted.  SB-649868 and suvorexant have demonstrated efficacy and tolerability in Phase II and III trials resp.  Furthermore, suvorexant is currently under review by the Food and Drug Administration for the treatment of insomnia.  Based on the publication of recent non-clin. and clin. data, orexin receptor antagonists potentially represent a targeted, effective and well-tolerated new class of medications for insomnia.  Linked Articles : This article is part of a themed section on Orexin Receptors.  To view the other articles in this section visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFkesyU8tIxrVg90H21EOLACvtfcHk0lhq39khUQqrsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3O&md5=48f92a02b193a648d387c55329fb5fcf</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1111%2Fbph.12261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12261%26sid%3Dliteratum%253Aachs%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520development%2520of%2520orexin%2520receptor%2520antagonists%2520as%2520therapeutics%2520for%2520insomnia%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D283%26epage%3D293%26doi%3D10.1111%2Fbph.12261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists in development for insomnia and CNS disorders</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">â</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=73-87&author=S.+D.+Kudukauthor=C.+J.+Winrowauthor=P.+J.+Coleman&title=Orexin+receptor+antagonists+in+development+for+insomnia+and+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DOrexin%2520receptor%2520antagonists%2520in%2520development%2520for%2520insomnia%2520and%2520CNS%2520disorders%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D73%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hoever, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiossi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gerven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">â</span> <span class="NLM_lpage">600</span><span class="refDoi">Â DOI: 10.1038/clpt.2010.19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1038%2Fclpt.2010.19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=20376002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFCntLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2010&pages=593-600&author=P.+Hoeverauthor=S.+de+Haasauthor=J.+Winklerauthor=R.+C.+Schoemakerauthor=E.+Chiossiauthor=J.+van+Gervenauthor=J.+Dingemanse&title=Orexin+receptor+antagonism%2C+a+new+sleep-promoting+paradigm%3A+an+ascending+single-dose+study+with+almorexant&doi=10.1038%2Fclpt.2010.19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant</span></div><div class="casAuthors">Hoever, P.; de Haas, S.; Winkler, J.; Schoemaker, R. C.; Chiossi, E.; van Gerven, J.; Dingemanse, J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-600</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Almorexant, a dual orexin receptor antagonist potentially representing a new class of sleep-promoting compds., was administered in an ascending single-dose study to evaluate tolerability, pharmacokinetics, and pharmacodynamics.  Seventy healthy male subjects were enrolled in this double-blind, placebo- and active-controlled study.  Each dose level (1-1,000 mg) was investigated in a sep. group of 10 subjects (6 on almorexant, 2 on placebo, 2 on zolpidem 10 mg).  Almorexant was well tolerated with no signs of cataplexy.  Peak plasma concn. (Cmax) was quickly attained (median time to max. concn. (tmax) ranged from 0.7 to 2.3 h), and plasma concns. subsequently decreased quickly to â¼20% of Cmax over the course of 8 h.  Vigilance, alertness, and visuomotor and motor coordination were reduced following daytime administration of zolpidem or almorexant at doses of â¥400 mg.  Population pharmacokinetic/pharmacodynamic modeling suggested that doses of â¼500 mg almorexant and 10 mg zolpidem are equiv. with respect to subjectively assessed alertness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ9nYFrp8FEbVg90H21EOLACvtfcHk0li3o_jsWP2RVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFCntLk%253D&md5=528965794ed9ae22a832f66b8047ed7b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2010.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2010.19%26sid%3Dliteratum%253Aachs%26aulast%3DHoever%26aufirst%3DP.%26aulast%3Dde%2BHaas%26aufirst%3DS.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DSchoemaker%26aufirst%3DR.%2BC.%26aulast%3DChiossi%26aufirst%3DE.%26aulast%3Dvan%2BGerven%26aufirst%3DJ.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DOrexin%2520receptor%2520antagonism%252C%2520a%2520new%2520sleep-promoting%2520paradigm%253A%2520an%2520ascending%2520single-dose%2520study%2520with%2520almorexant%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2010%26volume%3D87%26spage%3D593%26epage%3D600%26doi%3D10.1038%2Fclpt.2010.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5320</span><span class="NLM_x">â</span> <span class="NLM_lpage">5332</span><span class="refDoi">Â DOI: 10.1021/jm100541c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100541c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVegsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5320-5332&author=C.+D.+Coxauthor=M.+J.+Breslinauthor=D.+B.+Whitmanauthor=J.+D.+Schreierauthor=G.+B.+McGaugheyauthor=M.+J.+Boguskyauthor=A.+J.+Roeckerauthor=S.+P.+Mercerauthor=R.+A.+Bednarauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=D.+R.+Reissauthor=C.+M.+Harrellauthor=K.+L.+Murphyauthor=S.+L.+Garsonauthor=S.+M.+Doranauthor=T.+Prueksaritanontauthor=W.+B.+Andersonauthor=C.+Tangauthor=S.+Rollerauthor=T.+D.+Cabaluauthor=D.+Cuiauthor=G.+D.+Hartmanauthor=S.+D.+Youngauthor=K.+S.+Koblanauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+the+dual+orexin+receptor+antagonist+%5B%287R%29-4-%285-chloro-1%2C3-benzoxazol-2-yl%29-7-methyl-1%2C4-diazepan-1-yl%5D%5B5-methyl-2-%282H-1%2C2%2C3-triazol-2-yl%29phenyl%5Dmethanone+%28MK-4305%29+for+the+treatment+of+insomnia&doi=10.1021%2Fjm100541c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia</span></div><div class="casAuthors">Cox, Christopher D.; Breslin, Michael J.; Whitman, David B.; Schreier, John D.; McGaughey, Georgia B.; Bogusky, Michael J.; Roecker, Anthony J.; Mercer, Swati P.; Bednar, Rodney A.; Lemaire, Wei; Bruno, Joseph G.; Reiss, Duane R.; Harrell, C. Meacham; Murphy, Kathy L.; Garson, Susan L.; Doran, Scott M.; Prueksaritanont, Thomayant; Anderson, Wayne B.; Tang, Cuyue; Roller, Shane; Cabalu, Tamara D.; Cui, Donghui; Hartman, George D.; Young, Steven D.; Koblan, Ken S.; Winrow, Christopher J.; Renger, John J.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5320-5332</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite increased understanding of the biol. basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years.  One notable exception is inhibition of the excitatory neuropeptides orexins A and B by design of orexin receptor antagonists.  Herein, we describe how efforts to understand the origin of poor oral pharmacokinetics in a leading HTS-derived diazepane orexin receptor antagonist led to the identification of compd. 10 with a 7-Me substitution on the diazepane core.  Though 10 displayed good potency, improved pharmacokinetics, and excellent in vivo efficacy, it formed reactive metabolites in microsomal incubations.  A mechanistic hypothesis coupled with an in vitro assay to assess bioactivation led to replacement of the fluoroquinazoline ring of 10 with a chlorobenzoxazole to provide 3 (MK-4305), a potent dual orexin receptor antagonist that is currently being tested in phase III clin. trials for the treatment of primary insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZsDTh00qOaLVg90H21EOLACvtfcHk0li3o_jsWP2RVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVegsrw%253D&md5=8930a483f7058c4b51e2a941fb779180</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm100541c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100541c%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BM.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DW.%2BB.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520the%2520dual%2520orexin%2520receptor%2520antagonist%2520%255B%25287R%2529-4-%25285-chloro-1%252C3-benzoxazol-2-yl%2529-7-methyl-1%252C4-diazepan-1-yl%255D%255B5-methyl-2-%25282H-1%252C2%252C3-triazol-2-yl%2529phenyl%255Dmethanone%2520%2528MK-4305%2529%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5320%26epage%3D5332%26doi%3D10.1021%2Fjm100541c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yang, L. P. H.</span><span> </span><span class="NLM_article-title">Suvorexant: first global approval</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">â</span> <span class="NLM_lpage">1822</span><span class="refDoi">Â DOI: 10.1007/s40265-014-0294-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1007%2Fs40265-014-0294-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=25227290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFynsrzI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1817-1822&author=L.+P.+H.+Yang&title=Suvorexant%3A+first+global+approval&doi=10.1007%2Fs40265-014-0294-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Suvorexant: First Global Approval</span></div><div class="casAuthors">Yang, Lily P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1817-1822</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Suvorexant (Belsomra), a first-in-class, orally active dual orexin-1 receptor and orexin-2 receptor antagonist, has been developed by Merck for the treatment of insomnia.  Variations in the levels of the neuropeptides orexin A and orexin B have been linked to circadian rhythms and wakefulness.  Orexin-producing neurons in the lateral hypothalamus regulate wakefulness by signalling through orexin receptors.  Blockade of orexin receptors is known to promote sleep.  Suvorexant was approved in the US in August 2014 for the treatment of adults with sleep onset and/or sleep maintenance insomnia.  The drug is also preregistration in Japan, with approval submissions planned for other countries worldwide for this indication.  This article summarizes the milestones in the development of suvorexant leading to this first approval for insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok1XSXeQfbzrVg90H21EOLACvtfcHk0lgnwKsraKSGNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFynsrzI&md5=4c5382921082b25a5a4c16ea5703cedc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40265-014-0294-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-014-0294-5%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%2BP.%2BH.%26atitle%3DSuvorexant%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2014%26volume%3D74%26spage%3D1817%26epage%3D1822%26doi%3D10.1007%2Fs40265-014-0294-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><div class="note"><p class="first last">For a review describing selective orexin receptor antagonist see the following:</p></div><span class="NLM_contrib-group">Lebold, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span> </span><span class="NLM_article-title">Selective orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">4761</span><span class="NLM_x">â</span> <span class="NLM_lpage">4769</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.06.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2013.06.057" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4761-4769&issue=17&author=T.+P.+Leboldauthor=P.+Bonaventureauthor=B.+T.+Shireman&title=Selective+orexin+receptor+antagonists&doi=10.1016%2Fj.bmcl.2013.06.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.057%26sid%3Dliteratum%253Aachs%26aulast%3DLebold%26aufirst%3DT.%2BP.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26atitle%3DSelective%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4761%26epage%3D4769%26doi%3D10.1016%2Fj.bmcl.2013.06.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Dugovic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span> </span><span class="NLM_article-title">Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">â</span> <span class="NLM_lpage">151</span><span class="refDoi">Â DOI: 10.1124/jpet.109.152009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1124%2Fjpet.109.152009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=19363060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFeltLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=142-151&author=C.+Dugovicauthor=J.+E.+Sheltonauthor=L.+E.+Aluisioauthor=I.+C.+Fraserauthor=X.+Jiangauthor=S.W.+Suttonauthor=P.+Bonaventureauthor=S.+Yunauthor=X.+Liauthor=B.+Lordauthor=C.+A.+Dvorakauthor=N.+I.+Carruthersauthor=T.+W.+Lovenberg&title=Blockade+of+orexin-1+receptors+attenuates+orexin-2+receptor+antagonism-induced+sleep+promotion+in+the+rat&doi=10.1124%2Fjpet.109.152009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat</span></div><div class="casAuthors">Dugovic, Christine; Shelton, Jonathan E.; Aluisio, Leah E.; Fraser, Ian C.; Jiang, Xiaohui; Sutton, Steven W.; Bonaventure, Pascal; Yun, Sujin; Li, Xiaorong; Lord, Brian; Dvorak, Curt A.; Carruthers, Nicholas I.; Lovenberg, Timothy W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-151</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Orexins are peptides produced by lateral hypothalamic neurons that exert a prominent role in the maintenance of wakefulness by activating orexin-1 (OX1R) and orexin-2 (OX2R) receptor located in wake-active structures.  Pharmacol. blockade of both receptors by the dual OX1/2R antagonist (2R)-2-[(1S)-6,7-dimethoxy-1-{2-[4-(trifluoromethyl)phenyl]ethyl}-3,4-dihydroisoquinolin-2(1H)-yl]-N-methyl-2-phenylethanamide (almorexant) has been shown to promote sleep in animals and humans during their active period.  However, the selective distribution of OX1R and OX2R in distinct neuronal circuits may result in a differential impact of these receptors in sleep-wake modulation.  The resp. role of OX1R and OX2R on sleep in correlation with monoamine release was evaluated in rats treated with selective antagonists alone or in combination.  When administered in either phase of the light/dark cycle, the OX2R antagonist 1-(2,4-dibromophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea (JNJ-10397049) decreased the latency for persistent sleep and increased nonrapid eye movement and rapid eye movement sleep time.  Almorexant produced less hypnotic activity, whereas the OX1R antagonist 1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea (SB-408124) had no effect.  Microdialysis studies showed that either OX2R or OX1/2R antagonism decreased extracellular histamine concn. in the lateral hypothalamus, whereas both OX1R and OX1/2R antagonists increased dopamine release in the prefrontal cortex.  Finally, coadministration of the OX1R with the OX2R antagonist greatly attenuated the sleep-promoting effects of the OX2R antagonist.  These results indicate that blockade of OX2R is sufficient to initiate and prolong sleep, consistent with the hypothesis of a deactivation of the histaminergic system.  In addn., it is suggested that simultaneous inhibition of OX1R attenuates the sleep-promoting effects mediated by selective OX2R blockade, possibly correlated with dopaminergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPXVs02jXOYLVg90H21EOLACvtfcHk0lgfnvJG-s_rqA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFeltLk%253D&md5=32a5fc48d949eef2a633187c274cec80</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.152009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.152009%26sid%3Dliteratum%253Aachs%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSutton%26aufirst%3DS.W.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26atitle%3DBlockade%2520of%2520orexin-1%2520receptors%2520attenuates%2520orexin-2%2520receptor%2520antagonism-induced%2520sleep%2520promotion%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D142%26epage%3D151%26doi%3D10.1124%2Fjpet.109.152009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dugovic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span> </span><span class="NLM_article-title">Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism</span> <span class="citation_source-journal">Front. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="refDoi">Â DOI: 10.3389/fnins.2014.00028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.3389%2Ffnins.2014.00028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=24592208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A280%3ADC%252BC2crgt1amuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=28&author=C.+Dugovicauthor=J.+E.+Sheltonauthor=S.+Yunauthor=P.+Bonaventureauthor=B.+T.+Shiremanauthor=T.+W.+Lovenberg&title=Orexin-1+receptor+blockade+dysregulates+REM+sleep+in+the+presence+of+orexin-2+receptor+antagonism&doi=10.3389%2Ffnins.2014.00028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism</span></div><div class="casAuthors">Dugovic Christine; Shelton Jonathan E; Yun Sujin; Bonaventure Pascal; Shireman Brock T; Lovenberg Timothy W</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">In accordance with the prominent role of orexins in the maintenance of wakefulness via activation of orexin-1 (OX1R) and orexin-2 (OX2R) receptors, various dual OX1/2R antagonists have been shown to promote sleep in animals and humans.  While selective blockade of OX2R seems to be sufficient to initiate and prolong sleep, the beneficial effect of additional inhibition of OX1R remains controversial.  The relative contribution of OX1R and OX2R to the sleep effects induced by a dual OX1/2R antagonist was further investigated in the rat, and specifically on rapid eye movement (REM) sleep since a deficiency of the orexin system is associated with narcolepsy/cataplexy based on clinical and pre-clinical data.  As expected, the dual OX1/2R antagonist SB-649868 was effective in promoting non-REM (NREM) and REM sleep following oral dosing (10 and 30 mg/kg) at the onset of the dark phase.  However, a disruption of REM sleep was evidenced by a more pronounced reduction in the onset of REM as compared to NREM sleep, a marked enhancement of the REM/total sleep ratio, and the occurrence of a few episodes of direct wake to REM sleep transitions (REM intrusion).  When administered subcutaneously, the OX2R antagonist JNJ-10397049 (10 mg/kg) increased NREM duration whereas the OX1R antagonist GSK-1059865 (10 mg/kg) did not alter sleep.  REM sleep was not affected either by OX2R or OX1R blockade alone, but administration of the OX1R antagonist in combination with the OX2R antagonist induced a significant reduction in REM sleep latency and an increase in REM sleep duration at the expense of the time spent in NREM sleep.  These results indicate that additional blockade of OX1R to OX2R antagonism elicits a dysregulation of REM sleep by shifting the balance in favor of REM sleep at the expense of NREM sleep that may increase the risk of adverse events.  Translation of this hypothesis remains to be tested in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuN2mc5LjFPFZoq0fPSOTvfW6udTcc2eawNWa_MaaM2bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crgt1amuw%253D%253D&md5=2edae8f4ded288f283742691d9285ee0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2014.00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2014.00028%26sid%3Dliteratum%253Aachs%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26atitle%3DOrexin-1%2520receptor%2520blockade%2520dysregulates%2520REM%2520sleep%2520in%2520the%2520presence%2520of%2520orexin-2%2520receptor%2520antagonism%26jtitle%3DFront.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D28%26doi%3D10.3389%2Ffnins.2014.00028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">Reference <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> and references therein.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Morairty, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revel, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valladao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilduff, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span> </span><span class="NLM_article-title">Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">e39131</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0039131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1371%2Fjournal.pone.0039131" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39131&issue=7&author=S.+R.+Morairtyauthor=F.+G.+Revelauthor=P.+Malherbeauthor=J.+L.+Moreauauthor=D.+Valladaoauthor=J.+G.+Wettsteinauthor=T.+S.+Kilduffauthor=E.+Borroni&title=Dual+hypocretin+receptor+antagonism+is+more+effective+for+sleep+promotion+than+antagonism+of+either+receptor+alone&doi=10.1371%2Fjournal.pone.0039131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039131%26sid%3Dliteratum%253Aachs%26aulast%3DMorairty%26aufirst%3DS.%2BR.%26aulast%3DRevel%26aufirst%3DF.%2BG.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DValladao%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DBorroni%26aufirst%3DE.%26atitle%3DDual%2520hypocretin%2520receptor%2520antagonism%2520is%2520more%2520effective%2520for%2520sleep%2520promotion%2520than%2520antagonism%2520of%2520either%2520receptor%2520alone%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D7%26spage%3De39131%26doi%3D10.1371%2Fjournal.pone.0039131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">McAtee, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phuong, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. K.</span><span> </span><span class="NLM_article-title">Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX2R) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4225</span><span class="NLM_x">â</span> <span class="NLM_lpage">4229</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2004.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2004.06.032" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4225-4229&issue=16&author=L.+C.+McAteeauthor=S.+W.+Suttonauthor=D.+A.+Rudolphauthor=X.+Liauthor=L.+E.+Aluisioauthor=V.+K.+Phuongauthor=C.+A.+Dvorakauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=T.+K.+Jones&title=Novel+substituted+4-phenyl-%5B1%2C3%5Ddioxanes%3A+potent+and+selective+orexin+receptor+2+%28OX2R%29+antagonists&doi=10.1016%2Fj.bmcl.2004.06.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DL.%2BC.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DPhuong%26aufirst%3DV.%2BK.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DJones%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520substituted%25204-phenyl-%255B1%252C3%255Ddioxanes%253A%2520potent%2520and%2520selective%2520orexin%2520receptor%25202%2520%2528OX2R%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D16%26spage%3D4225%26epage%3D4229%26doi%3D10.1016%2Fj.bmcl.2004.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an N,N-disubstituted-1,4-diazepane scaffold that promotes sleep in rats</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1069</span><span class="NLM_x">â</span> <span class="NLM_lpage">1074</span><span class="refDoi">Â DOI: 10.1002/cmdc.200900069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1002%2Fcmdc.200900069" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1069-1074&issue=7&author=D.+B.+Whitmanauthor=C.+D.+Coxauthor=M.+J.+Breslinauthor=K.+M.+Brashearauthor=J.+D.+Schreierauthor=M.+J.+Boguskyauthor=R.+A.+Bednarauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=G.+D.+Hartmanauthor=D.+R.+Reissauthor=C.+M.+Harrellauthor=R.+L.+Krausauthor=Y.+Liauthor=S.+L.+Garsonauthor=S.+M.+Doranauthor=T.+Prueksaritanontauthor=C.+Liauthor=C.+J.+Winrowauthor=K.+S.+Koblanauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+a+potent%2C+CNS-penetrant+orexin+receptor+antagonist+based+on+an+N%2CN-disubstituted-1%2C4-diazepane+scaffold+that+promotes+sleep+in+rats&doi=10.1002%2Fcmdc.200900069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900069%26sid%3Dliteratum%253Aachs%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DBrashear%26aufirst%3DK.%2BM.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BM.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520CNS-penetrant%2520orexin%2520receptor%2520antagonist%2520based%2520on%2520an%2520N%252CN-disubstituted-1%252C4-diazepane%2520scaffold%2520that%2520promotes%2520sleep%2520in%2520rats%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26issue%3D7%26spage%3D1069%26epage%3D1074%26doi%3D10.1002%2Fcmdc.200900069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellabott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 5â³-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2â²:5â²,3â³-terpyridine-3â²-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">332</span><span class="refDoi">Â DOI: 10.1002/cmdc.201300447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1002%2Fcmdc.201300447" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=311-332&issue=2&author=A.+J.+Roeckerauthor=S.+P.+Mercerauthor=J.+D.+Schreierauthor=C.+D.+Coxauthor=M.+E.+Fraleyauthor=J.+T.+Steenauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=C.+M.+Harrellauthor=S.+L.+Garsonauthor=A.+L.+Gotterauthor=S.+V.+Foxauthor=J.+Stevensauthor=P.+L.+Tannenbaumauthor=T.+Prueksaritanontauthor=T.+D.+Cabaluauthor=D.+Cuiauthor=J.+Stellabottauthor=G.+D.+Hartmanauthor=S.+D.+Youngauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+5%E2%80%B3-chloro-N-%5B%285%2C6-dimethoxypyridin-2-yl%29methyl%5D-2%2C2%E2%80%B2%3A5%E2%80%B2%2C3%E2%80%B3-terpyridine-3%E2%80%B2-carboxamide+%28MK-1064%29%3A+a+selective+orexin+2+receptor+antagonist+%282-SORA%29+for+the+treatment+of+insomnia&doi=10.1002%2Fcmdc.201300447"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300447%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DFox%26aufirst%3DS.%2BV.%26aulast%3DStevens%26aufirst%3DJ.%26aulast%3DTannenbaum%26aufirst%3DP.%2BL.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DStellabott%26aufirst%3DJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25205%25E2%2580%25B3-chloro-N-%255B%25285%252C6-dimethoxypyridin-2-yl%2529methyl%255D-2%252C2%25E2%2580%25B2%253A5%25E2%2580%25B2%252C3%25E2%2580%25B3-terpyridine-3%25E2%2580%25B2-carboxamide%2520%2528MK-1064%2529%253A%2520a%2520selective%2520orexin%25202%2520receptor%2520antagonist%2520%25282-SORA%2529%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D311%26epage%3D332%26doi%3D10.1002%2Fcmdc.201300447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reger, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattern, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellabott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">4884</span><span class="NLM_x">â</span> <span class="NLM_lpage">4890</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2014.08.041" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4884-4890&issue=20&author=A.+J.+Roeckerauthor=T.+S.+Regerauthor=M.+C.+Matternauthor=S.+P.+Mercerauthor=J.+M.+Bergmanauthor=J.+D.+Schreierauthor=R.+V.+Cubeauthor=C.+D.+Coxauthor=D.+Liauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=C.+M.+Harrellauthor=S.+L.+Garsonauthor=A.+L.+Gotterauthor=S.+V.+Foxauthor=J.+Stevensauthor=P.+L.+Tannenbaumauthor=T.+Prueksaritanontauthor=T.+D.+Cabaluauthor=D.+Cuiauthor=J.+Stellabottauthor=G.+D.+Hartmanauthor=S.+D.+Youngauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+MK-3697%3A+a+selective+orexin+2+receptor+antagonist+%282-SORA%29+for+the+treatment+of+insomnia&doi=10.1016%2Fj.bmcl.2014.08.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DReger%26aufirst%3DT.%2BS.%26aulast%3DMattern%26aufirst%3DM.%2BC.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DBergman%26aufirst%3DJ.%2BM.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DFox%26aufirst%3DS.%2BV.%26aulast%3DStevens%26aufirst%3DJ.%26aulast%3DTannenbaum%26aufirst%3DP.%2BL.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DStellabott%26aufirst%3DJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-3697%253A%2520a%2520selective%2520orexin%25202%2520receptor%2520antagonist%2520%25282-SORA%2529%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D20%26spage%3D4884%26epage%3D4890%26doi%3D10.1016%2Fj.bmcl.2014.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Betschart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hintermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotesta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badiger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span> </span><span class="NLM_article-title">Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">7590</span><span class="NLM_x">â</span> <span class="NLM_lpage">7607</span><span class="refDoi">Â DOI: 10.1021/jm4007627</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4007627" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7590-7607&issue=19&author=C.+Betschartauthor=S.+Hintermannauthor=D.+Behnkeauthor=S.+Cotestaauthor=M.+Fendtauthor=C.+E.+Geeauthor=L.+H.+Jacobsonauthor=G.+Laueauthor=S.+Ofnerauthor=V.+Chaudhariauthor=S.+Badigerauthor=C.+Panditauthor=J.+Wagnerauthor=D.+Hoyer&title=Identification+of+a+novel+series+of+orexin+receptor+antagonists+with+a+distinct+effect+on+sleep+architecture+for+the+treatment+of+insomnia&doi=10.1021%2Fjm4007627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm4007627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4007627%26sid%3Dliteratum%253Aachs%26aulast%3DBetschart%26aufirst%3DC.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DBehnke%26aufirst%3DD.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DFendt%26aufirst%3DM.%26aulast%3DGee%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DChaudhari%26aufirst%3DV.%26aulast%3DBadiger%26aufirst%3DS.%26aulast%3DPandit%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520orexin%2520receptor%2520antagonists%2520with%2520a%2520distinct%2520effect%2520on%2520sleep%2520architecture%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D19%26spage%3D7590%26epage%3D7607%26doi%3D10.1021%2Fjm4007627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Raheem, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of piperidine ethers as selective orexin receptor antagonist (SORAs) inspired by filorexant</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">â</span> <span class="NLM_lpage">450</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2014.12.056" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=444-450&author=I.+T.+Raheemauthor=M.+J.+Breslinauthor=J.+Brunoauthor=T.+D.+Cabaluauthor=A.+Cookeauthor=C.+D.+Coxauthor=D.+Cuiauthor=S.+Garsonauthor=A.+L.+Gotterauthor=S.+V.+Foxauthor=C.+M.+Harrellauthor=S.+D.+Kudukauthor=W.+Lemaireauthor=T.+Prueksaritanontauthor=J.+J.+Rengerauthor=C.+Stumpauthor=P.+L.+Tannenbaumauthor=P.+D.+Williamsauthor=C.+J.+Winrowauthor=P.+J.+Coleman&title=Discovery+of+piperidine+ethers+as+selective+orexin+receptor+antagonist+%28SORAs%29+inspired+by+filorexant&doi=10.1016%2Fj.bmcl.2014.12.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.056%26sid%3Dliteratum%253Aachs%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DBruno%26aufirst%3DJ.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DFox%26aufirst%3DS.%2BV.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DStump%26aufirst%3DC.%26aulast%3DTannenbaum%26aufirst%3DP.%2BL.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520piperidine%2520ethers%2520as%2520selective%2520orexin%2520receptor%2520antagonist%2520%2528SORAs%2529%2520inspired%2520by%2520filorexant%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D444%26epage%3D450%26doi%3D10.1016%2Fj.bmcl.2014.12.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Roecker, A. J.; Mercer, S. P.; Bergman, J. M.; Gilbert, K. F.; Kuduk, S. D.; Harrell, C. M.; Garson, S.; Fox, S. V.; Gotter, A. L.; Tannenbaum, P. L.; Prueksaritanont, T.; Cabalu, T. D.; Cui, D.; Lemaire, W.; Winrow, C. J.; Renger, J. J.; Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.081</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2014.12.081" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+J.+Roecker&author=S.+P.+Mercer&author=J.+M.+Bergman&author=K.+F.+Gilbert&author=S.+D.+Kuduk&author=C.+M.+Harrell&author=S.+Garson&author=S.+V.+Fox&author=A.+L.+Gotter&author=P.+L.+Tannenbaum&author=T.+Prueksaritanont&author=T.+D.+Cabalu&author=D.+Cui&author=W.+Lemaire&author=C.+J.+Winrow&author=J.+J.+Renger&author=P.+J.+Coleman&title=Discovery+of+diazepane+amide+DORAs+and+2-SORAs+enabled+by+exploration+of+isosteric+quinazoline+replacements&doi=10.1016%2Fj.bmcl.2014.12.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.081%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520diazepane%2520amide%2520DORAs%2520and%25202-SORAs%2520enabled%2520by%2520exploration%2520of%2520isosteric%2520quinazoline%2520replacements%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26doi%3D10.1016%2Fj.bmcl.2014.12.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Branstetter, B. J.; Letavic, M. A.; Ly, K. S.; Rudolph, D. A.; Savall, B. M.; Shah, C. R.; Shireman, B. T.</span> PCT Int. Appl. WO 2011050202 A1, Apr 28,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Branstetter%2C+B.+J.%3B+Letavic%2C+M.+A.%3B+Ly%2C+K.+S.%3B+Rudolph%2C+D.+A.%3B+Savall%2C+B.+M.%3B+Shah%2C+C.+R.%3B+Shireman%2C+B.+T.+PCT+Int.+Appl.+WO+2011050202+A1%2C+Apr+28%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBranstetter%26aufirst%3DB.%2BJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chai, W.; Letavic, M. A.; Ly, K. S.; Pippel, D. J.; Rudolph, D. A.; Sappey, K. C.; Savall, B. M.; Shah, C. R.; Shireman, B. T.; Soyode-Johnson, A.; Stocking, E. M.; Swanson, D. M.</span> PCT Int. Appl. WO 2011050198 A1, Apr 28,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chai%2C+W.%3B+Letavic%2C+M.+A.%3B+Ly%2C+K.+S.%3B+Pippel%2C+D.+J.%3B+Rudolph%2C+D.+A.%3B+Sappey%2C+K.+C.%3B+Savall%2C+B.+M.%3B+Shah%2C+C.+R.%3B+Shireman%2C+B.+T.%3B+Soyode-Johnson%2C+A.%3B+Stocking%2C+E.+M.%3B+Swanson%2C+D.+M.+PCT+Int.+Appl.+WO+2011050198+A1%2C+Apr+28%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DW.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">The detailed procedures used to measure OX2R and OX1R <i>K</i><sub>i</sub> values can be found in the following:</p></div><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shekhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitz, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebold, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugovic, C.</span><span> </span><span class="NLM_article-title">A selective orexin-1 receptor antagonist attenuates stress-induced hyprarousal without hypnotic effects</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">590</span><span class="NLM_x">â</span> <span class="NLM_lpage">601</span><span class="refDoi">Â DOI: 10.1124/jpet.114.220392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1124%2Fjpet.114.220392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=25583879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=590-601&issue=3&author=P.+Bonaventureauthor=S.+Yunauthor=P.+L.+Johnsonauthor=A.+Shekharauthor=S.+D.+Fitzauthor=B.+T.+Shiremanauthor=T.+P.+Leboldauthor=D.+Nepomucenoauthor=B.+Lordauthor=M.+Wennerholmauthor=J.+Sheltonauthor=N.+Carruthersauthor=T.+Lovenbergauthor=C.+Dugovic&title=A+selective+orexin-1+receptor+antagonist+attenuates+stress-induced+hyprarousal+without+hypnotic+effects&doi=10.1124%2Fjpet.114.220392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects</span></div><div class="casAuthors">Bonaventure, Pascal; Yun, Sujin; Johnson, Philip L.; Shekhar, Anantha; Fitz, Stephanie D.; Shireman, Brock T.; Lebold, Terry P.; Nepomuceno, Diane; Lord, Brian; Wennerholm, Michelle; Shelton, Jonathan; Carruthers, Nicholas; Lovenberg, Timothy; Dugovic, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">590-601, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Orexins (OXs) are peptides produced by perifornical (PeF) and lateral hypothalamic neurons that exert a prominent role in arousal-related processes, including stress.  A crit. role for the orexin-1 receptor (OX1R) in complex emotional behavior is emerging, such as overactivation of the OX1R pathway being assocd. with panic or anxiety states.  Here we characterize a brain-penetrant, selective, and high-affinity OX1R antagonist, compd. 56 [N-({3-[(3-ethoxy-6-methylpyridin-2-yl)carbonyl]-3-azabicyclo[4.1.0]hept-4-yl}methyl)-5-(trifluoromethyl)pyrimidin-2-amine].  Ex vivo receptor binding studies demonstrated that, after s.c. administration, compd. 56 crossed the blood-brain barrier and occupied OX1Rs in the rat brain at lower doses than std. OX1R antagonists GSK-1059865 [5-bromo-N-({1-[(3-fluoro-2-methoxyphenyl)carbonyl]-5-methylpiperidin-2-yl}methyl)pyridin-2-amine], SB-334867 [1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea], and SB-408124 [1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea].  Although compd. 56 did not alter spontaneous sleep in rats and in wild-type mice, its administration in orexin-2 receptor knockout mice selectively promoted rapid eye movement sleep, demonstrating target engagement and specific OX1R blockade.  In a rat model of psychol. stress induced by cage exchange, the OX1R antagonist prevented the prolongation of sleep onset without affecting sleep duration.  In a rat model of panic vulnerability (involving disinhibition of the PeF OX region) to threatening internal state changes (i.e., i.v. sodium lactate infusion), compd. 56 attenuated sodium lactate-induced panic-like behaviors and cardiovascular responses without altering baseline locomotor or autonomic activity.  In conclusion, OX1R antagonism represents a novel therapeutic strategy for the treatment of various psychiatric disorders assocd. with stress or hyperarousal states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobTtYJtwsEh7Vg90H21EOLACvtfcHk0lj5IZy2NTUQTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omuro%253D&md5=0793591a77a5bf93b9e448cb1381da2a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.220392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.220392%26sid%3Dliteratum%253Aachs%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DP.%2BL.%26aulast%3DShekhar%26aufirst%3DA.%26aulast%3DFitz%26aufirst%3DS.%2BD.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26aulast%3DLebold%26aufirst%3DT.%2BP.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWennerholm%26aufirst%3DM.%26aulast%3DShelton%26aufirst%3DJ.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%26aulast%3DDugovic%26aufirst%3DC.%26atitle%3DA%2520selective%2520orexin-1%2520receptor%2520antagonist%2520attenuates%2520stress-induced%2520hyprarousal%2520without%2520hypnotic%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26issue%3D3%26spage%3D590%26epage%3D601%26doi%3D10.1124%2Fjpet.114.220392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">The detailed procedures used for conducting these experiments can be found in ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bonaventure, P.; Shelton, J.; Yun, S.; Nepomuceno, D.; Sutton, S.; Aluisio, L.; Frazer, I.; Lord, B.; Shoblock, J.; Welty, N.; Chaplan, S. R.; Aguilar, Z.; Halter, R.; Ndifor, A.; Koudriakova, T.; Rizzolio, M.; Letavic, M.; Carruthers, N.; Lovenberg, T.; Dugovic, C.</span><span> </span><span class="NLM_article-title">Characterization of JNJ-42847922, a selective orexin-2 receptor antagonist, as a clinical candidate for the treatment of insomnia.</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span>, submitted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bonaventure%2C+P.%3B+Shelton%2C+J.%3B+Yun%2C+S.%3B+Nepomuceno%2C+D.%3B+Sutton%2C+S.%3B+Aluisio%2C+L.%3B+Frazer%2C+I.%3B+Lord%2C+B.%3B+Shoblock%2C+J.%3B+Welty%2C+N.%3B+Chaplan%2C+S.+R.%3B+Aguilar%2C+Z.%3B+Halter%2C+R.%3B+Ndifor%2C+A.%3B+Koudriakova%2C+T.%3B+Rizzolio%2C+M.%3B+Letavic%2C+M.%3B+Carruthers%2C+N.%3B+Lovenberg%2C+T.%3B+Dugovic%2C+C.+Characterization+of+JNJ-42847922%2C+a+selective+orexin-2+receptor+antagonist%2C+as+a+clinical+candidate+for+the+treatment+of+insomnia.J.+Pharmacol.+Exp.+Ther.%2C+submitted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonaventure%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520JNJ-42847922%252C%2520a%2520selective%2520orexin-2%2520receptor%2520antagonist%252C%2520as%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520insomnia.%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lave, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span> </span><span class="NLM_article-title">Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">584</span><span class="NLM_x">â</span> <span class="NLM_lpage">590</span><span class="refDoi">Â DOI: 10.1021/js960440h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1021%2Fjs960440h" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1997&pages=584-590&issue=5&author=T.+H.+Laveauthor=S.+Dupinauthor=C.+Schmittauthor=R.+C.+Chouauthor=D.+Jaeckauthor=P.+Coassolo&title=Integration+of+in+vitro+data+into+allometric+scaling+to+predict+hepatic+metabolic+clearance+in+man%3A+application+to+10+extensively+metabolized+drugs&doi=10.1021%2Fjs960440h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjs960440h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs960440h%26sid%3Dliteratum%253Aachs%26aulast%3DLave%26aufirst%3DT.%2BH.%26aulast%3DDupin%26aufirst%3DS.%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DR.%2BC.%26aulast%3DJaeck%26aufirst%3DD.%26aulast%3DCoassolo%26aufirst%3DP.%26atitle%3DIntegration%2520of%2520in%2520vitro%2520data%2520into%2520allometric%2520scaling%2520to%2520predict%2520hepatic%2520metabolic%2520clearance%2520in%2520man%253A%2520application%2520to%252010%2520extensively%2520metabolized%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1997%26volume%3D86%26issue%3D5%26spage%3D584%26epage%3D590%26doi%3D10.1021%2Fjs960440h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':[],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':[],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francesca Deflorian, Laura Perez-Benito, Eelke B Lenselink, Miles Congreve, Herman W. T. van Vlijmen, Jonathan S. Mason, Chris de Graaf, <span class="NLM_string-name hlFld-ContribAuthor">Gary Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">Accurate Prediction of GPCR Ligand Binding Affinity with Free Energy Perturbation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (11)
                                     , 5563-5579. <a href="https://doi.org/10.1021/acs.jcim.0c00449" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00449%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccurate%252BPrediction%252Bof%252BGPCR%252BLigand%252BBinding%252BAffinity%252Bwith%252BFree%252BEnergy%252BPerturbation%26aulast%3DDeflorian%26aufirst%3DFrancesca%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D06072020%26date%3D15062020%26volume%3D60%26issue%3D11%26spage%3D5563%26epage%3D5579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lewis D. Pennington, Brian M. Aquila, Younggi Choi, Roman A. Valiulin, <span class="NLM_string-name hlFld-ContribAuthor">Ingo Muegge</span>. </span><span class="cited-content_cbyCitation_article-title">Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8956-8976. <a href="https://doi.org/10.1021/acs.jmedchem.9b02092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositional%252BAnalogue%252BScanning%25253A%252BAn%252BEffective%252BStrategy%252Bfor%252BMultiparameter%252BOptimization%252Bin%252BDrug%252BDesign%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D24042020%26volume%3D63%26issue%3D17%26spage%3D8956%26epage%3D8976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Illia
O. Feskov, Anton V. Chernykh, Yuliya O. Kuchkovska, Constantin G. Daniliuc, Ivan S. Kondratov, <span class="NLM_string-name hlFld-ContribAuthor">Oleksandr O. Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">3-((Hetera)cyclobutyl)azetidines, âStretchedâ Analogues of Piperidine, Piperazine, and Morpholine: Advanced Building Blocks for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (3)
                                     , 1363-1371. <a href="https://doi.org/10.1021/acs.joc.8b02822" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02822%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D3-%252528%252528Hetera%252529cyclobutyl%252529azetidines%25252C%252B%2525E2%252580%25259CStretched%2525E2%252580%25259D%252BAnalogues%252Bof%252BPiperidine%25252C%252BPiperazine%25252C%252Band%252BMorpholine%25253A%252BAdvanced%252BBuilding%252BBlocks%252Bfor%252BDrug%252BDiscovery%26aulast%3DFeskov%26aufirst%3DIllia%2BO.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05112018%26date%3D08012019%26date%3D24122018%26volume%3D84%26issue%3D3%26spage%3D1363%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Roecker</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Cox</span>, and <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>  . </span><span class="cited-content_cbyCitation_article-title">Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 504-530. <a href="https://doi.org/10.1021/acs.jmedchem.5b00832" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00832%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOrexin%252BReceptor%252BAntagonists%25253A%252BNew%252BTherapeutic%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BInsomnia%26aulast%3DRoecker%26aufirst%3DAnthony%2BJ.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D30052015%26date%3D15092015%26date%3D28012016%26date%3D28082015%26volume%3D59%26issue%3D2%26spage%3D504%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Boss</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>, <span class="hlFld-ContribAuthor ">Christine  Brotschi</span>, <span class="hlFld-ContribAuthor ">Bibia  Heidmann</span>, <span class="hlFld-ContribAuthor ">Thierry  Sifferlen</span>, <span class="hlFld-ContribAuthor ">Markus  Raumer</span>, <span class="hlFld-ContribAuthor ">Gunther  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jodi T.  Williams</span>, <span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>. </span><span class="cited-content_cbyCitation_article-title">The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (23)
                                     , 2286-2305. <a href="https://doi.org/10.1002/cmdc.202000453" title="DOI URL">https://doi.org/10.1002/cmdc.202000453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000453%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BQuest%252Bfor%252Bthe%252BBest%252BDual%252BOrexin%252BReceptor%252BAntagonist%252B%252528Daridorexant%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BInsomnia%252BDisorders%26aulast%3DBoss%26aufirst%3DChristoph%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D23%26spage%3D2286%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunsuke  Maehara</span>, <span class="hlFld-ContribAuthor ">Natsuko  Yuge</span>, <span class="hlFld-ContribAuthor ">Chika  Higashi</span>, <span class="hlFld-ContribAuthor ">Takumi  Ota</span>, <span class="hlFld-ContribAuthor ">Junji  Furukawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Takeuchi</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDMâ878. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology Reports</span><span> <strong>2020,</strong> <em>40 </em>
                                    (2)
                                     , 182-189. <a href="https://doi.org/10.1002/npr2.12105" title="DOI URL">https://doi.org/10.1002/npr2.12105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/npr2.12105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fnpr2.12105%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%2520Reports%26atitle%3DPharmacological%252Bcharacterization%252Bof%252Ba%252Bnovel%252Bpotent%25252C%252Bselective%25252C%252Band%252Borally%252Bactive%252Borexin%252B2%252Breceptor%252Bantagonist%25252C%252BSDM%2525E2%252580%252590878%26aulast%3DMaehara%26aufirst%3DShunsuke%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D2%26spage%3D182%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-yi  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Lu</span>, <span class="hlFld-ContribAuthor ">Mareike C.  Holland</span>, <span class="hlFld-ContribAuthor ">Shichang  Lv</span>, <span class="hlFld-ContribAuthor ">Xuebao  Ji</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Dominique  Depre</span>, <span class="hlFld-ContribAuthor ">Pieter  Westerduin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Substituted 1,2,3-Triazoles via an Intramolecular
              N
              -
              N
              Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (5)
                                     , 548-551. <a href="https://doi.org/10.1002/ejoc.201901519" title="DOI URL">https://doi.org/10.1002/ejoc.201901519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901519%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Substituted%252B1%25252C2%25252C3-Triazoles%252Bvia%252Ban%252BIntramolecular%252BN%252B-%252BN%252BBond%252BFormation%26aulast%3DChen%26aufirst%3DCheng-yi%26date%3D2020%26date%3D2019%26volume%3D2020%26issue%3D5%26spage%3D548%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Vanda</span>, <span class="hlFld-ContribAuthor ">PaweÅ  Zajdel</span>, <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111569. <a href="https://doi.org/10.1016/j.ejmech.2019.111569" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111569%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImidazopyridine-based%252Bselective%252Band%252Bmultifunctional%252Bligands%252Bof%252Bbiological%252Btargets%252Bassociated%252Bwith%252Bpsychiatric%252Band%252Bneurodegenerative%252Bdiseases%26aulast%3DVanda%26aufirst%3DDavid%26date%3D2019%26volume%3D181%26spage%3D111569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sander  Brooks</span>, <span class="hlFld-ContribAuthor ">GabriÃ«l E  Jacobs</span>, <span class="hlFld-ContribAuthor ">Peter  de Boer</span>, <span class="hlFld-ContribAuthor ">Justine M  Kent</span>, <span class="hlFld-ContribAuthor ">Luc  Van Nueten</span>, <span class="hlFld-ContribAuthor ">Guido  van Amerongen</span>, <span class="hlFld-ContribAuthor ">Rob  Zuiker</span>, <span class="hlFld-ContribAuthor ">Iva  Kezic</span>, <span class="hlFld-ContribAuthor ">Remy  Luthringer</span>, <span class="hlFld-ContribAuthor ">Peter  van der Ark</span>, <span class="hlFld-ContribAuthor ">Joop MA  van Gerven</span>, <span class="hlFld-ContribAuthor ">Wayne  Drevets</span>. </span><span class="cited-content_cbyCitation_article-title">The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2019,</strong> <em>33 </em>
                                    (2)
                                     , 202-209. <a href="https://doi.org/10.1177/0269881118822258" title="DOI URL">https://doi.org/10.1177/0269881118822258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881118822258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881118822258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DThe%252Bselective%252Borexin-2%252Breceptor%252Bantagonist%252Bseltorexant%252Bimproves%252Bsleep%25253A%252BAn%252Bexploratory%252Bdouble-blind%25252C%252Bplacebo%252Bcontrolled%25252C%252Bcrossover%252Bstudy%252Bin%252Bantidepressant-treated%252Bmajor%252Bdepressive%252Bdisorder%252Bpatients%252Bwith%252Bpersistent%252Binsomnia%26aulast%3DBrooks%26aufirst%3DSander%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D2%26spage%3D202%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qifeng  Bai</span>, <span class="hlFld-ContribAuthor ">Horacio  PÃ©rez-SÃ¡nchez</span>, <span class="hlFld-ContribAuthor ">Zhuoyu  Shi</span>, <span class="hlFld-ContribAuthor ">Lanlan  Li</span>, <span class="hlFld-ContribAuthor ">Danfeng  Shi</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Computational studies on horseshoe shape pocket of human orexin receptor type 2 and boat conformation of suvorexant by molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (1)
                                     , 1221-1231. <a href="https://doi.org/10.1111/cbdd.13181" title="DOI URL">https://doi.org/10.1111/cbdd.13181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13181%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComputational%252Bstudies%252Bon%252Bhorseshoe%252Bshape%252Bpocket%252Bof%252Bhuman%252Borexin%252Breceptor%252Btype%252B2%252Band%252Bboat%252Bconformation%252Bof%252Bsuvorexant%252Bby%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DBai%26aufirst%3DQifeng%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D1%26spage%3D1221%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taylor A  Gentile</span>, <span class="hlFld-ContribAuthor ">Steven J  Simmons</span>, <span class="hlFld-ContribAuthor ">Mia N  Watson</span>, <span class="hlFld-ContribAuthor ">Krista L  Connelly</span>, <span class="hlFld-ContribAuthor ">Eugen  Brailoiu</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>, <span class="hlFld-ContribAuthor ">John W  Muschamp</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>43 </em>
                                    (5)
                                     , 1001-1009. <a href="https://doi.org/10.1038/npp.2017.158" title="DOI URL">https://doi.org/10.1038/npp.2017.158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/npp.2017.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnpp.2017.158%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DEffects%252Bof%252BSuvorexant%25252C%252Ba%252BDual%252BOrexin%25252FHypocretin%252BReceptor%252BAntagonist%25252C%252Bon%252BImpulsive%252BBehavior%252BAssociated%252Bwith%252BCocaine%26aulast%3DGentile%26aufirst%3DTaylor%2BA%26date%3D2018%26date%3D2017%26volume%3D43%26issue%3D5%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, <span class="hlFld-ContribAuthor ">Laura H.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Current Sleep Medicine Reports</span><span> <strong>2017,</strong> <em>3 </em>
                                    (4)
                                     , 342-353. <a href="https://doi.org/10.1007/s40675-017-0099-7" title="DOI URL">https://doi.org/10.1007/s40675-017-0099-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40675-017-0099-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40675-017-0099-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Sleep%2520Medicine%2520Reports%26atitle%3DOrexin%252BReceptor%252BAntagonists%26aulast%3DHoyer%26aufirst%3DDaniel%26date%3D2017%26date%3D2017%26volume%3D3%26issue%3D4%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Boss</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin research: patent news from 2016. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (10)
                                     , 1123-1133. <a href="https://doi.org/10.1080/13543776.2017.1344221" title="DOI URL">https://doi.org/10.1080/13543776.2017.1344221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1344221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1344221%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DOrexin%252Bresearch%25253A%252Bpatent%252Bnews%252Bfrom%252B2016%26aulast%3DBoss%26aufirst%3DChristoph%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D10%26spage%3D1123%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aya  Futamura</span>, <span class="hlFld-ContribAuthor ">Dai  Nozawa</span>, <span class="hlFld-ContribAuthor ">Yuko  Araki</span>, <span class="hlFld-ContribAuthor ">Yunoshin  Tamura</span>, <span class="hlFld-ContribAuthor ">Seiken  Tokura</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Yuichi  Tokumaru</span>, <span class="hlFld-ContribAuthor ">Sora  Kakihara</span>, <span class="hlFld-ContribAuthor ">Takeshi  Aoki</span>, <span class="hlFld-ContribAuthor ">Norikazu  Ohtake</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5203-5215. <a href="https://doi.org/10.1016/j.bmc.2017.07.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bhighly%252Bselective%252Band%252Bpotent%252Borexin%252Breceptor%252B1%252Bantagonists%252Bderived%252Bfrom%252Ba%252Bdual%252Borexin%252Breceptor%252B1%25252F2%252Bantagonist%252Bbased%252Bon%252Bthe%252Bstructural%252Bframework%252Bof%252Bpyrazoylethylbenzamide%26aulast%3DFutamura%26aufirst%3DAya%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5203%26epage%3D5215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Wei</span>, <span class="hlFld-ContribAuthor ">Qingxia  Hu</span>, <span class="hlFld-ContribAuthor ">Yutao  Ma</span>, <span class="hlFld-ContribAuthor ">Liangming  Wei</span>, <span class="hlFld-ContribAuthor ">Jiaqiang  Liu</span>, <span class="hlFld-ContribAuthor ">Min  Shi</span>, <span class="hlFld-ContribAuthor ">Feijun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly N
              2
              -Regioselective TsOH-Catalyzed Olefin Hydroamination: Metal-Free Synthesis of
              N
              2
              -Alkyl-1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>6 </em>
                                    (6)
                                     , 662-665. <a href="https://doi.org/10.1002/ajoc.201700045" title="DOI URL">https://doi.org/10.1002/ajoc.201700045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201700045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201700045%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHighly%252BN%252B2%252B-Regioselective%252BTsOH-Catalyzed%252BOlefin%252BHydroamination%25253A%252BMetal-Free%252BSynthesis%252Bof%252BN%252B2%252B-Alkyl-1%25252C2%25252C3-triazoles%26aulast%3DWei%26aufirst%3DHao%26date%3D2017%26date%3D2017%26volume%3D6%26issue%3D6%26spage%3D662%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michihiro  Mieda</span>. </span><span class="cited-content_cbyCitation_article-title">The roles of orexins in sleep/wake regulation. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Research</span><span> <strong>2017,</strong> <em>118 </em>, 56-65. <a href="https://doi.org/10.1016/j.neures.2017.03.015" title="DOI URL">https://doi.org/10.1016/j.neures.2017.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neures.2017.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neures.2017.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Research%26atitle%3DThe%252Broles%252Bof%252Borexins%252Bin%252Bsleep%25252Fwake%252Bregulation%26aulast%3DMieda%26aufirst%3DMichihiro%26date%3D2017%26volume%3D118%26spage%3D56%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songliang  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Hu</span>, <span class="hlFld-ContribAuthor ">Hongmei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Hou</span>, <span class="hlFld-ContribAuthor ">Xing  Liu</span>, <span class="hlFld-ContribAuthor ">Yufeng  Li</span>, <span class="hlFld-ContribAuthor ">Haiying  He</span>, <span class="hlFld-ContribAuthor ">Zhi  Luo</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yuhe  Wang</span>, <span class="hlFld-ContribAuthor ">Weihua  Shi</span>, <span class="hlFld-ContribAuthor ">Liang  Shen</span>, <span class="hlFld-ContribAuthor ">Changqing  Cao</span>, <span class="hlFld-ContribAuthor ">Wei  Liang</span>, <span class="hlFld-ContribAuthor ">Qing  Xu</span>, <span class="hlFld-ContribAuthor ">Qiang  Lv</span>, <span class="hlFld-ContribAuthor ">Jiong  Lan</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Shuhui  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel substituted octahydropyrrolo[3,4- c ]pyrroles as dual orexin receptor antagonists for insomnia treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1458-1462. <a href="https://doi.org/10.1016/j.bmcl.2017.01.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bsubstituted%252Boctahydropyrrolo%25255B3%25252C4-%252Bc%252B%25255Dpyrroles%252Bas%252Bdual%252Borexin%252Breceptor%252Bantagonists%252Bfor%252Binsomnia%252Btreatment%26aulast%3DWu%26aufirst%3DSongliang%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1458%26epage%3D1462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Anthony L.  Gotter</span>, <span class="hlFld-ContribAuthor ">W. Joseph  Herring</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Winrow</span>, <span class="hlFld-ContribAuthor ">John J.  Renger</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2017,</strong> <em>57 </em>
                                    (1)
                                     , 509-533. <a href="https://doi.org/10.1146/annurev-pharmtox-010716-104837" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010716-104837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010716-104837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010716-104837%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DThe%252BDiscovery%252Bof%252BSuvorexant%25252C%252Bthe%252BFirst%252BOrexin%252BReceptor%252BDrug%252Bfor%252BInsomnia%26aulast%3DColeman%26aufirst%3DPaul%2BJ.%26date%3D2017%26volume%3D57%26issue%3D1%26spage%3D509%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.T.  Shireman</span>, <span class="hlFld-ContribAuthor ">M.A.  Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 225-279. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12442-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12442-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12442-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12442-4%26sid%3Dliteratum%253Aachs%26atitle%3DOrexin%252BReceptor%252BAntagonists%26aulast%3DShireman%26aufirst%3DB.T.%26date%3D2017%26spage%3D225%26epage%3D279%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig A.  Stump</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Cooke</span>, <span class="hlFld-ContribAuthor ">Joseph  Bruno</span>, <span class="hlFld-ContribAuthor ">Tamara D.  Cabalu</span>, <span class="hlFld-ContribAuthor ">Anthony L.  Gotter</span>, <span class="hlFld-ContribAuthor ">C. Meacham  Harell</span>, <span class="hlFld-ContribAuthor ">Scott D.  Kuduk</span>, <span class="hlFld-ContribAuthor ">Terrence P.  McDonald</span>, <span class="hlFld-ContribAuthor ">Julie  OâBrien</span>, <span class="hlFld-ContribAuthor ">John J.  Renger</span>, <span class="hlFld-ContribAuthor ">Peter D.  Williams</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Winrow</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5809-5814. <a href="https://doi.org/10.1016/j.bmcl.2016.10.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bhighly%252Bpotent%252Band%252Bselective%252Borexin%252B1%252Breceptor%252Bantagonists%252B%2525281-SORAs%252529%252Bsuitable%252Bfor%252Bin%252Bvivo%252Binterrogation%252Bof%252Borexin%252B1%252Breceptor%252Bpharmacology%26aulast%3DStump%26aufirst%3DCraig%2BA.%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5809%26epage%3D5814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Boss</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 409-415. <a href="https://doi.org/10.1517/13543776.2016.1124087" title="DOI URL">https://doi.org/10.1517/13543776.2016.1124087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2016.1124087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2016.1124087%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSubstituted%252Bcyclopentanes%25252C%252Btetrahydrofurans%252Band%252Bpyrrolidines%252Bas%252Borexin-1-receptor%252Bantagonists%252Bfor%252Btreatment%252Bof%252Bvarious%252BCNS%252Bdisorders%252B%252528WO2015%25252F055994%25253B%252BWO2015%25252F124932%25253B%252BWO2015%25252F124934%252529%26aulast%3DBoss%26aufirst%3DChristoph%26date%3D2016%26date%3D2015%26volume%3D26%26issue%3D3%26spage%3D409%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura H.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Sui  Chen</span>, <span class="hlFld-ContribAuthor ">Sanjida  Mir</span>, <span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin OX2 Receptor Antagonists as Sleep Aids. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 105-136. <a href="https://doi.org/10.1007/7854_2016_47" title="DOI URL">https://doi.org/10.1007/7854_2016_47</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7854_2016_47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7854_2016_47%26sid%3Dliteratum%253Aachs%26atitle%3DOrexin%252BOX2%252BReceptor%252BAntagonists%252Bas%252BSleep%252BAids%26aulast%3DJacobson%26aufirst%3DLaura%2BH.%26date%3D2016%26date%3D2016%26spage%3D105%26epage%3D136%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBehavioral%252BNeuroscience%252Bof%252BOrexin%25252FHypocretin%26aulast%3DLawrence%26aufirst%3DAndrew%2BJ%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascal  Bonaventure</span>, <span class="hlFld-ContribAuthor ">Jonathan  Shelton</span>, <span class="hlFld-ContribAuthor ">Sujin  Yun</span>, <span class="hlFld-ContribAuthor ">Diane  Nepomuceno</span>, <span class="hlFld-ContribAuthor ">Steven  Sutton</span>, <span class="hlFld-ContribAuthor ">Leah  Aluisio</span>, <span class="hlFld-ContribAuthor ">Ian  Fraser</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">James  Shoblock</span>, <span class="hlFld-ContribAuthor ">Natalie  Welty</span>, <span class="hlFld-ContribAuthor ">Sandra R.  Chaplan</span>, <span class="hlFld-ContribAuthor ">Zuleima  Aguilar</span>, <span class="hlFld-ContribAuthor ">Robin  Halter</span>, <span class="hlFld-ContribAuthor ">Anthony  Ndifor</span>, <span class="hlFld-ContribAuthor ">Tatiana  Koudriakova</span>, <span class="hlFld-ContribAuthor ">Michele  Rizzolio</span>, <span class="hlFld-ContribAuthor ">Michael  Letavic</span>, <span class="hlFld-ContribAuthor ">Nicholas I.  Carruthers</span>, <span class="hlFld-ContribAuthor ">Timothy  Lovenberg</span>, <span class="hlFld-ContribAuthor ">Christine  Dugovic</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2015,</strong> <em>354 </em>
                                    (3)
                                     , 471-482. <a href="https://doi.org/10.1124/jpet.115.225466" title="DOI URL">https://doi.org/10.1124/jpet.115.225466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.115.225466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.115.225466%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DCharacterization%252Bof%252BJNJ-42847922%25252C%252Ba%252BSelective%252BOrexin-2%252BReceptor%252BAntagonist%25252C%252Bas%252Ba%252BClinical%252BCandidate%252Bfor%252Bthe%252BTreatment%252Bof%252BInsomnia%26aulast%3DBonaventure%26aufirst%3DPascal%26date%3D2015%26date%3D2015%26volume%3D354%26issue%3D3%26spage%3D471%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Dual OX1R/OX2R Clinical Candidates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Lead Compounds Used To Identify Selective OX2R Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. MK-1064 and MK-3697</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 4. Compounds <b>5</b> and <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>11</b>â<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DCM; (b) 10% Pd/C, HOAc, 70 psi H<sub>2</sub>, MeOH; (c) various benzoic acids, HATU (or similar), diisopropylethylamine, DMF; (d) DCM, TFA,; (e) various 2-chloroheterocycles, cesium carbonate, DMF.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ex vivo OX2R occupancy with compound <b>34</b> in rat: concentrationâresponse after oral administration. Data were collected 15 min postdose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Doseâresponse effects of <b>34</b> (1, 3, 10, and 30 mg/kg, po) on sleep parameters in rat. Data are expressed in minutes (mean Â± SEM of the same 8 animals per dose). Latency to NREM and REM sleep and duration of NREM and REM sleep were calculated for 2 h after compound or vehicle administration at the onset of the dark phase: (â) <i>P</i> < 0.05, (ââ) <i>P</i> < 0.01, and (âââ) <i>P</i> < 0.001 vs vehicle based on one-way ANOVA followed by Dunnettâs multiple comparison post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/medium/jm-2015-00742w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Optimized Synthesis of Compound <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00742/20150717/images/large/jm-2015-00742w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00742&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, water, <i>trans</i>-1,2-dimethyl-1,2-diamine, 60 Â°C, then 83 Â°C, then 100 Â°C (used crude, â¼80%); (b) thionyl chloride, toluene, 50 Â°C, used in situ; (c) 2-chloro-4,6-methylpyridine, Cs<sub>2</sub>CO<sub>3</sub>, DMF 100 Â°C, 15 h, 96%; (d) 5% Pd/C, HOAc, H<sub>2</sub>, 50 Â°C, 4 h, quant; (e) toluene, 0 Â°C, sodium carbonate in water, then <b>43</b>, 30 Â°C; (f) ethanol, 77 Â°C, cool to 23 Â°C to crystallize, 74% over two steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i121">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">de Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilduff, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foye, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battenberg, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, F. S.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankel, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Pol, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span><span class="refDoi">Â DOI: 10.1073/pnas.95.1.322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1073%2Fpnas.95.1.322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=9419374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=322-327&author=L.+de+Leceaauthor=T.+S.+Kilduffauthor=C.+Peyronauthor=X.+Gaoauthor=P.+E.+Foyeauthor=P.+E.+Danielsonauthor=C.+Fukuharaauthor=E.+L.+Battenbergauthor=V.+T.+Gautvikauthor=F.+S.+Bartlettauthor=W.+N.+Frankelauthor=A.+N.+van+den+Polauthor=F.+E.+Bloomauthor=K.+M.+Gautvikauthor=J.+G.+Sutcliffe&title=The+hypocretins%3A+hypothalamus-specific+peptides+with+neuroexcitatory+activity&doi=10.1073%2Fpnas.95.1.322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span></div><div class="casAuthors">De Lecea, L.; Kilduff, T. S.; Peyron, C.; Gao, X. -B.; Foye, P. E.; Danielson, P. E.; Fukuhara, C.; Battenberg, E. L. F.; Gautvik, V. T.; Bartlett, F. S., II; Frankel, W. N.; Van Den Pol, A. N.; Bloom, F. E.; Gautvik, K. M.; Sutcliffe, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin.  The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas.  The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus.  Hcrt immunoreactivity is assocd. with large granular vesicles at synapses.  One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons.  These observations suggest that the hypocretins function within the CNS as neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEQa5lFLKr7Vg90H21EOLACvtfcHk0liXUs3OZ0DSfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D&md5=52bde93a7933953f02930a6f57a0f1b1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.1.322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.1.322%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLecea%26aufirst%3DL.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DPeyron%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DFoye%26aufirst%3DP.%2BE.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DFukuhara%26aufirst%3DC.%26aulast%3DBattenberg%26aufirst%3DE.%2BL.%26aulast%3DGautvik%26aufirst%3DV.%2BT.%26aulast%3DBartlett%26aufirst%3DF.%2BS.%26aulast%3DFrankel%26aufirst%3DW.%2BN.%26aulast%3Dvan%2Bden%2BPol%26aufirst%3DA.%2BN.%26aulast%3DBloom%26aufirst%3DF.%2BE.%26aulast%3DGautvik%26aufirst%3DK.%2BM.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520hypocretins%253A%2520hypothalamus-specific%2520peptides%2520with%2520neuroexcitatory%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D322%26epage%3D327%26doi%3D10.1073%2Fpnas.95.1.322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chemelli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinton, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisanuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">451</span><span class="refDoi">Â DOI: 10.1016/S0092-8674(00)81973-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2FS0092-8674%2800%2981973-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=437-451&author=R.+M.+Chemelliauthor=J.+T.+Willieauthor=C.+M.+Sintonauthor=J.+K.+Elmquistauthor=T.+Scammellauthor=C.+Leeauthor=J.+A.+Richardsonauthor=S.+C.+Williamsauthor=Y.+Xiongauthor=Y.+Kisanukiauthor=T.+E.+Fitchauthor=M.+Nakazatoauthor=R.+E.+Hammerauthor=C.+B.+Saperauthor=M.+Yanagisawa&title=Narcolepsy+in+orexin+knockout+mice%3A+molecular+genetics+of+sleep+regulation&doi=10.1016%2FS0092-8674%2800%2981973-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981973-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981973-X%26sid%3Dliteratum%253Aachs%26aulast%3DChemelli%26aufirst%3DR.%2BM.%26aulast%3DWillie%26aufirst%3DJ.%2BT.%26aulast%3DSinton%26aufirst%3DC.%2BM.%26aulast%3DElmquist%26aufirst%3DJ.%2BK.%26aulast%3DScammell%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKisanuki%26aufirst%3DY.%26aulast%3DFitch%26aufirst%3DT.%2BE.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DHammer%26aufirst%3DR.%2BE.%26aulast%3DSaper%26aufirst%3DC.%2BB.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DNarcolepsy%2520in%2520orexin%2520knockout%2520mice%253A%2520molecular%2520genetics%2520of%2520sleep%2520regulation%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D437%26epage%3D451%26doi%3D10.1016%2FS0092-8674%2800%2981973-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Peyron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overeem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevsimalova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padigaru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku-cherlapati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignot, E.</span><span> </span><span class="NLM_article-title">A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">â</span> <span class="NLM_lpage">997</span><span class="refDoi">Â DOI: 10.1038/79690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1038%2F79690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10973318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms12kt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=991-997&author=C.+Peyronauthor=J.+Faracoauthor=W.+Rogersauthor=B.+Ripleyauthor=S.+Overeemauthor=Y.+Charnayauthor=S.+Nevsimalovaauthor=M.+Aldrichauthor=D.+Reynoldsauthor=R.+Albinauthor=R.+Liauthor=M.+Hungsauthor=M.+Pedrazzoliauthor=M.+Padigaruauthor=M.+Ku-cherlapatiauthor=J.+Fanauthor=R.+Makiauthor=G.+J.+Lammersauthor=C.+Bourasauthor=R.+Kucherlapatiauthor=S.+Nishinoauthor=E.+Mignot&title=A+mutation+in+a+case+of+early+onset+narcolepsy+and+a+generalized+absence+of+hypocretin+peptides+in+human+narcoleptic+brains&doi=10.1038%2F79690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains</span></div><div class="casAuthors">Peyron, Christelle; Farago, Juliette; Rogers, William; Ripley, Beth; Overeem, Sebastiaan; Charnay, Yves; Nevsimalova, Sona; Aldrich, Michael; Reynolds, David; Albin, Roger; Li, Robin; Hungs, Marcel; Pedrazzoli, Mario; Padigaru, Muralidhara; Kucherlapati, Melanie; Fan, Jun; Maki, Richard; Lamers, Gert Jan; Bouras, Constantin; Kucherlapati, Raju; Nishino, Seiji; Mignot, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">991-997</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The authors explored the role of hypocretins in human narcolepsy through histopathol. of six narcolepsy brains and mutation screening of Hcrt, Hcrtr1 and Hcrtr2 in 74 patients of various human leukocyte antigen and family history status.  One Hcrt mutation, impairing peptide trafficking and processing, was found in a single case with early onset narcolepsy.  In situ hybridization of the perifornical area and peptide RIAs indicated global loss of hypocretins, without gliosis or signs of inflammation in all human cases examd.  Although hypocretin loci do not contribute significantly to genetic predisposition, most cases of human narcolepsy are assocd. with a deficient hypocretin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUmBvCqyh0ELVg90H21EOLACvtfcHk0ljlVYcF9lP2UQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms12kt7o%253D&md5=dad91a4477e7305a4b565241ddcc350b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F79690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79690%26sid%3Dliteratum%253Aachs%26aulast%3DPeyron%26aufirst%3DC.%26aulast%3DFaraco%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DW.%26aulast%3DRipley%26aufirst%3DB.%26aulast%3DOvereem%26aufirst%3DS.%26aulast%3DCharnay%26aufirst%3DY.%26aulast%3DNevsimalova%26aufirst%3DS.%26aulast%3DAldrich%26aufirst%3DM.%26aulast%3DReynolds%26aufirst%3DD.%26aulast%3DAlbin%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DHungs%26aufirst%3DM.%26aulast%3DPedrazzoli%26aufirst%3DM.%26aulast%3DPadigaru%26aufirst%3DM.%26aulast%3DKu-cherlapati%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DMaki%26aufirst%3DR.%26aulast%3DLammers%26aufirst%3DG.%2BJ.%26aulast%3DBouras%26aufirst%3DC.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DMignot%26aufirst%3DE.%26atitle%3DA%2520mutation%2520in%2520a%2520case%2520of%2520early%2520onset%2520narcolepsy%2520and%2520a%2520generalized%2520absence%2520of%2520hypocretin%2520peptides%2520in%2520human%2520narcoleptic%2520brains%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D991%26epage%3D997%26doi%3D10.1038%2F79690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="note"><p class="first last">For reviews on orexin antagonists see the following:</p></div><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Orexin receptors as therapeutic drug targets</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">â</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2FB978-0-444-59489-1.00010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=22813974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgsLbM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2012&pages=163-188&author=A.+L.+Gotterauthor=A.+J.+Roeckerauthor=R.+Hargreavesauthor=P.+J.+Colemanauthor=C.+J.+Winrowauthor=J.+J.+Renger&title=Orexin+receptors+as+therapeutic+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptors as therapeutic drug targets</span></div><div class="casAuthors">Gotter, Anthony L.; Roecker, Anthony J.; Hargreaves, Richard; Coleman, Paul J.; Winrow, Christopher J.; Renger, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">Orexin/Hypocretin System</span>),
    <span class="NLM_cas:pages">163-188</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Orexin (hypocretin) receptor antagonists stand as a model for the development of targeted CNS small-mol. therapeutics.  The identification of mutations in the gene for the orexin 2 receptor responsible for canine narcolepsy, the demonstration of a hypersomnolence phenotype in hypocretin knockout mice and the disruption in orexin signaling in narcoleptic patients provides clear genetic proof of concept for targeting orexin-induced arousal for the treatment of insomnia.  The full characterization of the genes encoding orexin and its two cognate receptors enabled the rapid development of in vitro and ex vivo assays with which to identify lead compd. structures and to optimize potency and pharmacokinetic properties.  Polysomnog. measures with cross-species translatability capable of measuring the sleep-promoting effects of orexin receptor antagonists from mice to man, and the existence of knockout models not only allow efficacy assessment but also the demonstration of mechanism of action.  Focused efforts by a no. of groups have identified potent compds. of diverse chem. structure with differential orexin receptor selectivity for either the orexin 1 receptor (OX1R) or the orexin 2 receptor (OX2R), or both.  This work has yielded tool compds. that, along with genetic models, have been used to specifically define the role these receptors in mediating orexin-induced arousal and vigilance state control.  Optimized dual receptor antagonists with favorable pharmacokinetic and safety profiles have now demonstrated efficacy in clin. development and represent a distinct mechanism of action for the treatment of insomnia relative to current std. of care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL4kWIM-gesbVg90H21EOLACvtfcHk0ljlVYcF9lP2UQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgsLbM&md5=3f18a84253a9dc9692c5d07c616dc189</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-59489-1.00010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-59489-1.00010-0%26sid%3Dliteratum%253Aachs%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DOrexin%2520receptors%2520as%2520therapeutic%2520drug%2520targets%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2012%26volume%3D198%26spage%3D163%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists: a new concept in CNS disorders</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">â</span> <span class="NLM_lpage">1214</span><span class="refDoi">Â DOI: 10.1002/cmdc.201000132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1002%2Fcmdc.201000132" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1197-1214&author=J.+Gatfieldauthor=C.+Brisbare-Rochauthor=F.+Jenckauthor=C.+Boss&title=Orexin+receptor+antagonists%3A+a+new+concept+in+CNS+disorders&doi=10.1002%2Fcmdc.201000132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000132%26sid%3Dliteratum%253Aachs%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DBoss%26aufirst%3DC.%26atitle%3DOrexin%2520receptor%2520antagonists%253A%2520a%2520new%2520concept%2520in%2520CNS%2520disorders%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1197%26epage%3D1214%26doi%3D10.1002%2Fcmdc.201000132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mieda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span> </span><span class="NLM_article-title">Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">90</span><span class="refDoi">Â DOI: 10.1007/s40263-012-0036-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1007%2Fs40263-012-0036-8" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=83-90&author=M.+Miedaauthor=T.+Sakurai&title=Orexin+%28hypocretin%29+receptor+agonists+and+antagonists+for+treatment+of+sleep+disorders%3A+rationale+for+development+and+current+status&doi=10.1007%2Fs40263-012-0036-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1007%2Fs40263-012-0036-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-012-0036-8%26sid%3Dliteratum%253Aachs%26aulast%3DMieda%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DT.%26atitle%3DOrexin%2520%2528hypocretin%2529%2520receptor%2520agonists%2520and%2520antagonists%2520for%2520treatment%2520of%2520sleep%2520disorders%253A%2520rationale%2520for%2520development%2520and%2520current%2520status%26jtitle%3DCNS%2520Drugs%26date%3D2013%26volume%3D27%26spage%3D83%26epage%3D90%26doi%3D10.1007%2Fs40263-012-0036-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Discovery and development of orexin receptor antagonists as therapeutics for insomnia</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">â</span> <span class="NLM_lpage">293</span><span class="refDoi">Â DOI: 10.1111/bph.12261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1111%2Fbph.12261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=23731216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=283-293&author=C.+J.+Winrowauthor=J.+J.+Renger&title=Discovery+and+development+of+orexin+receptor+antagonists+as+therapeutics+for+insomnia&doi=10.1111%2Fbph.12261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of orexin receptor antagonists as therapeutics for insomnia</span></div><div class="casAuthors">Winrow, C. J.; Renger, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-293</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Insomnia persistently affects the quality and quantity of sleep.  Currently approved treatments for insomnia primarily target Î³-aminobutyric acid-A (GABA-A) receptor signalling and include benzodiazepines and GABA-A receptor modulators.  These drugs are used to address this sleep disorder, but have the potential for side effects such as tolerance and dependence, making them less attractive as maintenance therapy.  Forward and reverse genetic approaches in animals have implicated orexin signalling (also referred to as hypocretin signalling) in the control of vigilance and sleep/wake states.  Screening for orexin receptor antagonists using in vitro and in vivo methods in animals has identified compds. that block one or other of the orexin receptors (single or dual orexin receptor antagonists [SORAs and DORAs], resp.) in animals and humans.  SORAs have primarily been used as probes to further elucidate the roles of the individual orexin receptors, while a no. of DORAs have progressed to clin. development as pharmaceutical candidates for insomnia.  The DORA almorexant demonstrated significant improvements in a no. of clin. relevant sleep parameters in animal models and in patients with insomnia but its development was halted.  SB-649868 and suvorexant have demonstrated efficacy and tolerability in Phase II and III trials resp.  Furthermore, suvorexant is currently under review by the Food and Drug Administration for the treatment of insomnia.  Based on the publication of recent non-clin. and clin. data, orexin receptor antagonists potentially represent a targeted, effective and well-tolerated new class of medications for insomnia.  Linked Articles : This article is part of a themed section on Orexin Receptors.  To view the other articles in this section visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFkesyU8tIxrVg90H21EOLACvtfcHk0lgLhs9pOERI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3O&md5=48f92a02b193a648d387c55329fb5fcf</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1111%2Fbph.12261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12261%26sid%3Dliteratum%253Aachs%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520development%2520of%2520orexin%2520receptor%2520antagonists%2520as%2520therapeutics%2520for%2520insomnia%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D283%26epage%3D293%26doi%3D10.1111%2Fbph.12261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists in development for insomnia and CNS disorders</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">â</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=73-87&author=S.+D.+Kudukauthor=C.+J.+Winrowauthor=P.+J.+Coleman&title=Orexin+receptor+antagonists+in+development+for+insomnia+and+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DOrexin%2520receptor%2520antagonists%2520in%2520development%2520for%2520insomnia%2520and%2520CNS%2520disorders%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D73%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hoever, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiossi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gerven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">â</span> <span class="NLM_lpage">600</span><span class="refDoi">Â DOI: 10.1038/clpt.2010.19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1038%2Fclpt.2010.19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=20376002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFCntLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2010&pages=593-600&author=P.+Hoeverauthor=S.+de+Haasauthor=J.+Winklerauthor=R.+C.+Schoemakerauthor=E.+Chiossiauthor=J.+van+Gervenauthor=J.+Dingemanse&title=Orexin+receptor+antagonism%2C+a+new+sleep-promoting+paradigm%3A+an+ascending+single-dose+study+with+almorexant&doi=10.1038%2Fclpt.2010.19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant</span></div><div class="casAuthors">Hoever, P.; de Haas, S.; Winkler, J.; Schoemaker, R. C.; Chiossi, E.; van Gerven, J.; Dingemanse, J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-600</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Almorexant, a dual orexin receptor antagonist potentially representing a new class of sleep-promoting compds., was administered in an ascending single-dose study to evaluate tolerability, pharmacokinetics, and pharmacodynamics.  Seventy healthy male subjects were enrolled in this double-blind, placebo- and active-controlled study.  Each dose level (1-1,000 mg) was investigated in a sep. group of 10 subjects (6 on almorexant, 2 on placebo, 2 on zolpidem 10 mg).  Almorexant was well tolerated with no signs of cataplexy.  Peak plasma concn. (Cmax) was quickly attained (median time to max. concn. (tmax) ranged from 0.7 to 2.3 h), and plasma concns. subsequently decreased quickly to â¼20% of Cmax over the course of 8 h.  Vigilance, alertness, and visuomotor and motor coordination were reduced following daytime administration of zolpidem or almorexant at doses of â¥400 mg.  Population pharmacokinetic/pharmacodynamic modeling suggested that doses of â¼500 mg almorexant and 10 mg zolpidem are equiv. with respect to subjectively assessed alertness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ9nYFrp8FEbVg90H21EOLACvtfcHk0lgLhs9pOERI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFCntLk%253D&md5=528965794ed9ae22a832f66b8047ed7b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2010.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2010.19%26sid%3Dliteratum%253Aachs%26aulast%3DHoever%26aufirst%3DP.%26aulast%3Dde%2BHaas%26aufirst%3DS.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DSchoemaker%26aufirst%3DR.%2BC.%26aulast%3DChiossi%26aufirst%3DE.%26aulast%3Dvan%2BGerven%26aufirst%3DJ.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DOrexin%2520receptor%2520antagonism%252C%2520a%2520new%2520sleep-promoting%2520paradigm%253A%2520an%2520ascending%2520single-dose%2520study%2520with%2520almorexant%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2010%26volume%3D87%26spage%3D593%26epage%3D600%26doi%3D10.1038%2Fclpt.2010.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5320</span><span class="NLM_x">â</span> <span class="NLM_lpage">5332</span><span class="refDoi">Â DOI: 10.1021/jm100541c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100541c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVegsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5320-5332&author=C.+D.+Coxauthor=M.+J.+Breslinauthor=D.+B.+Whitmanauthor=J.+D.+Schreierauthor=G.+B.+McGaugheyauthor=M.+J.+Boguskyauthor=A.+J.+Roeckerauthor=S.+P.+Mercerauthor=R.+A.+Bednarauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=D.+R.+Reissauthor=C.+M.+Harrellauthor=K.+L.+Murphyauthor=S.+L.+Garsonauthor=S.+M.+Doranauthor=T.+Prueksaritanontauthor=W.+B.+Andersonauthor=C.+Tangauthor=S.+Rollerauthor=T.+D.+Cabaluauthor=D.+Cuiauthor=G.+D.+Hartmanauthor=S.+D.+Youngauthor=K.+S.+Koblanauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+the+dual+orexin+receptor+antagonist+%5B%287R%29-4-%285-chloro-1%2C3-benzoxazol-2-yl%29-7-methyl-1%2C4-diazepan-1-yl%5D%5B5-methyl-2-%282H-1%2C2%2C3-triazol-2-yl%29phenyl%5Dmethanone+%28MK-4305%29+for+the+treatment+of+insomnia&doi=10.1021%2Fjm100541c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia</span></div><div class="casAuthors">Cox, Christopher D.; Breslin, Michael J.; Whitman, David B.; Schreier, John D.; McGaughey, Georgia B.; Bogusky, Michael J.; Roecker, Anthony J.; Mercer, Swati P.; Bednar, Rodney A.; Lemaire, Wei; Bruno, Joseph G.; Reiss, Duane R.; Harrell, C. Meacham; Murphy, Kathy L.; Garson, Susan L.; Doran, Scott M.; Prueksaritanont, Thomayant; Anderson, Wayne B.; Tang, Cuyue; Roller, Shane; Cabalu, Tamara D.; Cui, Donghui; Hartman, George D.; Young, Steven D.; Koblan, Ken S.; Winrow, Christopher J.; Renger, John J.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5320-5332</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite increased understanding of the biol. basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years.  One notable exception is inhibition of the excitatory neuropeptides orexins A and B by design of orexin receptor antagonists.  Herein, we describe how efforts to understand the origin of poor oral pharmacokinetics in a leading HTS-derived diazepane orexin receptor antagonist led to the identification of compd. 10 with a 7-Me substitution on the diazepane core.  Though 10 displayed good potency, improved pharmacokinetics, and excellent in vivo efficacy, it formed reactive metabolites in microsomal incubations.  A mechanistic hypothesis coupled with an in vitro assay to assess bioactivation led to replacement of the fluoroquinazoline ring of 10 with a chlorobenzoxazole to provide 3 (MK-4305), a potent dual orexin receptor antagonist that is currently being tested in phase III clin. trials for the treatment of primary insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZsDTh00qOaLVg90H21EOLACvtfcHk0lj5wnxa1p_wAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVegsrw%253D&md5=8930a483f7058c4b51e2a941fb779180</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm100541c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100541c%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BM.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DW.%2BB.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520the%2520dual%2520orexin%2520receptor%2520antagonist%2520%255B%25287R%2529-4-%25285-chloro-1%252C3-benzoxazol-2-yl%2529-7-methyl-1%252C4-diazepan-1-yl%255D%255B5-methyl-2-%25282H-1%252C2%252C3-triazol-2-yl%2529phenyl%255Dmethanone%2520%2528MK-4305%2529%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5320%26epage%3D5332%26doi%3D10.1021%2Fjm100541c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yang, L. P. H.</span><span> </span><span class="NLM_article-title">Suvorexant: first global approval</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">â</span> <span class="NLM_lpage">1822</span><span class="refDoi">Â DOI: 10.1007/s40265-014-0294-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1007%2Fs40265-014-0294-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=25227290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFynsrzI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1817-1822&author=L.+P.+H.+Yang&title=Suvorexant%3A+first+global+approval&doi=10.1007%2Fs40265-014-0294-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Suvorexant: First Global Approval</span></div><div class="casAuthors">Yang, Lily P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1817-1822</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Suvorexant (Belsomra), a first-in-class, orally active dual orexin-1 receptor and orexin-2 receptor antagonist, has been developed by Merck for the treatment of insomnia.  Variations in the levels of the neuropeptides orexin A and orexin B have been linked to circadian rhythms and wakefulness.  Orexin-producing neurons in the lateral hypothalamus regulate wakefulness by signalling through orexin receptors.  Blockade of orexin receptors is known to promote sleep.  Suvorexant was approved in the US in August 2014 for the treatment of adults with sleep onset and/or sleep maintenance insomnia.  The drug is also preregistration in Japan, with approval submissions planned for other countries worldwide for this indication.  This article summarizes the milestones in the development of suvorexant leading to this first approval for insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok1XSXeQfbzrVg90H21EOLACvtfcHk0lj5wnxa1p_wAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFynsrzI&md5=4c5382921082b25a5a4c16ea5703cedc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40265-014-0294-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-014-0294-5%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%2BP.%2BH.%26atitle%3DSuvorexant%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2014%26volume%3D74%26spage%3D1817%26epage%3D1822%26doi%3D10.1007%2Fs40265-014-0294-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><div class="note"><p class="first last">For a review describing selective orexin receptor antagonist see the following:</p></div><span class="NLM_contrib-group">Lebold, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span> </span><span class="NLM_article-title">Selective orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">4761</span><span class="NLM_x">â</span> <span class="NLM_lpage">4769</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.06.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2013.06.057" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4761-4769&issue=17&author=T.+P.+Leboldauthor=P.+Bonaventureauthor=B.+T.+Shireman&title=Selective+orexin+receptor+antagonists&doi=10.1016%2Fj.bmcl.2013.06.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.057%26sid%3Dliteratum%253Aachs%26aulast%3DLebold%26aufirst%3DT.%2BP.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26atitle%3DSelective%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4761%26epage%3D4769%26doi%3D10.1016%2Fj.bmcl.2013.06.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Dugovic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span> </span><span class="NLM_article-title">Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">â</span> <span class="NLM_lpage">151</span><span class="refDoi">Â DOI: 10.1124/jpet.109.152009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1124%2Fjpet.109.152009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=19363060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFeltLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=142-151&author=C.+Dugovicauthor=J.+E.+Sheltonauthor=L.+E.+Aluisioauthor=I.+C.+Fraserauthor=X.+Jiangauthor=S.W.+Suttonauthor=P.+Bonaventureauthor=S.+Yunauthor=X.+Liauthor=B.+Lordauthor=C.+A.+Dvorakauthor=N.+I.+Carruthersauthor=T.+W.+Lovenberg&title=Blockade+of+orexin-1+receptors+attenuates+orexin-2+receptor+antagonism-induced+sleep+promotion+in+the+rat&doi=10.1124%2Fjpet.109.152009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat</span></div><div class="casAuthors">Dugovic, Christine; Shelton, Jonathan E.; Aluisio, Leah E.; Fraser, Ian C.; Jiang, Xiaohui; Sutton, Steven W.; Bonaventure, Pascal; Yun, Sujin; Li, Xiaorong; Lord, Brian; Dvorak, Curt A.; Carruthers, Nicholas I.; Lovenberg, Timothy W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-151</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Orexins are peptides produced by lateral hypothalamic neurons that exert a prominent role in the maintenance of wakefulness by activating orexin-1 (OX1R) and orexin-2 (OX2R) receptor located in wake-active structures.  Pharmacol. blockade of both receptors by the dual OX1/2R antagonist (2R)-2-[(1S)-6,7-dimethoxy-1-{2-[4-(trifluoromethyl)phenyl]ethyl}-3,4-dihydroisoquinolin-2(1H)-yl]-N-methyl-2-phenylethanamide (almorexant) has been shown to promote sleep in animals and humans during their active period.  However, the selective distribution of OX1R and OX2R in distinct neuronal circuits may result in a differential impact of these receptors in sleep-wake modulation.  The resp. role of OX1R and OX2R on sleep in correlation with monoamine release was evaluated in rats treated with selective antagonists alone or in combination.  When administered in either phase of the light/dark cycle, the OX2R antagonist 1-(2,4-dibromophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea (JNJ-10397049) decreased the latency for persistent sleep and increased nonrapid eye movement and rapid eye movement sleep time.  Almorexant produced less hypnotic activity, whereas the OX1R antagonist 1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea (SB-408124) had no effect.  Microdialysis studies showed that either OX2R or OX1/2R antagonism decreased extracellular histamine concn. in the lateral hypothalamus, whereas both OX1R and OX1/2R antagonists increased dopamine release in the prefrontal cortex.  Finally, coadministration of the OX1R with the OX2R antagonist greatly attenuated the sleep-promoting effects of the OX2R antagonist.  These results indicate that blockade of OX2R is sufficient to initiate and prolong sleep, consistent with the hypothesis of a deactivation of the histaminergic system.  In addn., it is suggested that simultaneous inhibition of OX1R attenuates the sleep-promoting effects mediated by selective OX2R blockade, possibly correlated with dopaminergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPXVs02jXOYLVg90H21EOLACvtfcHk0lj5wnxa1p_wAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFeltLk%253D&md5=32a5fc48d949eef2a633187c274cec80</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.152009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.152009%26sid%3Dliteratum%253Aachs%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSutton%26aufirst%3DS.W.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26atitle%3DBlockade%2520of%2520orexin-1%2520receptors%2520attenuates%2520orexin-2%2520receptor%2520antagonism-induced%2520sleep%2520promotion%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D142%26epage%3D151%26doi%3D10.1124%2Fjpet.109.152009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dugovic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span> </span><span class="NLM_article-title">Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism</span> <span class="citation_source-journal">Front. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="refDoi">Â DOI: 10.3389/fnins.2014.00028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.3389%2Ffnins.2014.00028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=24592208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A280%3ADC%252BC2crgt1amuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=28&author=C.+Dugovicauthor=J.+E.+Sheltonauthor=S.+Yunauthor=P.+Bonaventureauthor=B.+T.+Shiremanauthor=T.+W.+Lovenberg&title=Orexin-1+receptor+blockade+dysregulates+REM+sleep+in+the+presence+of+orexin-2+receptor+antagonism&doi=10.3389%2Ffnins.2014.00028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism</span></div><div class="casAuthors">Dugovic Christine; Shelton Jonathan E; Yun Sujin; Bonaventure Pascal; Shireman Brock T; Lovenberg Timothy W</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">In accordance with the prominent role of orexins in the maintenance of wakefulness via activation of orexin-1 (OX1R) and orexin-2 (OX2R) receptors, various dual OX1/2R antagonists have been shown to promote sleep in animals and humans.  While selective blockade of OX2R seems to be sufficient to initiate and prolong sleep, the beneficial effect of additional inhibition of OX1R remains controversial.  The relative contribution of OX1R and OX2R to the sleep effects induced by a dual OX1/2R antagonist was further investigated in the rat, and specifically on rapid eye movement (REM) sleep since a deficiency of the orexin system is associated with narcolepsy/cataplexy based on clinical and pre-clinical data.  As expected, the dual OX1/2R antagonist SB-649868 was effective in promoting non-REM (NREM) and REM sleep following oral dosing (10 and 30 mg/kg) at the onset of the dark phase.  However, a disruption of REM sleep was evidenced by a more pronounced reduction in the onset of REM as compared to NREM sleep, a marked enhancement of the REM/total sleep ratio, and the occurrence of a few episodes of direct wake to REM sleep transitions (REM intrusion).  When administered subcutaneously, the OX2R antagonist JNJ-10397049 (10 mg/kg) increased NREM duration whereas the OX1R antagonist GSK-1059865 (10 mg/kg) did not alter sleep.  REM sleep was not affected either by OX2R or OX1R blockade alone, but administration of the OX1R antagonist in combination with the OX2R antagonist induced a significant reduction in REM sleep latency and an increase in REM sleep duration at the expense of the time spent in NREM sleep.  These results indicate that additional blockade of OX1R to OX2R antagonism elicits a dysregulation of REM sleep by shifting the balance in favor of REM sleep at the expense of NREM sleep that may increase the risk of adverse events.  Translation of this hypothesis remains to be tested in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuN2mc5LjFPFZoq0fPSOTvfW6udTcc2ebJe1Hwk5VEqrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crgt1amuw%253D%253D&md5=2edae8f4ded288f283742691d9285ee0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2014.00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2014.00028%26sid%3Dliteratum%253Aachs%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26atitle%3DOrexin-1%2520receptor%2520blockade%2520dysregulates%2520REM%2520sleep%2520in%2520the%2520presence%2520of%2520orexin-2%2520receptor%2520antagonism%26jtitle%3DFront.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D28%26doi%3D10.3389%2Ffnins.2014.00028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">Reference <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> and references therein.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Morairty, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revel, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valladao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilduff, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span> </span><span class="NLM_article-title">Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">e39131</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0039131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1371%2Fjournal.pone.0039131" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39131&issue=7&author=S.+R.+Morairtyauthor=F.+G.+Revelauthor=P.+Malherbeauthor=J.+L.+Moreauauthor=D.+Valladaoauthor=J.+G.+Wettsteinauthor=T.+S.+Kilduffauthor=E.+Borroni&title=Dual+hypocretin+receptor+antagonism+is+more+effective+for+sleep+promotion+than+antagonism+of+either+receptor+alone&doi=10.1371%2Fjournal.pone.0039131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039131%26sid%3Dliteratum%253Aachs%26aulast%3DMorairty%26aufirst%3DS.%2BR.%26aulast%3DRevel%26aufirst%3DF.%2BG.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DValladao%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DBorroni%26aufirst%3DE.%26atitle%3DDual%2520hypocretin%2520receptor%2520antagonism%2520is%2520more%2520effective%2520for%2520sleep%2520promotion%2520than%2520antagonism%2520of%2520either%2520receptor%2520alone%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D7%26spage%3De39131%26doi%3D10.1371%2Fjournal.pone.0039131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">McAtee, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phuong, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. K.</span><span> </span><span class="NLM_article-title">Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX2R) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4225</span><span class="NLM_x">â</span> <span class="NLM_lpage">4229</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2004.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2004.06.032" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4225-4229&issue=16&author=L.+C.+McAteeauthor=S.+W.+Suttonauthor=D.+A.+Rudolphauthor=X.+Liauthor=L.+E.+Aluisioauthor=V.+K.+Phuongauthor=C.+A.+Dvorakauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=T.+K.+Jones&title=Novel+substituted+4-phenyl-%5B1%2C3%5Ddioxanes%3A+potent+and+selective+orexin+receptor+2+%28OX2R%29+antagonists&doi=10.1016%2Fj.bmcl.2004.06.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DL.%2BC.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DPhuong%26aufirst%3DV.%2BK.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DJones%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520substituted%25204-phenyl-%255B1%252C3%255Ddioxanes%253A%2520potent%2520and%2520selective%2520orexin%2520receptor%25202%2520%2528OX2R%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D16%26spage%3D4225%26epage%3D4229%26doi%3D10.1016%2Fj.bmcl.2004.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an N,N-disubstituted-1,4-diazepane scaffold that promotes sleep in rats</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1069</span><span class="NLM_x">â</span> <span class="NLM_lpage">1074</span><span class="refDoi">Â DOI: 10.1002/cmdc.200900069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1002%2Fcmdc.200900069" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1069-1074&issue=7&author=D.+B.+Whitmanauthor=C.+D.+Coxauthor=M.+J.+Breslinauthor=K.+M.+Brashearauthor=J.+D.+Schreierauthor=M.+J.+Boguskyauthor=R.+A.+Bednarauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=G.+D.+Hartmanauthor=D.+R.+Reissauthor=C.+M.+Harrellauthor=R.+L.+Krausauthor=Y.+Liauthor=S.+L.+Garsonauthor=S.+M.+Doranauthor=T.+Prueksaritanontauthor=C.+Liauthor=C.+J.+Winrowauthor=K.+S.+Koblanauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+a+potent%2C+CNS-penetrant+orexin+receptor+antagonist+based+on+an+N%2CN-disubstituted-1%2C4-diazepane+scaffold+that+promotes+sleep+in+rats&doi=10.1002%2Fcmdc.200900069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900069%26sid%3Dliteratum%253Aachs%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DBrashear%26aufirst%3DK.%2BM.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BM.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520CNS-penetrant%2520orexin%2520receptor%2520antagonist%2520based%2520on%2520an%2520N%252CN-disubstituted-1%252C4-diazepane%2520scaffold%2520that%2520promotes%2520sleep%2520in%2520rats%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26issue%3D7%26spage%3D1069%26epage%3D1074%26doi%3D10.1002%2Fcmdc.200900069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellabott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 5â³-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2â²:5â²,3â³-terpyridine-3â²-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">332</span><span class="refDoi">Â DOI: 10.1002/cmdc.201300447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1002%2Fcmdc.201300447" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=311-332&issue=2&author=A.+J.+Roeckerauthor=S.+P.+Mercerauthor=J.+D.+Schreierauthor=C.+D.+Coxauthor=M.+E.+Fraleyauthor=J.+T.+Steenauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=C.+M.+Harrellauthor=S.+L.+Garsonauthor=A.+L.+Gotterauthor=S.+V.+Foxauthor=J.+Stevensauthor=P.+L.+Tannenbaumauthor=T.+Prueksaritanontauthor=T.+D.+Cabaluauthor=D.+Cuiauthor=J.+Stellabottauthor=G.+D.+Hartmanauthor=S.+D.+Youngauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+5%E2%80%B3-chloro-N-%5B%285%2C6-dimethoxypyridin-2-yl%29methyl%5D-2%2C2%E2%80%B2%3A5%E2%80%B2%2C3%E2%80%B3-terpyridine-3%E2%80%B2-carboxamide+%28MK-1064%29%3A+a+selective+orexin+2+receptor+antagonist+%282-SORA%29+for+the+treatment+of+insomnia&doi=10.1002%2Fcmdc.201300447"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300447%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DFox%26aufirst%3DS.%2BV.%26aulast%3DStevens%26aufirst%3DJ.%26aulast%3DTannenbaum%26aufirst%3DP.%2BL.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DStellabott%26aufirst%3DJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25205%25E2%2580%25B3-chloro-N-%255B%25285%252C6-dimethoxypyridin-2-yl%2529methyl%255D-2%252C2%25E2%2580%25B2%253A5%25E2%2580%25B2%252C3%25E2%2580%25B3-terpyridine-3%25E2%2580%25B2-carboxamide%2520%2528MK-1064%2529%253A%2520a%2520selective%2520orexin%25202%2520receptor%2520antagonist%2520%25282-SORA%2529%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D311%26epage%3D332%26doi%3D10.1002%2Fcmdc.201300447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reger, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattern, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellabott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">4884</span><span class="NLM_x">â</span> <span class="NLM_lpage">4890</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2014.08.041" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4884-4890&issue=20&author=A.+J.+Roeckerauthor=T.+S.+Regerauthor=M.+C.+Matternauthor=S.+P.+Mercerauthor=J.+M.+Bergmanauthor=J.+D.+Schreierauthor=R.+V.+Cubeauthor=C.+D.+Coxauthor=D.+Liauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=C.+M.+Harrellauthor=S.+L.+Garsonauthor=A.+L.+Gotterauthor=S.+V.+Foxauthor=J.+Stevensauthor=P.+L.+Tannenbaumauthor=T.+Prueksaritanontauthor=T.+D.+Cabaluauthor=D.+Cuiauthor=J.+Stellabottauthor=G.+D.+Hartmanauthor=S.+D.+Youngauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+MK-3697%3A+a+selective+orexin+2+receptor+antagonist+%282-SORA%29+for+the+treatment+of+insomnia&doi=10.1016%2Fj.bmcl.2014.08.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DReger%26aufirst%3DT.%2BS.%26aulast%3DMattern%26aufirst%3DM.%2BC.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DBergman%26aufirst%3DJ.%2BM.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DFox%26aufirst%3DS.%2BV.%26aulast%3DStevens%26aufirst%3DJ.%26aulast%3DTannenbaum%26aufirst%3DP.%2BL.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DStellabott%26aufirst%3DJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-3697%253A%2520a%2520selective%2520orexin%25202%2520receptor%2520antagonist%2520%25282-SORA%2529%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D20%26spage%3D4884%26epage%3D4890%26doi%3D10.1016%2Fj.bmcl.2014.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Betschart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hintermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotesta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badiger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span> </span><span class="NLM_article-title">Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">7590</span><span class="NLM_x">â</span> <span class="NLM_lpage">7607</span><span class="refDoi">Â DOI: 10.1021/jm4007627</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4007627" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7590-7607&issue=19&author=C.+Betschartauthor=S.+Hintermannauthor=D.+Behnkeauthor=S.+Cotestaauthor=M.+Fendtauthor=C.+E.+Geeauthor=L.+H.+Jacobsonauthor=G.+Laueauthor=S.+Ofnerauthor=V.+Chaudhariauthor=S.+Badigerauthor=C.+Panditauthor=J.+Wagnerauthor=D.+Hoyer&title=Identification+of+a+novel+series+of+orexin+receptor+antagonists+with+a+distinct+effect+on+sleep+architecture+for+the+treatment+of+insomnia&doi=10.1021%2Fjm4007627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm4007627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4007627%26sid%3Dliteratum%253Aachs%26aulast%3DBetschart%26aufirst%3DC.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DBehnke%26aufirst%3DD.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DFendt%26aufirst%3DM.%26aulast%3DGee%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DChaudhari%26aufirst%3DV.%26aulast%3DBadiger%26aufirst%3DS.%26aulast%3DPandit%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520orexin%2520receptor%2520antagonists%2520with%2520a%2520distinct%2520effect%2520on%2520sleep%2520architecture%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D19%26spage%3D7590%26epage%3D7607%26doi%3D10.1021%2Fjm4007627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Raheem, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalu, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotter, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of piperidine ethers as selective orexin receptor antagonist (SORAs) inspired by filorexant</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">â</span> <span class="NLM_lpage">450</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2014.12.056" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=444-450&author=I.+T.+Raheemauthor=M.+J.+Breslinauthor=J.+Brunoauthor=T.+D.+Cabaluauthor=A.+Cookeauthor=C.+D.+Coxauthor=D.+Cuiauthor=S.+Garsonauthor=A.+L.+Gotterauthor=S.+V.+Foxauthor=C.+M.+Harrellauthor=S.+D.+Kudukauthor=W.+Lemaireauthor=T.+Prueksaritanontauthor=J.+J.+Rengerauthor=C.+Stumpauthor=P.+L.+Tannenbaumauthor=P.+D.+Williamsauthor=C.+J.+Winrowauthor=P.+J.+Coleman&title=Discovery+of+piperidine+ethers+as+selective+orexin+receptor+antagonist+%28SORAs%29+inspired+by+filorexant&doi=10.1016%2Fj.bmcl.2014.12.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.056%26sid%3Dliteratum%253Aachs%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DBruno%26aufirst%3DJ.%26aulast%3DCabalu%26aufirst%3DT.%2BD.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DGotter%26aufirst%3DA.%2BL.%26aulast%3DFox%26aufirst%3DS.%2BV.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DStump%26aufirst%3DC.%26aulast%3DTannenbaum%26aufirst%3DP.%2BL.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520piperidine%2520ethers%2520as%2520selective%2520orexin%2520receptor%2520antagonist%2520%2528SORAs%2529%2520inspired%2520by%2520filorexant%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D444%26epage%3D450%26doi%3D10.1016%2Fj.bmcl.2014.12.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Roecker, A. J.; Mercer, S. P.; Bergman, J. M.; Gilbert, K. F.; Kuduk, S. D.; Harrell, C. M.; Garson, S.; Fox, S. V.; Gotter, A. L.; Tannenbaum, P. L.; Prueksaritanont, T.; Cabalu, T. D.; Cui, D.; Lemaire, W.; Winrow, C. J.; Renger, J. J.; Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.081</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1016%2Fj.bmcl.2014.12.081" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+J.+Roecker&author=S.+P.+Mercer&author=J.+M.+Bergman&author=K.+F.+Gilbert&author=S.+D.+Kuduk&author=C.+M.+Harrell&author=S.+Garson&author=S.+V.+Fox&author=A.+L.+Gotter&author=P.+L.+Tannenbaum&author=T.+Prueksaritanont&author=T.+D.+Cabalu&author=D.+Cui&author=W.+Lemaire&author=C.+J.+Winrow&author=J.+J.+Renger&author=P.+J.+Coleman&title=Discovery+of+diazepane+amide+DORAs+and+2-SORAs+enabled+by+exploration+of+isosteric+quinazoline+replacements&doi=10.1016%2Fj.bmcl.2014.12.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.081%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520diazepane%2520amide%2520DORAs%2520and%25202-SORAs%2520enabled%2520by%2520exploration%2520of%2520isosteric%2520quinazoline%2520replacements%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26doi%3D10.1016%2Fj.bmcl.2014.12.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Branstetter, B. J.; Letavic, M. A.; Ly, K. S.; Rudolph, D. A.; Savall, B. M.; Shah, C. R.; Shireman, B. T.</span> PCT Int. Appl. WO 2011050202 A1, Apr 28,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Branstetter%2C+B.+J.%3B+Letavic%2C+M.+A.%3B+Ly%2C+K.+S.%3B+Rudolph%2C+D.+A.%3B+Savall%2C+B.+M.%3B+Shah%2C+C.+R.%3B+Shireman%2C+B.+T.+PCT+Int.+Appl.+WO+2011050202+A1%2C+Apr+28%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBranstetter%26aufirst%3DB.%2BJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chai, W.; Letavic, M. A.; Ly, K. S.; Pippel, D. J.; Rudolph, D. A.; Sappey, K. C.; Savall, B. M.; Shah, C. R.; Shireman, B. T.; Soyode-Johnson, A.; Stocking, E. M.; Swanson, D. M.</span> PCT Int. Appl. WO 2011050198 A1, Apr 28,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chai%2C+W.%3B+Letavic%2C+M.+A.%3B+Ly%2C+K.+S.%3B+Pippel%2C+D.+J.%3B+Rudolph%2C+D.+A.%3B+Sappey%2C+K.+C.%3B+Savall%2C+B.+M.%3B+Shah%2C+C.+R.%3B+Shireman%2C+B.+T.%3B+Soyode-Johnson%2C+A.%3B+Stocking%2C+E.+M.%3B+Swanson%2C+D.+M.+PCT+Int.+Appl.+WO+2011050198+A1%2C+Apr+28%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DW.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">The detailed procedures used to measure OX2R and OX1R <i>K</i><sub>i</sub> values can be found in the following:</p></div><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shekhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitz, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebold, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugovic, C.</span><span> </span><span class="NLM_article-title">A selective orexin-1 receptor antagonist attenuates stress-induced hyprarousal without hypnotic effects</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">590</span><span class="NLM_x">â</span> <span class="NLM_lpage">601</span><span class="refDoi">Â DOI: 10.1124/jpet.114.220392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1124%2Fjpet.114.220392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=25583879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=590-601&issue=3&author=P.+Bonaventureauthor=S.+Yunauthor=P.+L.+Johnsonauthor=A.+Shekharauthor=S.+D.+Fitzauthor=B.+T.+Shiremanauthor=T.+P.+Leboldauthor=D.+Nepomucenoauthor=B.+Lordauthor=M.+Wennerholmauthor=J.+Sheltonauthor=N.+Carruthersauthor=T.+Lovenbergauthor=C.+Dugovic&title=A+selective+orexin-1+receptor+antagonist+attenuates+stress-induced+hyprarousal+without+hypnotic+effects&doi=10.1124%2Fjpet.114.220392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects</span></div><div class="casAuthors">Bonaventure, Pascal; Yun, Sujin; Johnson, Philip L.; Shekhar, Anantha; Fitz, Stephanie D.; Shireman, Brock T.; Lebold, Terry P.; Nepomuceno, Diane; Lord, Brian; Wennerholm, Michelle; Shelton, Jonathan; Carruthers, Nicholas; Lovenberg, Timothy; Dugovic, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">590-601, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Orexins (OXs) are peptides produced by perifornical (PeF) and lateral hypothalamic neurons that exert a prominent role in arousal-related processes, including stress.  A crit. role for the orexin-1 receptor (OX1R) in complex emotional behavior is emerging, such as overactivation of the OX1R pathway being assocd. with panic or anxiety states.  Here we characterize a brain-penetrant, selective, and high-affinity OX1R antagonist, compd. 56 [N-({3-[(3-ethoxy-6-methylpyridin-2-yl)carbonyl]-3-azabicyclo[4.1.0]hept-4-yl}methyl)-5-(trifluoromethyl)pyrimidin-2-amine].  Ex vivo receptor binding studies demonstrated that, after s.c. administration, compd. 56 crossed the blood-brain barrier and occupied OX1Rs in the rat brain at lower doses than std. OX1R antagonists GSK-1059865 [5-bromo-N-({1-[(3-fluoro-2-methoxyphenyl)carbonyl]-5-methylpiperidin-2-yl}methyl)pyridin-2-amine], SB-334867 [1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea], and SB-408124 [1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea].  Although compd. 56 did not alter spontaneous sleep in rats and in wild-type mice, its administration in orexin-2 receptor knockout mice selectively promoted rapid eye movement sleep, demonstrating target engagement and specific OX1R blockade.  In a rat model of psychol. stress induced by cage exchange, the OX1R antagonist prevented the prolongation of sleep onset without affecting sleep duration.  In a rat model of panic vulnerability (involving disinhibition of the PeF OX region) to threatening internal state changes (i.e., i.v. sodium lactate infusion), compd. 56 attenuated sodium lactate-induced panic-like behaviors and cardiovascular responses without altering baseline locomotor or autonomic activity.  In conclusion, OX1R antagonism represents a novel therapeutic strategy for the treatment of various psychiatric disorders assocd. with stress or hyperarousal states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobTtYJtwsEh7Vg90H21EOLACvtfcHk0liKcZbVJ2ldow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omuro%253D&md5=0793591a77a5bf93b9e448cb1381da2a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.220392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.220392%26sid%3Dliteratum%253Aachs%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DP.%2BL.%26aulast%3DShekhar%26aufirst%3DA.%26aulast%3DFitz%26aufirst%3DS.%2BD.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26aulast%3DLebold%26aufirst%3DT.%2BP.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWennerholm%26aufirst%3DM.%26aulast%3DShelton%26aufirst%3DJ.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%26aulast%3DDugovic%26aufirst%3DC.%26atitle%3DA%2520selective%2520orexin-1%2520receptor%2520antagonist%2520attenuates%2520stress-induced%2520hyprarousal%2520without%2520hypnotic%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26issue%3D3%26spage%3D590%26epage%3D601%26doi%3D10.1124%2Fjpet.114.220392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">The detailed procedures used for conducting these experiments can be found in ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bonaventure, P.; Shelton, J.; Yun, S.; Nepomuceno, D.; Sutton, S.; Aluisio, L.; Frazer, I.; Lord, B.; Shoblock, J.; Welty, N.; Chaplan, S. R.; Aguilar, Z.; Halter, R.; Ndifor, A.; Koudriakova, T.; Rizzolio, M.; Letavic, M.; Carruthers, N.; Lovenberg, T.; Dugovic, C.</span><span> </span><span class="NLM_article-title">Characterization of JNJ-42847922, a selective orexin-2 receptor antagonist, as a clinical candidate for the treatment of insomnia.</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span>, submitted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bonaventure%2C+P.%3B+Shelton%2C+J.%3B+Yun%2C+S.%3B+Nepomuceno%2C+D.%3B+Sutton%2C+S.%3B+Aluisio%2C+L.%3B+Frazer%2C+I.%3B+Lord%2C+B.%3B+Shoblock%2C+J.%3B+Welty%2C+N.%3B+Chaplan%2C+S.+R.%3B+Aguilar%2C+Z.%3B+Halter%2C+R.%3B+Ndifor%2C+A.%3B+Koudriakova%2C+T.%3B+Rizzolio%2C+M.%3B+Letavic%2C+M.%3B+Carruthers%2C+N.%3B+Lovenberg%2C+T.%3B+Dugovic%2C+C.+Characterization+of+JNJ-42847922%2C+a+selective+orexin-2+receptor+antagonist%2C+as+a+clinical+candidate+for+the+treatment+of+insomnia.J.+Pharmacol.+Exp.+Ther.%2C+submitted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonaventure%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520JNJ-42847922%252C%2520a%2520selective%2520orexin-2%2520receptor%2520antagonist%252C%2520as%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520insomnia.%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lave, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span> </span><span class="NLM_article-title">Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">584</span><span class="NLM_x">â</span> <span class="NLM_lpage">590</span><span class="refDoi">Â DOI: 10.1021/js960440h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;key=10.1021%2Fjs960440h" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1997&pages=584-590&issue=5&author=T.+H.+Laveauthor=S.+Dupinauthor=C.+Schmittauthor=R.+C.+Chouauthor=D.+Jaeckauthor=P.+Coassolo&title=Integration+of+in+vitro+data+into+allometric+scaling+to+predict+hepatic+metabolic+clearance+in+man%3A+application+to+10+extensively+metabolized+drugs&doi=10.1021%2Fjs960440h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjs960440h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs960440h%26sid%3Dliteratum%253Aachs%26aulast%3DLave%26aufirst%3DT.%2BH.%26aulast%3DDupin%26aufirst%3DS.%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DR.%2BC.%26aulast%3DJaeck%26aufirst%3DD.%26aulast%3DCoassolo%26aufirst%3DP.%26atitle%3DIntegration%2520of%2520in%2520vitro%2520data%2520into%2520allometric%2520scaling%2520to%2520predict%2520hepatic%2520metabolic%2520clearance%2520in%2520man%253A%2520application%2520to%252010%2520extensively%2520metabolized%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1997%26volume%3D86%26issue%3D5%26spage%3D584%26epage%3D590%26doi%3D10.1021%2Fjs960440h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i116"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00742">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61431"></div></div></div></div></div><hr /></hr><p class="last">PXRD scan, DSC, and TGA of <b>34</b>; a csv file containing molecular formula strings. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00742">10.1021/acs.jmedchem.5b00742</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00742/suppl_file/jm5b00742_si_001.pdf">jm5b00742_si_001.pdf (116.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00742/suppl_file/jm5b00742_si_002.csv">jm5b00742_si_002.csv (2.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-14%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00742" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00742" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                990KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996dc8090624fd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
